Difference between revisions of "FLICR"
Line 1: | Line 1: | ||
− | + | {|class="wikitable sortable" style="width:90%;text-align:center" | |
− | + | |- | |
− | == | + | !width="50"|Transcript ID |
− | = | + | !width="50"|Gene ID |
− | + | !width="50"|Symbol | |
− | = | + | !width="50"|Synonyms |
− | + | !width="50"|Functional Mechanism | |
− | + | !width="50"|Biological Process | |
− | + | !width="50"|Disease | |
− | = | + | !width="50"|Mesh Ontology |
− | + | |- | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNG0141612] | |
− | + | |HPVC1 | |
− | + | |PE5L,HPV18E5L | |
− | + | |NA | |
− | + | |pathogenic process | |
− | + | |NA | |
− | + | |NA | |
− | + | |- | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605] | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNG0141720] | |
− | + | |Alpha 250/ Alpha 280 | |
− | + | |NONHSAT104559,lnc-C9orf53-2:1 | |
− | + | |NA | |
− | + | |NA | |
− | + | |NA | |
− | + | |NA | |
− | + | |- | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632] | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNG0096226] | |
− | + | |N4BP2L2-IT2 | |
− | + | |CG030 | |
− | + | |NA | |
− | + | |NA | |
− | + | |NA | |
− | + | |NA | |
− | + | |- | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094] | |
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNG0082161] | |
− | + | |LINC01150 | |
− | + | |2G7,TCONS_00019134 | |
− | + | |NA | |
− | + | |pathogenic process | |
− | + | |Wilms' tumor | |
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNG0032599] | ||
+ | |LINC01587 | ||
+ | |C4orf6,aC1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNG0142220] | ||
+ | |NTT | ||
+ | |NONHSAT115106 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNG0053252] | ||
+ | |RNF217-AS1 | ||
+ | |STL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNG0136795] | ||
+ | |INE2 | ||
+ | |NCRNA00011 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNG0137683] | ||
+ | |INE1 | ||
+ | |NCRNA00010 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNG0141622] | ||
+ | |LINC01565 | ||
+ | |C3orf27,GR6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNG0006924] | ||
+ | |LINC00869 | ||
+ | |KIAA0493 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNG0026312] | ||
+ | |ERC2-IT1 | ||
+ | |C1orf1,C3orf51,Po42 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNG0142509] | ||
+ | |Y RNAs | ||
+ | |lnc-PDIA4-1:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNG0032409] | ||
+ | |NOP14-AS1 | ||
+ | |C4orf10,RES4-24 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNG0142424] | ||
+ | |TncRNA | ||
+ | |NONHSAT022116,AF080092,TSU | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNG0045080] | ||
+ | |SMAD5-AS1 | ||
+ | |SMAD5O,DAMS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant hematopoietic | ||
+ | |Cell Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNG0062672] | ||
+ | |LINC00244 | ||
+ | |C7orf4,NCRNA00244 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |preaxial polydactyly | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNG0055219] | ||
+ | |KIF25-AS1 | ||
+ | |C6orf54,NCRNA00300,HGC6.1.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNG0055207] | ||
+ | |LINC01558 | ||
+ | |C6orf123,LINC01557,HGC6.2,dJ431P23.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNG0055209] | ||
+ | |AFDN-AS1 | ||
+ | |C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNG0135027] | ||
+ | |RFPL3S | ||
+ | |RFPL3-AS1,RFPL3-A, NCRNA00005 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |opitz syndrome | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNG0134830] | ||
+ | |RFPL1S | ||
+ | |RFPL1-AS1,RFPL1-A, NCRNA00006 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNG0141611] | ||
+ | |HCG4B | ||
+ | |HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNG0142009] | ||
+ | |LINC00294 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNG0140599] | ||
+ | |LINC00893 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hunter syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNG0142248] | ||
+ | |PCBP3-OT1 | ||
+ | |PCBP3-OT1,FLJ44028 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNG0141599] | ||
+ | |BPESC1 | ||
+ | |NCRNA00187 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |blepharophimosis syndrome | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNG0141827] | ||
+ | |COPG2IT1 | ||
+ | |CIT1,NCRNA00170,COPG2AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNG0128978] | ||
+ | |LINC00652 | ||
+ | |HSPC072 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNG0108689] | ||
+ | |WASIR2 | ||
+ | |NCRNA00286A | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNG0119601] | ||
+ | |LINC00470 | ||
+ | |C18orf2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |age-related macular degeneration | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNG0141618] | ||
+ | |LINC00588 | ||
+ | |C8orf71,DKFZP434F122 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNG0134754] | ||
+ | |TTC28-AS1 | ||
+ | |TTC28AS,TTC28-AS,KIAA1648 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNG0114754] | ||
+ | |CDRT7 | ||
+ | |NCRNA00025,LINC00025 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNG0114755] | ||
+ | |CDRT8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNG0133887] | ||
+ | |CECR3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNG0133890] | ||
+ | |CECR9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNG0133878] | ||
+ | |HDHD5-AS1 | ||
+ | |CECR4,CECR5-AS1,NCRNA00017 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNG0133878] | ||
+ | |CECR5-AS1 | ||
+ | |NCRNA00017 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNG0029809] | ||
+ | |CLRN1-AS1 | ||
+ | |CLRN1O,UCRP | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |usher syndrome type 3 | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNG0082585] | ||
+ | |TMEM9B-AS1 | ||
+ | |C11orf18 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNG0133586] | ||
+ | |LINC01547 | ||
+ | |C21orf69,C21orf67 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Down syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNG0131587] | ||
+ | |LINC00029 | ||
+ | |C20orf51,NCRNA00029,bA305P22.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNG0141634] | ||
+ | |LINC00529 | ||
+ | |C8orf8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |keratolytic winter erythema | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNG0010403] | ||
+ | |FLVCR1-AS1 | ||
+ | |FLVCR1-DT,LQK1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNG0114969] | ||
+ | |SMCR2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNG0114982] | ||
+ | |SMCR5 | ||
+ | |NCRNA00034 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNG0142361] | ||
+ | |SMCR6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNG0133620] | ||
+ | |LINC00205 | ||
+ | |C21orf86,NCRNA00205, | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNG0132117] | ||
+ | |C21orf91-OT1 | ||
+ | |NCRNA00285,D21S2089E | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNG0132582] | ||
+ | |LINC00307 | ||
+ | |NCRNA00307,D21S2091E | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNG0133549] | ||
+ | |TSPEAR-AS2 | ||
+ | |C21orf90 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNG0133721] | ||
+ | |MCM3AP-AS1 | ||
+ | |C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNG0133144] | ||
+ | |B3GALT5-AS1 | ||
+ | |C21orf88 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNG0133127] | ||
+ | |BRWD1-AS2 | ||
+ | |C21orf87,NCRNA00257,BRWD1-IT2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNG0133621] | ||
+ | |LINC00315 | ||
+ | |C21orf93,NCRNA00315 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNG0133612] | ||
+ | |LINC00334 | ||
+ | |C21orf89,NCRNA00334 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNG0132477] | ||
+ | |LINC00314 | ||
+ | |C21orf94,NCRNA00314 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNG0132261] | ||
+ | |LINC00308 | ||
+ | |C21orf74,NCRNA00308,PRED16 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNG0132537] | ||
+ | |LINC00189 | ||
+ | |C21orf109,NCRNA00189 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNG0042788] | ||
+ | |NCRUPAR | ||
+ | |ncR-uPAR,ncRuPAR,NCRNA00193 | ||
+ | |transcriptional regulation | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNG0133048] | ||
+ | |DSCR10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNG0132984] | ||
+ | |DSCR9 | ||
+ | |NCRNA00038 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNG0142166] | ||
+ | |MDS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myelodysplastic syndrome | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNG0060777] | ||
+ | |ST7-AS2 | ||
+ | |ST7OT2,ST7AS2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNG0060778] | ||
+ | |ST7-OT3 | ||
+ | |ST7OT3,NCRNA00026 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNG0142373] | ||
+ | |ST7-OT4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNG0142372] | ||
+ | |ST7OT | ||
+ | |NONHSAT122926 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNG0074272] | ||
+ | |MIR600HG | ||
+ | |C9orf45,NCRNA00287,GL012,FLJ22161 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNG0006325] | ||
+ | |ATP1A1-AS1 | ||
+ | |C1orf203,ATP1A1OS,MGC16179 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNG0022910] | ||
+ | |SPATA3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNG0024100] | ||
+ | |LINC00852 | ||
+ | |C3orf42,GHRLOS2,NAG73,GHRL-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNG0033002] | ||
+ | |LINC01096 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNG0034486] | ||
+ | |LINC02260 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNG0036896] | ||
+ | |LINC01091 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNG0046004] | ||
+ | |SAP30L-AS1 | ||
+ | |FLJ38109,GALNT10-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNG0046927] | ||
+ | |PRR7-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNG0047338] | ||
+ | |LINC01622 | ||
+ | |TCONS_00011202 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNG0053588] | ||
+ | |LINC01312 | ||
+ | |MGC34034 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNG0064240] | ||
+ | |EXTL3-AS1 | ||
+ | |C8orf50 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNG0065979] | ||
+ | |C8orf34-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNG0074139] | ||
+ | |PSMD5-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNG0078227] | ||
+ | |LINC01553 | ||
+ | |C10orf40,AC023904.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNG0084463] | ||
+ | |LINC00301 | ||
+ | |C11orf64,NCRNA00301,MGC39681 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNG0119722] | ||
+ | |DLGAP1-AS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNG0123001] | ||
+ | |CIRBP-AS1 | ||
+ | |C19orf23,MGC39338 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNG0124987] | ||
+ | |LINC01785 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNG0127139] | ||
+ | |LINC01869 | ||
+ | |MGC45922 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNG0131262] | ||
+ | |LINC01711 | ||
+ | |MGC4294 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNG0141311] | ||
+ | |FAM41AY1 | ||
+ | |FAM41AY | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNG0045020] | ||
+ | |C5orf66-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNG0083517] | ||
+ | |CSTF3-AS1 | ||
+ | |CSTF3-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNG0014289] | ||
+ | |CYP1B1-AS1 | ||
+ | |C2orf58,MGC34824 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNG0025315] | ||
+ | |ENTPD3-AS1 | ||
+ | |FLJ36665 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNG0071511] | ||
+ | |FAM27E3 | ||
+ | |MGC42630 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNG0000046] | ||
+ | |FAM41C | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNG0007223] | ||
+ | |FLG-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNG0105871] | ||
+ | |GABPB1-IT1 | ||
+ | |FLJ10038 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNG0123950] | ||
+ | |ILF3-AS1 | ||
+ | |ILF3-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNG0097943] | ||
+ | |LINC00347 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNG0004105] | ||
+ | |LINC00466 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNG0022951] | ||
+ | |LINC00471 | ||
+ | |C2orf52,MGC43122 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNG0119752] | ||
+ | |LINC00526 | ||
+ | |C18orf18,MGC17515,HsT959 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNG0106873] | ||
+ | |LINC00593 | ||
+ | |C15orf50,MGC42951 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNG0022320] | ||
+ | |LINC00608 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNG0104144] | ||
+ | |LINC00638 | ||
+ | |MGC23270 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNG0124410] | ||
+ | |LINC00661 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNG0125113] | ||
+ | |LINC00662 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNG0024755] | ||
+ | |LINC00692 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNG0075805] | ||
+ | |LINC00705 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNG0118878] | ||
+ | |LINC00868 | ||
+ | |C17orf52 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNG0062275] | ||
+ | |LINC00996 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNG0089327] | ||
+ | |LINC01252 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNG0113283] | ||
+ | |LINC02135 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNG0018445] | ||
+ | |NIFK-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNG0008972] | ||
+ | |SMG7-AS1 | ||
+ | |DKFZP564C196 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNG0113528] | ||
+ | |SNAI3-AS1 | ||
+ | |MGC23284 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNG0103442] | ||
+ | |SNHG10 | ||
+ | |C14orf62,FLJ40557,NCRNA00063,LINC00063 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNG0109122] | ||
+ | |ZNF205-AS1 | ||
+ | |MGC3771 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNG0009820] | ||
+ | |LINC00260 | ||
+ | |C1orf217,NCRNA00260,MGC5457 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNG0000511] | ||
+ | |LINC00337 | ||
+ | |C1orf211,NCRNA00337,MGC40168 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNG0076905] | ||
+ | |WAC-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNG0077486] | ||
+ | |LINC00839 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNG0089110] | ||
+ | |LINC00612 | ||
+ | |C12orf33,MGC40170,FLJ41814 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNG0124755] | ||
+ | |LINC00663 | ||
+ | |MGC39821 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNG0130611] | ||
+ | |LINC00494 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNG0039733] | ||
+ | |LINC01019 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNG0057380] | ||
+ | |LINC00265 | ||
+ | |NCRNA00265,NCRNA00265-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNG0062824] | ||
+ | |LINC00689 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNG0068847] | ||
+ | |LINC01591 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNG0072666] | ||
+ | |LINC01501 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNG0137712] | ||
+ | |LINC01560 | ||
+ | |CXorf24 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNG0045051] | ||
+ | |LINC01959 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNG0110333] | ||
+ | |LINC02175 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNG0064321] | ||
+ | |LINC02209 | ||
+ | |FAM183CP | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNG0107406] | ||
+ | |LINGO1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNG0119342] | ||
+ | |MAFG-AS1 | ||
+ | |MAFG-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNG0139326] | ||
+ | |MORF4L2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNG0029035] | ||
+ | |NPHP3-AS1 | ||
+ | |NCRNA00119 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNG0062543] | ||
+ | |PAXIP1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNG0082091] | ||
+ | |TOLLIP-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNG0113198] | ||
+ | |LINC00311 | ||
+ | |TMEM148,NCRNA00311,MGC22001 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNG0069500] | ||
+ | |ZNF252P-AS1 | ||
+ | |C8orf77 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNG0001624] | ||
+ | |ZNF436-AS1 | ||
+ | |C1orf213,FLJ90508 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNG0029047] | ||
+ | |BFSP2-AS1 | ||
+ | |MGC2848 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNG0032263] | ||
+ | |CTBP1-AS1 | ||
+ | |C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNG0039444] | ||
+ | |EXOC3-AS1 | ||
+ | |C5orf55 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNG0049246] | ||
+ | |HCG27 | ||
+ | |bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNG0067505] | ||
+ | |BAALC-AS2 | ||
+ | |C8orf56,BAALCOS,MGC39526 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNG0062877] | ||
+ | |FAM87A | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNG0078365] | ||
+ | |JMJD1C-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNG0092957] | ||
+ | |ATP2B1-AS1 | ||
+ | |LINC00936 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNG0093183] | ||
+ | |CEP83-AS1 | ||
+ | |CEP83-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNG0107054] | ||
+ | |HEXA-AS1 | ||
+ | |C15orf34,FLJ13315 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNG0141598] | ||
+ | |BIN3-IT1 | ||
+ | |FLJ14107 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNG0141601] | ||
+ | |CSNK1G2-AS1 | ||
+ | |C19orf34,MGC39696 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNG0141619] | ||
+ | |LINC00634 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNG0141621] | ||
+ | |LINC00685 | ||
+ | |CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNG0141626] | ||
+ | |SHANK2-AS3 | ||
+ | |C11orf76 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNG0142188] | ||
+ | |NCBP2-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNG0141613] | ||
+ | |KCNIP4-IT1 | ||
+ | |NCRNA00099,UM9-5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNG0141971] | ||
+ | |GTSCR1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Gilles de la Tourette syndrome | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNG0008917] | ||
+ | |LINC00272 | ||
+ | |C1orf120,NCRNA00272,RP1-223H12.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNG0141348] | ||
+ | |TTTY9B | ||
+ | |NCRNA00132 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNG0142270] | ||
+ | |Prion-associated RNAs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prion disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNG0062567] | ||
+ | |BLACE | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute B lymphoblastic leukemias | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNG0028877] | ||
+ | |H1FX-AS1 | ||
+ | |C3orf47,FLJ34151 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNG0089868] | ||
+ | |LINC00477 | ||
+ | |C12orf67,FLJ32894,FAM191B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNG0133923] | ||
+ | |LINC00528 | ||
+ | |C22orf37,FLJ40542 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNG0140941] | ||
+ | |ASMTL-AS1 | ||
+ | |CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNG0106820] | ||
+ | |ANP32A-IT1 | ||
+ | |C15orf28,NCRNA00321,FLJ11722,HsT18971 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNT0289370] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNG0010128] | ||
+ | |MIR29B2CHG | ||
+ | |C1orf132,FLJ35650 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNG0007497] | ||
+ | |RUSC1-AS1 | ||
+ | |C1orf104,FLJ35976 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNG0040236] | ||
+ | |LINC01194 | ||
+ | |CT49,TAG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNG0103838] | ||
+ | |DIO3OS | ||
+ | |C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNG0057178] | ||
+ | |NPSR1-AS1 | ||
+ | |AAA1,IMAGE:4827585 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNG0035535] | ||
+ | |LINC00575 | ||
+ | |C4orf11 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNG0065537] | ||
+ | |LINC01602 | ||
+ | |T1560 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNG0035768] | ||
+ | |FAM13A-AS1 | ||
+ | |FAM13A1OS,FAM13AOS,NCRNA00039 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNG0072891] | ||
+ | |MIRLET7DHG | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNG0074353] | ||
+ | |MIR181A2HG | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNG0035624] | ||
+ | |WDFY3-AS2 | ||
+ | |C4orf12,NCRNA00247,FBI4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNG0073990] | ||
+ | |PAPPA-AS1 | ||
+ | |PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNG0065020] | ||
+ | |LINC00293 | ||
+ | |BEYLA | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNG0014614] | ||
+ | |SIX3-AS1 | ||
+ | |SIX3OS | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNG0101546] | ||
+ | |OTX2-AS1 | ||
+ | |OTX2OS1 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNG0030360] | ||
+ | |LINC01192 | ||
+ | |CT64 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNG0104394] | ||
+ | |LINC01193 | ||
+ | |CT60,LOC348120 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNG0141779] | ||
+ | |C1QTNF9B-AS1 | ||
+ | |PCOTH | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNG0141738] | ||
+ | |ATP6V1G2-DDX39B | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |dilated cardiomyopathy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNG0141609] | ||
+ | |FAM226B | ||
+ | |CXorf50B,NCRNA00246B,LINC00246B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNG0133590] | ||
+ | |LINC00163 | ||
+ | |C21orf134,NCRNA00163,NLC1-A,NLC1A | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |narcolepsy | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNG0141616] | ||
+ | |LINC00165 | ||
+ | |C21orf135,NCRNA00165,NLC1-B | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNG0142412] | ||
+ | |TEA-ncRNAs | ||
+ | |ENSG00000251002 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNG0133403] | ||
+ | |LINC00322 | ||
+ | |C21orf136,NCRNA00322,FLJ16545 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNG0141856] | ||
+ | |DHFR upstream transcripts | ||
+ | |DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNG0141642] | ||
+ | |21A | ||
+ | |ncRNA 21A,NONHSAT128494 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNG0080181] | ||
+ | |TLX1NB | ||
+ | |TD1,TDI,APT-B7 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemogenesis | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNG0141777] | ||
+ | |C15orf2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNG0142212] | ||
+ | |NPAP1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNG0104530] | ||
+ | |PWRN2 | ||
+ | |NCRNA00199 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNG0104528] | ||
+ | |PWRN1 | ||
+ | |NCRNA00198 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNG0127793] | ||
+ | |MIMT1 | ||
+ | |MIM1,NCRNA00067,LINC00067 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNG0000682] | ||
+ | |MIR34AHG | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNG0049203] | ||
+ | |LINC02570 | ||
+ | |XXbac-BPG27H4.8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |MHC-associated diseases | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNG0142292] | ||
+ | |RNY1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNG0129114] | ||
+ | |NKX2-2-AS1 | ||
+ | |NKX2-2AS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNG0142266] | ||
+ | |PR antisense transcripts | ||
+ | |FJ515872.1,NONHSAT023851 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNG0086714] | ||
+ | |PGR-AS1,PR antisense transcripts | ||
+ | |AT1,AT2,AT3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNG0141722] | ||
+ | |anti-NOS2A | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |meningioma;glioblastoma | ||
+ | |Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNG0141802] | ||
+ | |CDKN1A-AS1 | ||
+ | |p21NAT | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNT0289166] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNG0103805] | ||
+ | |MEG9 | ||
+ | |LINC00584 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNG0055114] | ||
+ | |RPS6KA2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNG0073983] | ||
+ | |PAPPA-AS2 | ||
+ | |AGU1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNG0127785] | ||
+ | |ZIM2-AS1 | ||
+ | |ZIM2as | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNG0141939] | ||
+ | |Evf2 | ||
+ | |Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNG0134495] | ||
+ | |ADORA2A-AS1 | ||
+ | |C22orf45,FLJ34651 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNG0142261] | ||
+ | |POU5F1P4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNG0142148] | ||
+ | |LSINCT1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNG0142149] | ||
+ | |LSINCT10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNG0142150] | ||
+ | |LSINCT11 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNG0142151] | ||
+ | |LSINCT12 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNG0142152] | ||
+ | |LSINCT2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNG0142153] | ||
+ | |LSINCT3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNG0142154] | ||
+ | |LSINCT4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNG0142156] | ||
+ | |LSINCT6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNG0142157] | ||
+ | |LSINCT7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNG0142158] | ||
+ | |LSINCT8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNG0142159] | ||
+ | |LSINCT9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNG0141791] | ||
+ | |CAR Intergenic 10 | ||
+ | |FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNG0142147] | ||
+ | |LRRC3DN | ||
+ | |C21orf30,DKFZP434C128 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNG0129985] | ||
+ | |SNHG11 | ||
+ | |C20orf198,LINC00101,NCRNA00101 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |obesity | ||
+ | |Nutritional and Metabolic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNG0141995] | ||
+ | |KRASP1 | ||
+ | |NONHSAT113225,ENSG00000220635 | ||
+ | |ceRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNG0003376] | ||
+ | |CYP4A22-AS1 | ||
+ | |ncRNA-a3 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNG0013045] | ||
+ | |LINC00570 | ||
+ | |ncRNA-a5 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNG0003381] | ||
+ | |LINC00853 | ||
+ | |PDZK1IP1-AS1,ncRNA-a4 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNG0142051] | ||
+ | |lincRNA-ROR | ||
+ | |ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNG0141820] | ||
+ | |CHL1-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNG0036316] | ||
+ | |SEC24B-AS1 | ||
+ | |1/2-SBSRNA4 | ||
+ | |siRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNG0142252] | ||
+ | |PDZRN3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNG0142352] | ||
+ | |SCAANT1 | ||
+ | |ATXN7-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNG0141709] | ||
+ | |AK123790 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNG0142026] | ||
+ | |LINC01451 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNG0142516] | ||
+ | |ZNF350-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNG0141960] | ||
+ | |GADD45G | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pituitary adenoma | ||
+ | |Endocrine System Diseases;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNG0043357] | ||
+ | |TMEM161B-AS1 | ||
+ | |AK082072,linc-POLR3G-8,ENSG00000247828 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNG0141851] | ||
+ | |DAPK1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNG0142163] | ||
+ | |MAP3K14 | ||
+ | |MAP3K14 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNG0142265] | ||
+ | |PPP3CB | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNG0072477] | ||
+ | |DAPK1-IT1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNG0041256] | ||
+ | |GDNF-AS1 | ||
+ | |GDNFOS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNG0014093] | ||
+ | |BIRC6-AS2 | ||
+ | |megamind | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNG0014085] | ||
+ | |BIRC6-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNG0116623] | ||
+ | |LINC00854 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNG0142447] | ||
+ | |uc.73 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNG0141956] | ||
+ | |FR0257520 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNG0142219] | ||
+ | |NRG1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNG0141804] | ||
+ | |CDKN2B-AS11 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |stroke | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNG0141805] | ||
+ | |CDKN2B-AS12 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNG0141806] | ||
+ | |CDKN2B-AS13 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |plexiform neurofibroma | ||
+ | |Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNG0141812] | ||
+ | |CDKN2B-AS7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNG0141941] | ||
+ | |FADS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lipid metabolism disorder | ||
+ | |Nutritional and Metabolic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNG0141813] | ||
+ | |CDKN2B-AS8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNG0141811] | ||
+ | |CDKN2B-AS6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNG0141814] | ||
+ | |CDKN2B-AS9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNG0141803] | ||
+ | |CDKN2B-AS10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |stroke | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNG0031716] | ||
+ | |ENST00000456816 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNG0142136] | ||
+ | |LOC389332 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNG0142421] | ||
+ | |TMEM72 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNG0141756] | ||
+ | |BC029135 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNG0142489] | ||
+ | |X91348 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNG0141809] | ||
+ | |CDKN2B-AS4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNG0141807] | ||
+ | |CDKN2B-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |coronary heart disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNG0141808] | ||
+ | |CDKN2B-AS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intracranial aneurysm | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNG0141810] | ||
+ | |CDKN2B-AS5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNG0142434] | ||
+ | |T-UCRs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNG0141645] | ||
+ | |51A | ||
+ | |NA | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNG0142278] | ||
+ | |RAB4B-EGLN2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNG0142282] | ||
+ | |RERT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNG0129088] | ||
+ | |LINC00237 | ||
+ | |NCRNA00237 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |macrocephaly;obesity | ||
+ | |Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNG0130081] | ||
+ | |LINC01370 | ||
+ | |HI-LNC25,HILNC25 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNG0046884] | ||
+ | |LINC01574 | ||
+ | |HI-LNC12,TCONS_00009551 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNG0142274] | ||
+ | |PTHLH | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |brachydactyly | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNG0091306] | ||
+ | |CISTR | ||
+ | |CISTR-ACT,CISTRACT,re52431 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |brachydactyly | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNG0141977] | ||
+ | |HELLPAR | ||
+ | |LINC-HELLP | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |HELLP syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNG0142019] | ||
+ | |LINC01125 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |uremia | ||
+ | |Male Urogenital Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNG0141659] | ||
+ | |AC002511.1 | ||
+ | |LINC01531 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNG0141724] | ||
+ | |AP000688.29 | ||
+ | |AP000688.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNG0141947] | ||
+ | |FFAR2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNG0142337] | ||
+ | |RP4-620F22.3 | ||
+ | |AC099063.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNG0142342] | ||
+ | |RP5-843L14.1 | ||
+ | |LINC01716 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |enterovirus 71 infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNG0140617] | ||
+ | |MAGEA8-AS1 | ||
+ | |RP5-869M20.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNG0094159] | ||
+ | |LHX5-AS1 | ||
+ | |locus4010 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNG0023597] | ||
+ | |CAPN10-AS1 | ||
+ | |CAPN10-DT,locus959 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNG0076463] | ||
+ | |STAM-AS1 | ||
+ | |locus3182 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNG0070806] | ||
+ | |PTENP1-AS | ||
+ | |PTENpg1-asRNA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNG0141677] | ||
+ | |AF116616 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNG0141704] | ||
+ | |AK094838 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNG0141735] | ||
+ | |ASLNC00339 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNG0141744] | ||
+ | |BC002350 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNG0141766] | ||
+ | |BC091525 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNG0141767] | ||
+ | |BE503655 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNG0141868] | ||
+ | |ENO1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNG0141950] | ||
+ | |FKBP10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNG0142179] | ||
+ | |MYHAS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNG0142100] | ||
+ | |LncRNA-LALR1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNT0289934] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNG0142049] | ||
+ | |lincRNA-LALR1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNG0043527] | ||
+ | |NR2F1-AS1 | ||
+ | |FLJ42709 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNG0141824] | ||
+ | |CK19 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNG0142058] | ||
+ | |Llme23 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNG0141668] | ||
+ | |AC096655.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNG0137593] | ||
+ | |MIR222HG | ||
+ | |Lnc-Ang362 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Ang II-associated cardiovascular disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNG0032541] | ||
+ | |STX18-AS1 | ||
+ | |LOC100507266 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial septal defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNG0141964] | ||
+ | |GHSR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNT0289850] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNG0141965] | ||
+ | |GHSROS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNG0072923] | ||
+ | |PCAT7 | ||
+ | |PCAN-R2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNG0141817] | ||
+ | |CES1P1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNG0142007] | ||
+ | |LINC00210 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNG0142121] | ||
+ | |LOC100506974 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNG0142334] | ||
+ | |RP3-508I15.14 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNG0142358] | ||
+ | |SLC6A6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNG0142457] | ||
+ | |uc003bgl.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNG0008302] | ||
+ | |LINC00970 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNG0101725] | ||
+ | |SALRNA1 | ||
+ | |SAL-RNA1,XLOC_023166 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNG0106957] | ||
+ | |SALRNA3 | ||
+ | |SAL-RNA3,XLOC_025918 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNG0106960] | ||
+ | |SALRNA2 | ||
+ | |SAL-RNA2,XLOC_025931 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNG0021790] | ||
+ | |GPR1-AS | ||
+ | |GPR1-AS1,GPR1AS | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNG0108743] | ||
+ | |LINC00235 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |anorexia nervosa | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNG0141641] | ||
+ | |1B FGF-antisense transcripts | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometriosis | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNG0142286] | ||
+ | |RNA polymerase III-dependent lncRNAs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse cerebral hypomyelination | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNG0142283] | ||
+ | |REST/CoREST-regulated lncRNAs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Huntington disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNG0141721] | ||
+ | |Alu lncRNAs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |macular degeneration | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNG0142473] | ||
+ | |UCH1LAS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNG0142359] | ||
+ | |SLC7A2-IT1A/B | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |progressive encephalopathy with severe infantile anorexia | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNG0141992] | ||
+ | |Kcna2-AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuropathic pain | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNG0053305] | ||
+ | |NCOA7-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNG0142135] | ||
+ | |LOC389023 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |psychiatric disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNG0084108] | ||
+ | |PTPRJ-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNG0141769] | ||
+ | |BM742401 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNG0049950] | ||
+ | |LINC00951 | ||
+ | |lincRNA-uc003opf.1,FLJ41649 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNG0142245] | ||
+ | |PAWR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNG0142379] | ||
+ | |T-ALL-R-LncR1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNG0141714] | ||
+ | |AK130977 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNG0141740] | ||
+ | |AX746718 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNG0141853] | ||
+ | |DDR2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNG0142118] | ||
+ | |LOC100131831 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNG0142259] | ||
+ | |POT1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNG0142368] | ||
+ | |SNORA17B | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNG0099625] | ||
+ | |GAS6-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNG0141953] | ||
+ | |FMR5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |fragile X syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNG0100287] | ||
+ | |FOXG1-AS1 | ||
+ | |FOXG1-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism spectrum disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNG0142378] | ||
+ | |SYNGAP1-AS1 | ||
+ | |SYNGAP1-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism spectrum disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNG0142291] | ||
+ | |RNase MRP | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cartilage hair hypoplaisia | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNG0105872] | ||
+ | |GABPB1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNG0075528] | ||
+ | |IDI2-AS1 | ||
+ | |C10orf110,IDI2-A,HT009,Em:AC022536.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNG0044716] | ||
+ | |LINC01184 | ||
+ | |FLJ33630 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNG0142223] | ||
+ | |OGT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNG0142192] | ||
+ | |ncNRFR | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNG0142452] | ||
+ | |uc001lsz | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;prostate cancer;liver cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNG0021008] | ||
+ | |LINC01090 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |post-traumatic stress disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNT0289746] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNG0141861] | ||
+ | |DQ786227 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNG0142096] | ||
+ | |lncRNA-DQ786227 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNG0141991] | ||
+ | |JADRR | ||
+ | |LINC00915,lncRNA-JADE | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNG0142369] | ||
+ | |SOX2OT-S1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNT0290404] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNG0142519] | ||
+ | |SOX2OT-S2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNG0141985] | ||
+ | |HOXA13 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNG0037661] | ||
+ | |SMAD1-AS1 | ||
+ | |ENST00000513542 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ventricular septal defects | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNG0041545] | ||
+ | |FGF10-AS1 | ||
+ | |RP11-473L15.2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |ventricular septal defects | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNG0142433] | ||
+ | |TUC339 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNG0141934] | ||
+ | |ERICD | ||
+ | |LINC01130,TCONS_00014875,ERIC | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |retinoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNG0141730] | ||
+ | |ARA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNG0141937] | ||
+ | |ESCCAL-5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNG0142189] | ||
+ | |ncC11orf49 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNG0142191] | ||
+ | |ncHDAC5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNG0142193] | ||
+ | |ncRAB31 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNG0142195] | ||
+ | |ncSRPK1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNG0008819] | ||
+ | |OVAAL | ||
+ | |LINC01131,OVAL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNG0141999] | ||
+ | |LALR | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNG0141816] | ||
+ | |CEACAMP8 | ||
+ | |CEACAMP8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pre-eclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNG0142133] | ||
+ | |LOC284100 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pre-eclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNG0142138] | ||
+ | |LOC391533 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pre-eclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNG0091365] | ||
+ | |LINC01154 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNG0094870] | ||
+ | |THRIL | ||
+ | |BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Kawasaki disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNG0098080] | ||
+ | |RNF219-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |blood pressure | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNG0141676] | ||
+ | |AF086415 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNG0141698] | ||
+ | |AK056098 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNG0141705] | ||
+ | |AK095147 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNG0141715] | ||
+ | |AK294004 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNG0141727] | ||
+ | |AP5M1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNG0142225] | ||
+ | |ORAOV1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNG0142325] | ||
+ | |RP1-179N16.3 | ||
+ | |Z95152.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNG0017545] | ||
+ | |LINC01159 | ||
+ | |linc-Brn1b | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNG0137988] | ||
+ | |KANTR | ||
+ | |KDM5C adjacent non-coding transcript | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNG0142020] | ||
+ | |LINC01157 | ||
+ | |TCONS_00010378,linc-Enc1 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNG0087416] | ||
+ | |APOA1-AS | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNG0142515] | ||
+ | |ZNF300P1 | ||
+ | |ZNF300P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNG0141865] | ||
+ | |EEF1A1P9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNG0141911] | ||
+ | |ENST00000318333 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNG0141912] | ||
+ | |ENST00000374520 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNG0141915] | ||
+ | |ENST00000422362 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNG0141923] | ||
+ | |ENST00000455912 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNG0141924] | ||
+ | |ENST00000456007 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNG0141925] | ||
+ | |ENST00000456185 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNG0141932] | ||
+ | |EPOR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNG0142028] | ||
+ | |LINC01550 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNG0142257] | ||
+ | |PMS2P5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNG0142384] | ||
+ | |TCF7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNG0142460] | ||
+ | |uc003jfz.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNG0018112] | ||
+ | |LINC01191 | ||
+ | |VIN,lnc-ACTR3 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |influenza A virus | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNG0140165] | ||
+ | |FIRRE | ||
+ | |LINC01200 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNG0046284] | ||
+ | |LINC01202 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNG0142386] | ||
+ | |TCONS_00014512 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNG0142387] | ||
+ | |TCONS_00014978 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNG0142389] | ||
+ | |TCONS_00024647 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNG0142394] | ||
+ | |TCONS_00090092_MEG3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNG0142395] | ||
+ | |TCONS_l2_00000179 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNG0142398] | ||
+ | |TCONS_l2_00004424 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNG0142399] | ||
+ | |TCONS_l2_00006843 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNG0142404] | ||
+ | |TCONS_l2_00014091 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNG0142406] | ||
+ | |TCONS_l2_00018070 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNG0142407] | ||
+ | |TCONS_l2_00020565 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNG0142408] | ||
+ | |TCONS_l2_00021262 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNG0142411] | ||
+ | |TCONS_l2_00030560 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatoblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNG0142042] | ||
+ | |lincRNA1611 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNG0142264] | ||
+ | |Ppp3ca | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNG0142380] | ||
+ | |TC0100223 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNG0142382] | ||
+ | |TC0101686 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNG0142383] | ||
+ | |TC1500845 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNG0128589] | ||
+ | |LAMP5-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNG0112916] | ||
+ | |LINC01228 | ||
+ | |lincRNA-DYNLRB2-2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNG0077963] | ||
+ | |SGMS1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNG0126202] | ||
+ | |PCAT19 | ||
+ | |LOC100505495,LINC01190 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNG0115583] | ||
+ | |ABHD15-AS1 | ||
+ | |linc-TP53I13,lnc-TP53I13 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiometabolic disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNG0069570] | ||
+ | |LINC01230 | ||
+ | |linc-DMRT2,lnc-DRMT2,TCONS_00015639 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiometabolic disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNG0120583] | ||
+ | |PCAT18 | ||
+ | |LINC01092 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNG0142144] | ||
+ | |LOC728606 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNG0094171] | ||
+ | |ENST00000547963.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNG0141917] | ||
+ | |ENST00000435885 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |oesophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNG0098920] | ||
+ | |LINC01232 | ||
+ | |FLJ41590,TCONS_00021520 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNG0124979] | ||
+ | |LINC01233 | ||
+ | |XLOC_013014 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNG0088110] | ||
+ | |SENCR | ||
+ | |FLI1-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |vascular SMC phenotype | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNG0010286] | ||
+ | |LINC00467 | ||
+ | |C1orf97,MGC14801 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNG0068435] | ||
+ | |CASC21 | ||
+ | |LINC01244,CARLo-2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNG0068424] | ||
+ | |CASC19 | ||
+ | |LINC01245,CARLo-6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNG0141869] | ||
+ | |ENSG00000135253.9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNG0141870] | ||
+ | |ENSG00000147753.5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNG0141871] | ||
+ | |ENSG00000196096 | ||
+ | |AC079610.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNG0141872] | ||
+ | |ENSG00000197251.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNG0141873] | ||
+ | |ENSG00000203325 | ||
+ | |AL445248.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNG0141874] | ||
+ | |ENSG00000206129 | ||
+ | |AC006305.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNG0141875] | ||
+ | |ENSG00000215231.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNG0141876] | ||
+ | |ENSG00000215374.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNG0141877] | ||
+ | |ENSG00000215808.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNG0141878] | ||
+ | |ENSG00000226496.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNG0141879] | ||
+ | |ENSG00000229563.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNG0141880] | ||
+ | |ENSG00000230133.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNG0141881] | ||
+ | |ENSG00000230544.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNG0141882] | ||
+ | |ENSG00000231133.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNG0141883] | ||
+ | |ENSG00000231185 | ||
+ | |AC010317.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNG0141884] | ||
+ | |ENSG00000232021.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNG0141885] | ||
+ | |ENSG00000232046.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNG0141886] | ||
+ | |ENSG00000232956.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNG0141887] | ||
+ | |ENSG00000233154.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNG0141888] | ||
+ | |ENSG00000233251 | ||
+ | |AC007743.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNG0141889] | ||
+ | |ENSG00000235285.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNG0141890] | ||
+ | |ENSG00000237036.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNG0141891] | ||
+ | |ENSG00000237548.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNG0141892] | ||
+ | |ENSG00000240453.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNG0141893] | ||
+ | |ENSG00000241269.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNG0141894] | ||
+ | |ENSG00000245910.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNG0141895] | ||
+ | |ENSG00000248176 | ||
+ | |AC109349.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNG0141896] | ||
+ | |ENSG00000249364 | ||
+ | |AC112206.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNG0141897] | ||
+ | |ENSG00000249772 | ||
+ | |AC026427.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNG0141898] | ||
+ | |ENSG00000250195 | ||
+ | |AC109927.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNG0141899] | ||
+ | |ENSG00000250608 | ||
+ | |AC010210.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNG0141900] | ||
+ | |ENSG00000254154 | ||
+ | |AL359075.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNG0141901] | ||
+ | |ENSG00000255471 | ||
+ | |AP001528.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNG0141902] | ||
+ | |ENSG00000256218 | ||
+ | |AC007848.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNG0141903] | ||
+ | |ENSG00000259150.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNG0141904] | ||
+ | |ENSG00000259334.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNG0141905] | ||
+ | |ENSG00000259484.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNG0141906] | ||
+ | |ENSG00000259758.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNG0141908] | ||
+ | |ENSG00000263753.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNG0141909] | ||
+ | |ENSG00000264772 | ||
+ | |AC016876.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNG0141910] | ||
+ | |ENSG00000266952.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNG0141943] | ||
+ | |FAM66B | ||
+ | |FAM66E | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNG0142010] | ||
+ | |LINC00336 | ||
+ | |C6orf227,NCRNA00336 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNG0142014] | ||
+ | |LINC00929 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNG0142021] | ||
+ | |LINC01204 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNG0142027] | ||
+ | |LINC01538 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNG0142030] | ||
+ | |LINC01721 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNG0142031] | ||
+ | |LINC01762 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNG0142032] | ||
+ | |LINC01798 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNG0142362] | ||
+ | |SMIM2-IT1 | ||
+ | |C13orf44-IT1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNG0142431] | ||
+ | |TTTY7 | ||
+ | |CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNT0289872] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNG0141987] | ||
+ | |HTTAS_v1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Huntington disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNG0142290] | ||
+ | |RNA-a | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Opitz-Kaveggia syndrome | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNG0141640] | ||
+ | |116HG | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNG0142435] | ||
+ | |U1 spliceosomal lncRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNG0039360] | ||
+ | |LINC01262 | ||
+ | |TCONS_l2_00021807,RP11-462G22.1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNG0141796] | ||
+ | |CCAT1-L | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNG0142177] | ||
+ | |MT-LIPCAR | ||
+ | |uc022bqs.1,LIPCAR | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |heart disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNG0142056] | ||
+ | |LIPCAR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |heart failure | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNG0096756] | ||
+ | |TUSC8 | ||
+ | |LINC01071,XLOC_010588 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNG0077519] | ||
+ | |LINC01264 | ||
+ | |RP11-124O11.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNG0141848] | ||
+ | |D4Z4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |facioscapulohumeral muscular dystrophy | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNG0141793] | ||
+ | |CARL | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |myocardial infarction | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNG0142038] | ||
+ | |linc-CBR1-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNG0117819] | ||
+ | |WFDC21P | ||
+ | |WAP four-disulfide core domain 21,pseudogene | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |DC dysfunction | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNG0142347] | ||
+ | |RUNX1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute myeloid leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNG0142349] | ||
+ | |RUNXOR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hematopoietic malignancies | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNG0142094] | ||
+ | |lncRNA-CIR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNG0142483] | ||
+ | |VIM2P | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNG0141994] | ||
+ | |KRAS1P | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNG0142169] | ||
+ | |MINA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNG0117279] | ||
+ | |TMEM92-AS1 | ||
+ | |RP11-893F2.9,lncRNA-508851,TCONS_00025237 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNG0054937] | ||
+ | |CAHM | ||
+ | |LINC00468 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNG0141708] | ||
+ | |AK123657 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNG0141774] | ||
+ | |BX648207 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNG0141775] | ||
+ | |BX649059 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNG0141961] | ||
+ | |GAS2L3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNG0141748] | ||
+ | |BC011663 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNG0141982] | ||
+ | |HIV1230 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNG0142160] | ||
+ | |M14574 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNG0142360] | ||
+ | |SLCO5A1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNG0142441] | ||
+ | |uc.341 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNG0142459] | ||
+ | |uc003iqu | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNG0142461] | ||
+ | |uc003tfx | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNG0142065] | ||
+ | |lnc-AL355149.1-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNG0142116] | ||
+ | |lnc-ZNF674-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNG0140423] | ||
+ | |LINC00632 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNG0014134] | ||
+ | |LINC01317 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNG0113279] | ||
+ | |LINC01081 | ||
+ | |TCONS_00024764 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |alveolar capillary dysplasia | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNG0141955] | ||
+ | |FOSB | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNG0141702] | ||
+ | |AK093543 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNG0141847] | ||
+ | |D16366 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNG0141929] | ||
+ | |ENST00000501583 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNT0290273] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNG0142388] | ||
+ | |TCONS_00018278 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNG0142022] | ||
+ | |LINC01374 | ||
+ | |TCONS_00018278 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNG0111452] | ||
+ | |CASC22 | ||
+ | |LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNG0027843] | ||
+ | |LINC00882 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |airway diseases | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNG0008840] | ||
+ | |KIAA1614-AS1 | ||
+ | |RP11-46A10.4 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |airway smooth muscle (ASM) disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNG0067913] | ||
+ | |LINC00536 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |trichorhinophalangeal syndrome | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNG0016063] | ||
+ | |LBX2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNG0071679] | ||
+ | |ENST00000414223 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNG0142127] | ||
+ | |LOC105374631 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNG0142420] | ||
+ | |TMEM179 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNG0142430] | ||
+ | |TSPAN8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNG0142449] | ||
+ | |uc001aka.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNG0142454] | ||
+ | |uc001vjj.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNG0142458] | ||
+ | |uc003erl.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNG0142469] | ||
+ | |uc009wkz.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNG0013204] | ||
+ | |MYCNUT | ||
+ | |MYCNUN,lncUSMycN | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNG0132900] | ||
+ | |LINC01436 | ||
+ | |AP000688.8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Down syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNG0129435] | ||
+ | |MIR663AHG | ||
+ | |RP3-410C9.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |turner syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNG0080498] | ||
+ | |LINC01435 | ||
+ | |RP11-215N21.1,TCONS_00018040 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNG0141789] | ||
+ | |CADM3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNG0141997] | ||
+ | |KRT19P3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNG0142425] | ||
+ | |TNXA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNG0004412] | ||
+ | |ZRANB2-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNG0141860] | ||
+ | |DMTF1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNG0142174] | ||
+ | |MRUL | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNG0089050] | ||
+ | |FAM66C | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNG0132414] | ||
+ | |CYYR1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNG0141650] | ||
+ | |AA174084 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNG0129511] | ||
+ | |ABALON | ||
+ | |INXS | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNG0142485] | ||
+ | |VTRNA2-1 | ||
+ | |CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNG0141734] | ||
+ | |ASK00420 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNG0141864] | ||
+ | |EBIC | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNG0142414] | ||
+ | |TI09485 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNG0142415] | ||
+ | |TI10124 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNG0142416] | ||
+ | |TI13831 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNG0142417] | ||
+ | |TI18318 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNG0142418] | ||
+ | |TI21327 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNG0142419] | ||
+ | |TI22687 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNG0142422] | ||
+ | |TMPOP2 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNG0141685] | ||
+ | |AK021444 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNG0141716] | ||
+ | |AK307796 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNG0141916] | ||
+ | |ENST00000425785 | ||
+ | |SEC63P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNG0141986] | ||
+ | |HOXB-AS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNG0142482] | ||
+ | |URHC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNG0098166] | ||
+ | |LINC01080 | ||
+ | |TCONS_00021856 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNG0141866] | ||
+ | |EFNA3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNG0141913] | ||
+ | |ENST00000395084 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNG0141944] | ||
+ | |FAM83A-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNG0142279] | ||
+ | |RAD1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNG0141700] | ||
+ | |AK056988 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNG0141753] | ||
+ | |BC017743 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNG0142271] | ||
+ | |PRR26 | ||
+ | |C10orf108 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNG0142464] | ||
+ | |uc003yqb.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNG0141790] | ||
+ | |CAI2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNT0289673] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNG0141788] | ||
+ | |CADM1-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNG0142428] | ||
+ | |TSLC1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNG0006378] | ||
+ | |LINC01525 | ||
+ | |lnc-MAN1A2-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNG0051540] | ||
+ | |LINC01526 | ||
+ | |Lnc-FAM46A-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNG0078013] | ||
+ | |LINC01468 | ||
+ | |lnc-MBL2-4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNG0074718] | ||
+ | |LINC01503 | ||
+ | |lnc-PPP2R4-5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tongue squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNG0142083] | ||
+ | |lnc-MBL2-4:3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tongue squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNG0142108] | ||
+ | |lnc-STXBP5-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tongue squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNG0141678] | ||
+ | |AF118081 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNG0141712] | ||
+ | |AK124939 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pulmonary adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNG0142268] | ||
+ | |PRAS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNG0142364] | ||
+ | |SNAR-A1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNG0142044] | ||
+ | |lincRNA-BC2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNG0142045] | ||
+ | |lincRNA-BC4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNG0142046] | ||
+ | |lincRNA-BC5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNG0142047] | ||
+ | |lincRNA-BC8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNG0039551] | ||
+ | |LINC01511 | ||
+ | |RP11-325I22.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNG0142141] | ||
+ | |LOC440905 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNG0039551] | ||
+ | |LINC01511 | ||
+ | |RP11-325I22.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNG0141667] | ||
+ | |AC079776.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNG0141835] | ||
+ | |CTA-363E6.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNG0142016] | ||
+ | |LINC00987 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNG0142300] | ||
+ | |RP11-1C1.7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNG0142312] | ||
+ | |RP11-445K13.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNG0142314] | ||
+ | |RP11-473M20.11 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNG0142328] | ||
+ | |RP11-893F2.6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNG0142332] | ||
+ | |RP13-514E23.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNG0142333] | ||
+ | |RP1-90D4.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNG0142335] | ||
+ | |RP4-575N6.5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNG0142341] | ||
+ | |RP5-826L7.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNG0142493] | ||
+ | |XLOC_003286 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNG0142494] | ||
+ | |XLOC_003405 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNG0142504] | ||
+ | |XLOC_012255 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNG0142171] | ||
+ | |MIR21 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNG0141736] | ||
+ | |ASncmtRNAs | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNG0022090] | ||
+ | |LINC01614 | ||
+ | |LCAL4,TCONS_00003105 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNG0142097] | ||
+ | |lncRNA-FER1L4 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNG0142131] | ||
+ | |LOC283177 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNG0134860] | ||
+ | |HORMAD2-AS1 | ||
+ | |MTMR3-AS1,NONHSAG033653 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 1 diabetes;bowel disease | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNG0142487] | ||
+ | |WNT4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometriosis | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNG0141655] | ||
+ | |AB074278 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNG0142281] | ||
+ | |RCCRT1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNG0043862] | ||
+ | |LINC00491 | ||
+ | |BC008363 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNT0289632] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNG0141747] | ||
+ | |BC008363 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNG0141973] | ||
+ | |H1.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNG0142011] | ||
+ | |LINC00582 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNG0141635] | ||
+ | |LINC01537 | ||
+ | |RP11-169D4.1-001 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNG0141666] | ||
+ | |AC026166.2 | ||
+ | |MTCO1P5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNG0142299] | ||
+ | |RP11-169D4.1-001 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNG0141660] | ||
+ | |AC006050.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNG0141671] | ||
+ | |AC138128.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNG0141933] | ||
+ | |ERCC1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNG0142176] | ||
+ | |MT1DP | ||
+ | |MT1DP | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNG0141693] | ||
+ | |AK023096 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Wilmsâ tumor;uterine leiomyomas | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNG0003560] | ||
+ | |LINC01562 | ||
+ | |RP11-296A18.3 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNG0141682] | ||
+ | |AK000974 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNG0141694] | ||
+ | |AK024118 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNG0141760] | ||
+ | |BC040204 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNG0142436] | ||
+ | |U79277 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNG0141984] | ||
+ | |HOST2 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNG0135509] | ||
+ | |MGAT3-AS1 | ||
+ | |TapSAKI | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute kidney injury | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNG0141739] | ||
+ | |ATXN7L3B | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNG0142105] | ||
+ | |lnc-SCA7 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNG0142119] | ||
+ | |LOC100287482 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNG0142498] | ||
+ | |XLOC_007697 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNG0142499] | ||
+ | |XLOC_008559 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNG0142500] | ||
+ | |XLOC_009911 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNG0141928] | ||
+ | |ENST00000480739 | ||
+ | |RPL13AP23 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNG0142226] | ||
+ | |OS9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNG0142439] | ||
+ | |uc.283-plus | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNG0051652] | ||
+ | |LINC01611 | ||
+ | |RP1-90L14.1,TCONS_l2_00025430 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diabetic retinopathy | ||
+ | |Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNG0141644] | ||
+ | |2900055J20Rik | ||
+ | |2900055J20Rik | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |left ventricular hypertrophy | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNG0141907] | ||
+ | |ENSG00000261777 | ||
+ | |AC012184.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNG0141733] | ||
+ | |Asb3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiovascular and renal disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNG0141818] | ||
+ | |Chac2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiovascular and renal disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNG0142254] | ||
+ | |Pex11b | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiovascular and renal disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNG0142370] | ||
+ | |Sp5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cardiovascular and renal disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNG0101614] | ||
+ | |PSMA3-AS1 | ||
+ | |FLJ31306 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNG0141639] | ||
+ | |LINC00493 | ||
+ | |LOC388789 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNG0126842] | ||
+ | |CARD8-AS1 | ||
+ | |LOC100505812 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |leukemia and neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNG0030929] | ||
+ | |KCNMB2-AS1 | ||
+ | |RP11-385J1.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNG0141663] | ||
+ | |AC013264.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNG0141972] | ||
+ | |GUCY1B2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNG0142305] | ||
+ | |RP11-385J1.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNG0142331] | ||
+ | |RP1-317E23.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNG0142432] | ||
+ | |TUBA4B | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNG0142490] | ||
+ | |XLOC_000371 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNG0142512] | ||
+ | |Z82214.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNG0141850] | ||
+ | |DALIR | ||
+ | |DALI | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNG0142491] | ||
+ | |XLOC_000620 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |H. pylori-related diseases | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNG0142495] | ||
+ | |XLOC_004122 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |H. pylori-related diseases | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNG0142496] | ||
+ | |XLOC_004562 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |H. pylori-related diseases | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNG0142497] | ||
+ | |XLOC_005912 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |H. pylori-related diseases | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNG0142506] | ||
+ | |XLOC_014388 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |H. pylori-related diseases | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNG0142143] | ||
+ | |LOC652276 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNG0142277] | ||
+ | |R05532 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNG0046752] | ||
+ | |LINC01411 | ||
+ | |RP11-267A15.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNG0142140] | ||
+ | |LOC401317 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNG0141841] | ||
+ | |CTD-2574D22.4 | ||
+ | |AC120114.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNG0142256] | ||
+ | |PMS2L2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNG0142089] | ||
+ | |lncRNA-422 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNG0133454] | ||
+ | |AATBC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNG0141637] | ||
+ | |LINC00974 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNG0042820] | ||
+ | |ZBED3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNG0135958] | ||
+ | |LINC01589 | ||
+ | |CTA-941F9.9,TCONS_00029353 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNG0142025] | ||
+ | |LINC01426 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNG0142456] | ||
+ | |uc002yug.2 | ||
+ | |NA | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNG0142365] | ||
+ | |SNCG | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNT0289949] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNG0142064] | ||
+ | |lnc-AF085935 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNG0142111] | ||
+ | |lnc-uc003wbd | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNG0141674] | ||
+ | |AF085935 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNG0142462] | ||
+ | |uc003wbd | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNG0142213] | ||
+ | |NR_001284 | ||
+ | |TNXA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic thromboembolic pulmonary hypertension | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNG0142442] | ||
+ | |uc.343 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNG0094525] | ||
+ | |NRAV | ||
+ | |DYNLL1-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |influenza A virus | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNG0142255] | ||
+ | |PLEC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic obstructive pulmonary disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNG0142287] | ||
+ | |RNA44121|UCSC-2000-3182 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic obstructive pulmonary disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNG0142288] | ||
+ | |RNA50010|UCSC-9199-1005 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic obstructive pulmonary disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNG0142289] | ||
+ | |RNA58351|CombinedLit_316_550 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic obstructive pulmonary disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNG0141829] | ||
+ | |CR613944 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNG0142048] | ||
+ | |lincRNA-CALCA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNG0142315] | ||
+ | |RP11-501G6.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNG0142323] | ||
+ | |RP11-672F9.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNG0142520] | ||
+ | |C14orf132 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNG0142052] | ||
+ | |lincRNA-TSPAN8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNG0142340] | ||
+ | |RP5-1014O16.1 | ||
+ | |AC244098.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNG0142390] | ||
+ | |TCONS_00026102 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial fibrillation | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNG0142392] | ||
+ | |TCONS_00032546 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial fibrillation | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNG0096978] | ||
+ | |LINC00441 | ||
+ | |RB1-DT,ncRNA-RB1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNG0141776] | ||
+ | |C1401f132 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNG0039030] | ||
+ | |LINC02365 | ||
+ | |LVCAT8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNG0095161] | ||
+ | |ADGRD1-AS1 | ||
+ | |LACAT8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNG0034152] | ||
+ | |LINC02475 | ||
+ | |LVCAT1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNG0141657] | ||
+ | |Abhd11os | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neurodegenerative diseases | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNG0124521] | ||
+ | |BISPR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |virus infection | ||
+ | |Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNG0112910] | ||
+ | |MAFTRR | ||
+ | |linc-MAF-4 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNG0142173] | ||
+ | |MRAK052686 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nonalcoholic fatty liver disease | ||
+ | |Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNG0142336] | ||
+ | |RP4-583P15.10 | ||
+ | |AL121845.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNG0101470] | ||
+ | |KTN1-AS1 | ||
+ | |C14orf33,MYCLo-3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNG0129835] | ||
+ | |DLGAP4-AS1 | ||
+ | |CCAT7 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNG0141797] | ||
+ | |CCAT3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNG0141799] | ||
+ | |CCAT8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNG0142013] | ||
+ | |LINC00659 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNT0289683] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNG0141798] | ||
+ | |CCAT7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNG0141742] | ||
+ | |BALR-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |B cell acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNG0142063] | ||
+ | |lnc-ACACA-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNG0142068] | ||
+ | |lnc-BMP2-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNG0142070] | ||
+ | |lnc-CPN2-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNG0142073] | ||
+ | |lnc-FOXG1-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNG0142075] | ||
+ | |lnc-FZD1-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNG0142077] | ||
+ | |lnc-ITPR2-3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNG0142080] | ||
+ | |lnc-LCP2-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNG0142103] | ||
+ | |lnc-RP3-368B9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNG0142106] | ||
+ | |lnc-SLC30A4-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNG0142107] | ||
+ | |lnc-SPAM1-6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNG0142110] | ||
+ | |lnc-TTC34-3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNG0106856] | ||
+ | |DRAIC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNT0005037] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNG0002618] | ||
+ | |LINC01137 | ||
+ | |LOC728431 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNG0142505] | ||
+ | |XLOC_014172 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNG0142129] | ||
+ | |LOC149086 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNG0142298] | ||
+ | |RP11-160H22.5 | ||
+ | |AL121983.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNG0142060] | ||
+ | |LNC00964-3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNG0141731] | ||
+ | |Arid2-IR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal inflammation | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNG0141831] | ||
+ | |CR619813 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNG0141854] | ||
+ | |DDX6P1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNG0142053] | ||
+ | |lincRNA-ZNF532 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNG0142126] | ||
+ | |LOC105372753 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNG0142128] | ||
+ | |LOC105377769 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNG0142320] | ||
+ | |RP11-58D2.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNG0105101] | ||
+ | |ENST00000434223 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNG0082178] | ||
+ | |ENST00000442037 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNG0088449] | ||
+ | |ENST00000540136 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNG0142218] | ||
+ | |NR_038125 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNG0142251] | ||
+ | |PDLIM3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNG0142450] | ||
+ | |uc001gch.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNG0142451] | ||
+ | |uc001gzl.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNG0142466] | ||
+ | |uc004bbl.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNG0142484] | ||
+ | |VNN2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNG0141692] | ||
+ | |AK022798 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNG0141778] | ||
+ | |C1orf74 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNG0141717] | ||
+ | |AKR7L | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNG0141826] | ||
+ | |COL3A1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNG0141993] | ||
+ | |KCNE2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNG0141751] | ||
+ | |BC015134 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNG0141828] | ||
+ | |CR594506 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNG0142043] | ||
+ | |lincRNA-BBOX1-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNG0132223] | ||
+ | |LINC00320 | ||
+ | |PRED14,FLJ37539 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |cortical white matter | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNG0141938] | ||
+ | |EVADR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | ||
+ | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNT0289944] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNG0142059] | ||
+ | |Lnc_bc060912 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNG0142067] | ||
+ | |lnc-bc060912 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNG0141728] | ||
+ | |APF | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |myocardial infarction | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNG0141732] | ||
+ | |AS Uchl1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNG0099739] | ||
+ | |LINC01296 | ||
+ | |FLJ39632 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNG0142518] | ||
+ | |ZXF2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNG0142228] | ||
+ | |P14695 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNG0142229] | ||
+ | |P16984 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNG0142230] | ||
+ | |P19780 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNG0142231] | ||
+ | |P23099 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNG0142232] | ||
+ | |P24363 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNG0142233] | ||
+ | |P28210 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNG0142235] | ||
+ | |P33863 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNG0142236] | ||
+ | |P4091 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNG0142237] | ||
+ | |P6391 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNG0142238] | ||
+ | |P6488 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNG0142239] | ||
+ | |P700 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNG0142240] | ||
+ | |P8611 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNG0142241] | ||
+ | |P8725 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNG0142242] | ||
+ | |P8860 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNG0142243] | ||
+ | |P9745 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNG0044864] | ||
+ | |TH2LCRR | ||
+ | |TH2-LCR | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |allergic asthma | ||
+ | |Respiratory Tract Diseases;Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNG0142079] | ||
+ | |lnc-LCE5A-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal cancer;head and neck squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNG0026441] | ||
+ | |FAM3D-AS1 | ||
+ | |lnc-KCTD6-3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | ||
+ | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNG0141958] | ||
+ | |FRLnc1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNG0117109] | ||
+ | |ENST00000575202 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNG0089220] | ||
+ | |ENST00000539009 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNG0089242] | ||
+ | |ENST00000544591 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNG0141867] | ||
+ | |EHHADH-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNG0141927] | ||
+ | |ENST00000468960 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNG0142391] | ||
+ | |TCONS_00026506 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNG0091595] | ||
+ | |LRP1-AS | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNG0015125] | ||
+ | |LINC01122 | ||
+ | |FLJ30838,AC007092.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNG0141680] | ||
+ | |AI364715 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNG0142036] | ||
+ | |LINC0949 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |systemic lupus erythematosus | ||
+ | |Immune System Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNG0141795] | ||
+ | |CCAL | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNG0077354] | ||
+ | |LINC00993 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNG0141926] | ||
+ | |ENST00000460164 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |triple-negative breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNG0142397] | ||
+ | |TCONS_l2_00003938 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |triple-negative breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNG0142003] | ||
+ | |LGALS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNG0142078] | ||
+ | |lnc-KCMF1-2:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNG0142082] | ||
+ | |lnc-LLPH-2:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNG0142086] | ||
+ | |lnc-PLA2R1-1:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNG0142087] | ||
+ | |lnc-PSD4-1:14 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNG0142181] | ||
+ | |n335550 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNG0142185] | ||
+ | |n340790 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNG0142187] | ||
+ | |n386477 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNG0142401] | ||
+ | |TCONS_l2_00010365 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNT0288944] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNG0129184] | ||
+ | |ENST00000422494 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNG0038513] | ||
+ | |LINC01612 | ||
+ | |RP11-789C1.1,TCONS_00008319 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNG0141725] | ||
+ | |AP001439.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNG0141786] | ||
+ | |CACNAICAS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNG0141968] | ||
+ | |GS1-5L10.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNT0289875] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNG0141990] | ||
+ | |INTS7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNG0142180] | ||
+ | |MYLK-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNG0142272] | ||
+ | |PRSS21 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNG0142317] | ||
+ | |RP11-528G1.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNG0142322] | ||
+ | |RP11-643M14.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNG0142324] | ||
+ | |RP11-789C1.1 | ||
+ | |LINC01612 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNG0142429] | ||
+ | |TSNAX-DISC1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNG0142501] | ||
+ | |XLOC_010235 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNG0141673] | ||
+ | |AF075041 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNG0141679] | ||
+ | |AF339813 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNG0141690] | ||
+ | |AK022029 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNG0141691] | ||
+ | |AK022159 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNG0141719] | ||
+ | |AL389956 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNG0141755] | ||
+ | |BC023629 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNG0142211] | ||
+ | |NONHSAT125629 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNG0142508] | ||
+ | |XR_250621.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNG0033002] | ||
+ | |ENST00000503938 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |triple-negative breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNG0142200] | ||
+ | |NONHSAT012762 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |triple-negative breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNG0023952] | ||
+ | |LMCD1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute kidney injury | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNG0142041] | ||
+ | |linc-PXN-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNG0142396] | ||
+ | |TCONS_l2_00001418 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNG0142400] | ||
+ | |TCONS_l2_00008237 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNG0142402] | ||
+ | |TCONS_l2_00011130 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNG0142403] | ||
+ | |TCONS_l2_00013175 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNG0142409] | ||
+ | |TCONS_l2_00022611 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNG0142410] | ||
+ | |TCONS_l2_00022670 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNG0142467] | ||
+ | |uc004bdv.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNG0142478] | ||
+ | |ULK4P2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNG0142057] | ||
+ | |LK4P2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNG0141653] | ||
+ | |AB019562 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hypopharyngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNG0043585] | ||
+ | |ENST00000503710 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNG0141921] | ||
+ | |ENST00000445734 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNG0141922] | ||
+ | |ENST00000448093 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNG0141930] | ||
+ | |ENST00000502941 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNG0142455] | ||
+ | |uc002nbr.3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNT0290348] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNG0142463] | ||
+ | |uc003xut. | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNG0142471] | ||
+ | |uc021re1.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNG0141664] | ||
+ | |AC016745.3 | ||
+ | |AC016745.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNG0142295] | ||
+ | |RP11-128A17.1 | ||
+ | |AC078909.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNG0142492] | ||
+ | |XLOC_001711 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNG0142090] | ||
+ | |lncRNA-AK058003 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNG0034072] | ||
+ | |LINC00682 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNG0089456] | ||
+ | |LINC01559 | ||
+ | |FLJ33810 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Huntington disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNG0141969] | ||
+ | |GSTT1-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |mycobacterium tuberculosis infection | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNG0142093] | ||
+ | |lncRNA-CD244 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |tuberculosis infection | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNG0068014] | ||
+ | |SAMD12-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNG0142294] | ||
+ | |RP11-119F7.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNG0142393] | ||
+ | |TCONS_00068220 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNG0139654] | ||
+ | |DANT1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNG0139662] | ||
+ | |DANT2 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNG0142514] | ||
+ | |ZMAT1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNG0141669] | ||
+ | |AC100865.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |coronary artery disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNG0105273] | ||
+ | |RAD51-AS1 | ||
+ | |TODRA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNG0141858] | ||
+ | |DKFZP434K028 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNG0141745] | ||
+ | |BC002811 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |astrocytoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNG0142502] | ||
+ | |XLOC_010967 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |astrocytoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNG0084672] | ||
+ | |ENST00000545440 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pediatric acute myeloid leukemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNG0133391] | ||
+ | |FRGCA | ||
+ | |LncRNA-AP001631.9 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289611 HSALNT0289611] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289611 HSALNG0141726] | ||
+ | |AP001631.9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNG0142091] | ||
+ | |LncRNA-AP001631.9 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNG0141801] | ||
+ | |CD99P1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |idiopathic pulmonary fibrosis | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNG0074097] | ||
+ | |LINC01613 | ||
+ | |n341773 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |idiopathic pulmonary fibrosis | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNG0141959] | ||
+ | |FTH1P3 | ||
+ | |FTH1P3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNG0141970] | ||
+ | |GTF2IRD2P1 | ||
+ | |GTF2IRD2P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNG0142250] | ||
+ | |PDIA3F | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNG0026562] | ||
+ | |LINC00994 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |inflammatory bowel disease | ||
+ | |Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNG0077290] | ||
+ | |PCAT5 | ||
+ | |LINC01452,TPCAT-10-36067 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNG0054158] | ||
+ | |LUADT1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNG0107133] | ||
+ | |LOXL1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |exfoliation syndrome | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNG0141849] | ||
+ | |DACOR1 | ||
+ | |TCONS_00023265 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNG0114548] | ||
+ | |LINC00675 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNG0070759] | ||
+ | |B4GALT1-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNG0083371] | ||
+ | |LINC01616 | ||
+ | |n341006 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNG0142183] | ||
+ | |n336934 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNG0142355] | ||
+ | |SIRT1-AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNG0142313] | ||
+ | |RP11-457M11.2 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNG0072141] | ||
+ | |LINC01507 | ||
+ | |XLOC_000303 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNG0142018] | ||
+ | |LINC01057 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNG0142029] | ||
+ | |LINC01617 | ||
+ | |C8orf23,NCRNA00249,XLOC_006844 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNG0142130] | ||
+ | |LOC152578 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNG0034426] | ||
+ | |LINC01618 | ||
+ | |LOC152578 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNG0075266] | ||
+ | |NALT1 | ||
+ | |MIR4674HG,LINC01573,TCONS_l2_00029132 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNG0045290] | ||
+ | |MALINC1 | ||
+ | |LINC01024,MA-linc1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |human breast and lung cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNG0142017] | ||
+ | |LINC01024 | ||
+ | |MA-linc1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNG0071043] | ||
+ | |LINC01627 | ||
+ | |RP11-397D12.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNG0015617] | ||
+ | |LINC01628 | ||
+ | |AC007403.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNG0141935] | ||
+ | |ERICH1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNG0142308] | ||
+ | |RP11-397D12.4 | ||
+ | |LINC01627 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNG0102605] | ||
+ | |LINC01629 | ||
+ | |linc-KIAA1737-2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hypoxic and inflammatory renal epithelial injury | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNG0142276] | ||
+ | |PTPRG-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNG0142095] | ||
+ | |lncRNA-DLEU1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNG0142098] | ||
+ | |lncRNA-Hh | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNG0072437] | ||
+ | |GAS1RR | ||
+ | |LncRNA-Hh | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNG0005250] | ||
+ | |CCDC18-AS1 | ||
+ | |ENST00000440778.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNG0132813] | ||
+ | |LINC00649 | ||
+ | |TCONS_00028768 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNG0075966] | ||
+ | |PRKCQ-AS1 | ||
+ | |ENST00000414894.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNG0142318] | ||
+ | |RP11-567G11.1 | ||
+ | |LINC02041 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNG0141920] | ||
+ | |ENST00000438550 | ||
+ | |RPS24P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNG0142198] | ||
+ | |NONHSAG011351 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 1 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNG0142164] | ||
+ | |MCHR2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |psychiatric disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNG0141914] | ||
+ | |ENST00000414355 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cadmium toxicology | ||
+ | |Disorders of Environmental Origin | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNG0142356] | ||
+ | |SKP2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNG0141952] | ||
+ | |FLJ90757 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNG0142132] | ||
+ | |LOC283663 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNG0142134] | ||
+ | |LOC338651 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNG0142247] | ||
+ | |PCATs | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNG0041277] | ||
+ | |EGFLAM-AS1 | ||
+ | |lncRNA-LOWEG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNG0142146] | ||
+ | |LOWEG | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNG0141750] | ||
+ | |BC014579 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNG0141836] | ||
+ | |CTB-167B5.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNG0141978] | ||
+ | |HELLS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNG0142310] | ||
+ | |RP11-401P9.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNG0142367] | ||
+ | |SNHG19 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNG0141672] | ||
+ | |AF070632 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNG0141684] | ||
+ | |AK021443 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNG0141843] | ||
+ | |CTD-3080P12.3 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNG0142102] | ||
+ | |lncRNA-n336928 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNG0141838] | ||
+ | |CTC-523E23.5 | ||
+ | |AC008555.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNG0141839] | ||
+ | |CTD-2246P4.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNG0142170] | ||
+ | |MIR132 | ||
+ | |MIRN132,miRNA132,mir-132 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNG0142304] | ||
+ | |RP11-363G2.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNG0142306] | ||
+ | |RP11-38F22.1 | ||
+ | |LINC02424 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNG0142338] | ||
+ | |RP4-639J15.1 | ||
+ | |AC006967.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNG0142348] | ||
+ | |RUNX1-IT1 | ||
+ | |C21orf96 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNG0053446] | ||
+ | |ENST00000415964 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pediatric acute myeloid leukemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNG0142124] | ||
+ | |LOC101927497 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNG0142071] | ||
+ | |lnc-CYP4A22-2/3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |clear cell renal cell cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNG0142114] | ||
+ | |lnc-ZNF180-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNG0142201] | ||
+ | |NONHSAT037832 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNG0141773] | ||
+ | |BX647187 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNT0288920] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNG0017086] | ||
+ | |CNNM3-DT | ||
+ | |LOC100506036 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNG0141699] | ||
+ | |AK056155 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Loeys-Dietz syndrome | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNG0142172] | ||
+ | |MR1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Loeys-Dietz syndrome | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNG0141658] | ||
+ | |AC002454.1 | ||
+ | |AC002454.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometriosis | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNG0142024] | ||
+ | |LINC01420 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |systemic lupus erythematosus | ||
+ | |Immune System Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNG0141646] | ||
+ | |53BP1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNG0142216] | ||
+ | |NR_024118 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNG0142354] | ||
+ | |SGO1-AS1 | ||
+ | |SGOL1-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNG0127764] | ||
+ | |ZNF667-AS1 | ||
+ | |MORT | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNG0142099] | ||
+ | |lncRNA-HIF2PUT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNG0018617] | ||
+ | |ENST00000433673 | ||
+ | |AC068282.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |polycystic ovary syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNG0008353] | ||
+ | |ENST00000454271 | ||
+ | |AL021940.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |polycystic ovary syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNG0141606] | ||
+ | |ENST00000432431 | ||
+ | |AC023128.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |polycystic ovary syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNG0142033] | ||
+ | |LINC01828 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |polycystic ovary syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNG0142503] | ||
+ | |XLOC_011402 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |polycystic ovary syndrome | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNG0141988] | ||
+ | |ICAM-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNT0289668] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNG0141783] | ||
+ | |C5T1lncRNA | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNT0289667] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNG0141782] | ||
+ | |C5T1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNG0141781] | ||
+ | |C5-OT1 | ||
+ | |C5T1lncRNA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNG0141741] | ||
+ | |AX800134 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNG0142453] | ||
+ | |uc001ncr | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNG0142445] | ||
+ | |uc.48+ | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diabetic neuropathic pain | ||
+ | |Male Urogenital Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNG0038313] | ||
+ | |LINC01207 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNG0141743] | ||
+ | |BALR-6 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |B-lymphoblastic leukemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNG0142137] | ||
+ | |LOC389641 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNG0141840] | ||
+ | |CTD-2541M15 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNG0142055] | ||
+ | |LINK-A | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |triple-negative breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNG0142222] | ||
+ | |NUTF2P3 | ||
+ | |NUTF2P3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNG0142210] | ||
+ | |NONHSAT123350 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNG0142477] | ||
+ | |UHRF1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNG0142481] | ||
+ | |UPAT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNG0114404] | ||
+ | |LINC00324 | ||
+ | |FLJ34790,MGC104931 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNG0142084] | ||
+ | |lnc-MX1-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNG0142139] | ||
+ | |LOC400891 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNG0141998] | ||
+ | |LA16c-313D11.11 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNG0142307] | ||
+ | |RP11-395G23.3 | ||
+ | |AC027031.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNT0289742] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNG0141857] | ||
+ | |DILC | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNT0289957] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNG0142072] | ||
+ | |lnc-DILC | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNG0141696] | ||
+ | |AK027294 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNG0142486] | ||
+ | |WISP1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNG0099020] | ||
+ | |FGF14-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNG0142246] | ||
+ | |PCAT2 | ||
+ | |CARLo-4,PCA2,TCONS_00015167 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNG0141643] | ||
+ | |2700086A05Rik | ||
+ | |2700086A05Rik | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |idiopathic pulmonary fibrosis | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNG0142366] | ||
+ | |SNED1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Idiopathic pulmonary fibrosis | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNG0142448] | ||
+ | |uc.77 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |idiopathic pulmonary fibrosis | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNG0141931] | ||
+ | |ENST00000537266 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNG0141975] | ||
+ | |HAGLROS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNG0141996] | ||
+ | |KRT18P55 | ||
+ | |KRT18P55 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNG0110450] | ||
+ | |IL21R-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |coronary artery disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNG0142227] | ||
+ | |OTTHUMT00000387022 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |coronary artery disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNG0000226] | ||
+ | |PRKCZ-AS1 | ||
+ | |RP11-181G12.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNG0014612] | ||
+ | |LINC01833 | ||
+ | |RP11-89,K21.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNG0142329] | ||
+ | |RP11-89K21 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNG0079188] | ||
+ | |LINC00857 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNG0142224] | ||
+ | |OR3A4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNG0142161] | ||
+ | |MAGI1-IT1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cardiac hypertrophy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNG0142357] | ||
+ | |SLC26A4-AS1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cardiac hypertrophy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNG0141636] | ||
+ | |KRT7-AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNG0105101] | ||
+ | |LINC01852 | ||
+ | |ENST00000434223 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNG0142293] | ||
+ | |RP11-1008C21.2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNG0141707] | ||
+ | |AK123072 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNG0141688] | ||
+ | |AK021954 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atherosclerosis | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNG0105961] | ||
+ | |CERNA1 | ||
+ | |LOC100129973 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cardiovascular disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNG0008959] | ||
+ | |LAMC1-AS1 | ||
+ | |lnc-LAMC2-1:1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNG0142202] | ||
+ | |NONHSAT040387 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial fibrillation | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNG0142207] | ||
+ | |NONHSAT098586 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial fibrillation | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNG0108626] | ||
+ | |PCSK6-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNG0141752] | ||
+ | |BC016831 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNG0141989] | ||
+ | |IGKV | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNG0142311] | ||
+ | |RP11-434D9.1 | ||
+ | |AC112206.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNG0142000] | ||
+ | |LCAL6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNG0141765] | ||
+ | |BC088254 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myocardial hypertrophy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNG0141711] | ||
+ | |AK124454 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNG0141846] | ||
+ | |CYP4B1-PS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diabetic nephropathy | ||
+ | |Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNG0094020] | ||
+ | |LINC01405 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNG0142374] | ||
+ | |ST8SIA6-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNG0047244] | ||
+ | |TRIM52-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNG0141749] | ||
+ | |BC012900 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ulcerative colitis | ||
+ | |Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNG0133283] | ||
+ | |UMODL1-AS1 | ||
+ | |FLJ33471 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNG0075449] | ||
+ | |ARRDC1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNG0071200] | ||
+ | |FAM74A3 | ||
+ | |OTTHUMG00000067149 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNG0141949] | ||
+ | |FH | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Fumarase deficiency | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNG0142076] | ||
+ | |lnc-HOXC4-3:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNG0142109] | ||
+ | |lnc-TEAD4-1:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNG0142385] | ||
+ | |TCONS_00003876 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNT0289825] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNG0141940] | ||
+ | |EVI1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNG0142350] | ||
+ | |SARCC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNG0142475] | ||
+ | |ucoo2kmd.1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNG0001020] | ||
+ | |KAZN-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNG0141837] | ||
+ | |CTB-89H12.4 | ||
+ | |AC021078.1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNG0141607] | ||
+ | |EPB41L4A-AS2 | ||
+ | |FLJ11235 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;breast cancer;kidney cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNG0004554] | ||
+ | |LINC02567 | ||
+ | |ENST00000427806 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |attention deficit hyperactivity disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNG0141948] | ||
+ | |FGFR3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNG0141822] | ||
+ | |CILinc01 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNG0141823] | ||
+ | |CILinc02 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNG0140235] | ||
+ | |LINC00629 | ||
+ | |LINC00629AB,LINC00629C,LINC00629D,LINC00629 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |choriocarcinoma | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNG0141780] | ||
+ | |C2dat1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ischemic brain injury | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNG0057357] | ||
+ | |POU6F2-AS2 | ||
+ | |FLJ12971 | ||
+ | |protein localization | ||
+ | |pathogenic process | ||
+ | |oesophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNG0142061] | ||
+ | |lnc13 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |celiac disease | ||
+ | |Nutritional and Metabolic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNG0141844] | ||
+ | |CTD903 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNG0142208] | ||
+ | |NONHSAT104436 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNG0141665] | ||
+ | |AC024560.2 | ||
+ | |AC024560.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNG0134219] | ||
+ | |ENST00000436681 | ||
+ | |AP000552.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |congenital heart defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNG0141651] | ||
+ | |AA584040 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |congenital heart defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNG0141652] | ||
+ | |AA709223 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |congenital heart defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNG0141772] | ||
+ | |BX478947 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |congenital heart defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNG0119819] | ||
+ | |LINC00668 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNG0141834] | ||
+ | |CRNDE-h | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNG0068121] | ||
+ | |SMILR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |vascular pathologies | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNG0142511] | ||
+ | |Z38 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNG0095037] | ||
+ | |LINC00507 | ||
+ | |NA | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNG0113270] | ||
+ | |LINC01082 | ||
+ | |TCONSNA00024492 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |alveolar capillary dysplasia with misalignment of pulmonary veins | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNG0015253] | ||
+ | |LINC01185 | ||
+ | |FLJ16341 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNG0142275] | ||
+ | |PTPRD-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNG0142301] | ||
+ | |RP11-254I22.1 | ||
+ | |MIR583HG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNG0142319] | ||
+ | |RP11-57P19.1 | ||
+ | |AC009432.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNG0142326] | ||
+ | |RP11-80H5.7 | ||
+ | |AL157400.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNG0142330] | ||
+ | |RP1-223E5.4 | ||
+ | |AL441883.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNG0142339] | ||
+ | |RP4-799P18.3 | ||
+ | |AL122008.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNG0045514] | ||
+ | |LINC01844 | ||
+ | |LOC101926975 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hirschsprung disease | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNG0142062] | ||
+ | |Lnc34a | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNG0075977] | ||
+ | |LINP1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNG0142066] | ||
+ | |lncARSR | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNG0005967] | ||
+ | |RBM15-AS1 | ||
+ | |AS-RBM15 | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |acute megakaryocytic leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNG0142204] | ||
+ | |NONHSAT073641 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |vascular diseases | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNG0142142] | ||
+ | |LOC572558 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNG0141697] | ||
+ | |AK033210 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |bronchopulmonary dysplasia | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNG0141963] | ||
+ | |GClnc1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNG0141687] | ||
+ | |AK021630 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNG0141718] | ||
+ | |AL049437 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNG0142122] | ||
+ | |LOC100507661 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNG0122663] | ||
+ | |LINC01029 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cognitive functions and neuronal plasticity | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNG0142284] | ||
+ | |RMEL3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNG0142074] | ||
+ | |lnc-FRG2C-3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ankylosing spondylitis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNG0142081] | ||
+ | |lnc-LIN54-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ankylosing spondylitis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNG0142112] | ||
+ | |lnc-USP50-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ankylosing spondylitis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNG0142115] | ||
+ | |lnc-ZNF354A-1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ankylosing spondylitis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNG0017887] | ||
+ | |ENST00000455309 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNG0142035] | ||
+ | |LINC02384 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNG0142113] | ||
+ | |Lnc-UTS2D-1:1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNG0142182] | ||
+ | |n336161 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNG0142184] | ||
+ | |n340599 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNG0142214] | ||
+ | |NR_002712 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNG0142405] | ||
+ | |TCONS_l2_00014794 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNG0142285] | ||
+ | |RMRP | ||
+ | |CHH,NME1R,RRP2,RMRP | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNG0142015] | ||
+ | |LINC00961 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNG0068551] | ||
+ | |LINC00977 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary spontaneous pneumothorax | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNG0141675] | ||
+ | |AF085995 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNG0141681] | ||
+ | |AK000053 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNG0141686] | ||
+ | |AK021595 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNG0141689] | ||
+ | |AK022024 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNG0141710] | ||
+ | |AK124307 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNG0141754] | ||
+ | |BC020384 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNG0141757] | ||
+ | |BC030759 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNG0141830] | ||
+ | |CR615992 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNG0142069] | ||
+ | |lnc-CC3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNG0141729] | ||
+ | |APOC1P1-3 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNG0142480] | ||
+ | |UNMIBC | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNG0142438] | ||
+ | |uc.167 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ventricular septal defects | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNG0142327] | ||
+ | |RP11-838N2.4 | ||
+ | |GAPLINC | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |glioblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNG0121223] | ||
+ | |LINC01478 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |blood pressure | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNG0016990] | ||
+ | |LINC00342 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNG0141792] | ||
+ | |CAR10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNG0141638] | ||
+ | |MAPT-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNG0141794] | ||
+ | |CAT104 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNG0142375] | ||
+ | |STXBP5-AS1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNG0141976] | ||
+ | |HAR1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Huntington disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNG0142474] | ||
+ | |UCHL1-AS1 | ||
+ | |NA | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |Parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNG0142353] | ||
+ | |SCAANT1-AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNG0141763] | ||
+ | |BC041488 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNG0142303] | ||
+ | |RP11-359E19.2 | ||
+ | |AC022733.1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNT0289669] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNG0141784] | ||
+ | |C6orf176-TV1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNT0289670] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNG0141785] | ||
+ | |C6orf176-TV2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNG0141966] | ||
+ | |GIHCG | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNG0141764] | ||
+ | |BC087858 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNG0142468] | ||
+ | |uc004cov.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hypertrophic cardiomyopathy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNG0142472] | ||
+ | |uc022bqu.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hypertrophic cardiomyopathy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNG0060796] | ||
+ | |CFTR-AS1 | ||
+ | |BGas | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNG0021858] | ||
+ | |MYOSLID | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |vascular smooth muscle cell (VSMC) contractile phenotype | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNG0142446] | ||
+ | |uc.63 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNG0142221] | ||
+ | |numb | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |uveal melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNG0141962] | ||
+ | |GCASPC | ||
+ | |TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNG0141683] | ||
+ | |AK001094 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNG0141703] | ||
+ | |AK093735 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNG0141746] | ||
+ | |BC003519 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNG0142215] | ||
+ | |NR_003573 | ||
+ | |ANXA2P2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNG0142234] | ||
+ | |P2RX7-V3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |uveal melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNG0142423] | ||
+ | |TMSB4 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNG0090163] | ||
+ | |DDX11-AS1 | ||
+ | |CONCR | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNG0142167] | ||
+ | |MELOE | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNG0142346] | ||
+ | |RSU1P2 | ||
+ | |RSU1P2 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNG0142280] | ||
+ | |RBMY2FP | ||
+ | |RBMY2FP | ||
+ | |NA | ||
+ | |NA | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNG0142186] | ||
+ | |n375709 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNG0141863] | ||
+ | |DUXAP8 | ||
+ | |DUXAP8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNG0142145] | ||
+ | |LOC729966 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNG0142258] | ||
+ | |POIR | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |periodontitis | ||
+ | |Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNG0031988] | ||
+ | |MELTF-AS1 | ||
+ | |MFI2-AS1,AC068302.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNG0142168] | ||
+ | |MFI2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNG0142037] | ||
+ | |linc-223 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |acute myeloid leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNG0006859] | ||
+ | |LINC01138 | ||
+ | |LINC00875,FLJ39739 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNG0142377] | ||
+ | |SUZ12P1 | ||
+ | |SUZ12P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNG0142120] | ||
+ | |LOC100505976 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNG0142507] | ||
+ | |XLOC_l2_010636 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |laryngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNG0043014] | ||
+ | |RASGRF2-AS1 | ||
+ | |CTC-459I6.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |sepsis-induced endothelial dysfunction | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNG0141967] | ||
+ | |GPC3-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNG0091321] | ||
+ | |HOXC-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |atherosclerosis | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNG0057557] | ||
+ | |LUARIS | ||
+ | |lncRNA#32 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNG0044828] | ||
+ | |MIR3936HG | ||
+ | |LOC553103,SLC22A5-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNG0142263] | ||
+ | |Ppp1r1b | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |congenital heart defect | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNG0099182] | ||
+ | |LINC00460 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNG0142309] | ||
+ | |RP1-13P20.6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNG0142479] | ||
+ | |Unigene56159 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNG0142470] | ||
+ | |uc009yby.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNG0048011] | ||
+ | |TFAP2A-AS2 | ||
+ | |HIPSTR | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNG0141819] | ||
+ | |Chaer | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cardiac hypertrophy | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNT0289865] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNG0141980] | ||
+ | |HIF-2α | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNG0101489] | ||
+ | |LINC00520 | ||
+ | |C14orf34 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNG0041561] | ||
+ | |MRPS30-DT | ||
+ | |BRCAT54 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNG0092662] | ||
+ | |PPP1R12A-AS1 | ||
+ | |R12A-AS1 | ||
+ | |translational control | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNG0088600] | ||
+ | |ITFG2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNG0142203] | ||
+ | |NONHSAT041499 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |schizophrenia | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNG0142206] | ||
+ | |NONHSAT089447 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |schizophrenia | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNG0142085] | ||
+ | |lnc-NKX2-3-1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNG0142104] | ||
+ | |lnc-RTN4R-1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNG0141936] | ||
+ | |ERL | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Marek's disease | ||
+ | |Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNG0092867] | ||
+ | |LINC02258 | ||
+ | |RP11-248E9.5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pneumonia | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNG0117085] | ||
+ | |SKAP1-AS1 | ||
+ | |RP11-456D7.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pneumonia | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNG0049760] | ||
+ | |DINOL | ||
+ | |DINO | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNG0000547] | ||
+ | |CAMTA1-DT | ||
+ | |lncCAMTA1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNG0142443] | ||
+ | |uc.345 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer | ||
+ | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNG0142175] | ||
+ | |MSNP1AS | ||
+ | |NA | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |autism spectrum disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNG0004596] | ||
+ | |NEXN-AS1 | ||
+ | |C1orf118,FLJ90637 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNG0088083] | ||
+ | |LINC02098 | ||
+ | |RP11-702B10.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNG0095473] | ||
+ | |PSPC1-AS2 | ||
+ | |RP11-523H24.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNG0114857] | ||
+ | |LRRC75A-AS1 | ||
+ | |C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNG0077999] | ||
+ | |PRKG1-AS1 | ||
+ | |RP11-573I11.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNG0076970] | ||
+ | |SVIL-AS1 | ||
+ | |RP11-534G20.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNG0108169] | ||
+ | |VPS33B-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNG0141919] | ||
+ | |ENST00000438399 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNG0142343] | ||
+ | |RPKG1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNG0142465] | ||
+ | |uc004afb.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNG0135015] | ||
+ | |SLC5A4-AS1 | ||
+ | |RP1-90G24.10 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNG0063964] | ||
+ | |TNFRSF10A-AS1 | ||
+ | |RP11-1149O23.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNG0141842] | ||
+ | |CTD-2616J11.14 | ||
+ | |AC008750.7 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNG0142297] | ||
+ | |RP11-150O12.3 | ||
+ | |AC124067.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNG0141845] | ||
+ | |CXCL1P1 | ||
+ | |CXCL1P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNG0141918] | ||
+ | |ENST00000438347 | ||
+ | |CCND3P1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNG0142012] | ||
+ | |LINC00601 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNG0141614] | ||
+ | |KIAA0087 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNG0141942] | ||
+ | |FAM212B-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNG0142125] | ||
+ | |LOC102723552 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNG0142296] | ||
+ | |RP11-140I24 | ||
+ | |LINC01568 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNG0142316] | ||
+ | |RP11-501O2 | ||
+ | |LINC02046 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNG0142321] | ||
+ | |RP11-600K151 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNG0142199] | ||
+ | |NONHSAG051968 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNG0142205] | ||
+ | |NONHSAT076747 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNG0142209] | ||
+ | |NONHSAT122730 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNG0066240] | ||
+ | |MIR2052HG | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNG0096884] | ||
+ | |LINC01198 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNG0096821] | ||
+ | |TPT1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNG0142039] | ||
+ | |linc-cdh4-2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNG0068878] | ||
+ | |LINC02055 | ||
+ | |RP1130-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNG0141852] | ||
+ | |DBCCR1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNG0141662] | ||
+ | |AC012065.7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic lymphocytic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNG0116565] | ||
+ | |RAMP2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNG0141706] | ||
+ | |AK098081 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNG0141759] | ||
+ | |BC037331 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNG0141761] | ||
+ | |BC040303 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNG0141832] | ||
+ | |CR749831 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNG0040073] | ||
+ | |SNHG18 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNG0050030] | ||
+ | |FOXP4-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNG0012584] | ||
+ | |RNASEH1-AS1 | ||
+ | |LOC100506054 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNG0088026] | ||
+ | |GSEC | ||
+ | |ST3GAL4-AS1,DCPS-AS1,FLJ39051 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNG0028799] | ||
+ | |DNAJB8-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNG0120059] | ||
+ | |CHMP1B-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNG0010602] | ||
+ | |TGFB2-AS1 | ||
+ | |NR_046268 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNG0037356] | ||
+ | |SLC7A11-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNG0064248] | ||
+ | |INTS9-AS1 | ||
+ | |ENST00000520055 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNG0111641] | ||
+ | |MMP2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNG0130456] | ||
+ | |SLC12A5-AS1 | ||
+ | |RP11-465L10.10 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNG0002415] | ||
+ | |CSMD2-AS1 | ||
+ | |ENST00000434181 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNG0052934] | ||
+ | |HDAC2-AS2 | ||
+ | |ENST00000421891 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNG0105327] | ||
+ | |INO80-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNG0075065] | ||
+ | |LINC02247 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNG0059170] | ||
+ | |MAGI2-AS3 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNG0062699] | ||
+ | |MNX1-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNG0140277] | ||
+ | |SMIM10L2B-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNG0102543] | ||
+ | |TGFB3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNG0073036] | ||
+ | |HSD17B3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNG0142034] | ||
+ | |LINC02246 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNG0100050] | ||
+ | |ZNF710-AS1 | ||
+ | |ENST00000558334 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |early-onset preeclampsia | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNG0007188] | ||
+ | |TDRKH-AS1 | ||
+ | |RP11-98D18.9 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNG0057684] | ||
+ | |LINC01952 | ||
+ | |AC004854.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |recurrent miscarriage | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNG0142190] | ||
+ | |NCF4-AS1 | ||
+ | |CTA-833B7.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |recurrent miscarriage | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNG0029603] | ||
+ | |LNCSRLR | ||
+ | |lncRNA-SRLR | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNG0021529] | ||
+ | |CFLAR-AS1 | ||
+ | |ALS2CR10 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNG0141825] | ||
+ | |COL1A2-AS1 | ||
+ | |TCONS_00013888,lncRNA8975-1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hypertrophic scar | ||
+ | |Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNG0035847] | ||
+ | |LNCPRESS2 | ||
+ | |lncPRESS2 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNG0005432] | ||
+ | |LINC01930 | ||
+ | |EU358092 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |schizophrenia | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNG0046325] | ||
+ | |HMMR-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |basal-like breast cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNG0088703] | ||
+ | |CCND2-AS1 | ||
+ | |CCND2-AS2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNG0030884] | ||
+ | |LINC00578 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |major depression disorder | ||
+ | |Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNG0026576] | ||
+ | |ADAMTS9-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNG0038152] | ||
+ | |FAM198B-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNG0048820] | ||
+ | |LINC00240 | ||
+ | |C6orf41,NCRNA00240,bA373D17.1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNG0122453] | ||
+ | |LINC00909 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNG0141620] | ||
+ | |LINC00680 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNG0061394] | ||
+ | |LINC00513 | ||
+ | |AC016831.7 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNG0115960] | ||
+ | |LINC02001 | ||
+ | |RP11-1094M14.11 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNG0092950] | ||
+ | |POC1B-AS1 | ||
+ | |RP11-734K2.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNG0060049] | ||
+ | |SLC12A9-AS1 | ||
+ | |RP11-126L15.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNG0050617] | ||
+ | |TRAM2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNG0001176] | ||
+ | |LINC01772 | ||
+ | |ENSG00000226029 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |oesophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNG0009693] | ||
+ | |ELF3-AS1 | ||
+ | |ENST00000415582 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNG0025450] | ||
+ | |LINC02158 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNG0133329] | ||
+ | |LINC01671 | ||
+ | |BC041455 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNG0132343] | ||
+ | |LINC01684 | ||
+ | |lnc-JAM2-6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nonalcoholic fatty liver disease | ||
+ | |Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNG0096092] | ||
+ | |LINC00365 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNG0043625] | ||
+ | |LINC01554 | ||
+ | |C5orf27,FLJ38821,FIS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNG0136701] | ||
+ | |LINC02154 | ||
+ | |GS1-600G8.5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNG0065704] | ||
+ | |LINC02155 | ||
+ | |RP11-705O24.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNG0108398] | ||
+ | |LINC02157 | ||
+ | |RP11-327J17.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNG0090758] | ||
+ | |LINC02156 | ||
+ | |RP1-90J4.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNG0063832] | ||
+ | |LINC02153 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |major depression disorder | ||
+ | |Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNG0087394] | ||
+ | |LINC02151 | ||
+ | |TCONS_00019174 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |major depression disorder | ||
+ | |Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNG0109385] | ||
+ | |LINC02152 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |major depression disorder | ||
+ | |Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNG0013844] | ||
+ | |BRE-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNG0056623] | ||
+ | |SNHG26 | ||
+ | |AC005682.5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder urothelial cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNG0122284] | ||
+ | |LIVAR | ||
+ | |lnc18q22.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nonalcoholic steatohepatiti | ||
+ | |Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNG0031832] | ||
+ | |LINC00969 | ||
+ | |ENST00000453324 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNG0140259] | ||
+ | |LINC02243 | ||
+ | |ENST00000441841 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNG0039449] | ||
+ | |SLC9A3-AS1 | ||
+ | |UC011CLY.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNG0126602] | ||
+ | |DM1-AS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myotonic dystrophy type 1 | ||
+ | |Musculoskeletal Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNG0004475] | ||
+ | |LINC02238 | ||
+ | |RP4-788P17.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |B cell lymphoma | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNG0043374] | ||
+ | |MEF2C-AS2 | ||
+ | |CTC-467M3.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNG0003824] | ||
+ | |MIR4422HG | ||
+ | |RP11-101C11.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNG0082800] | ||
+ | |SPON1-AS1 | ||
+ | |RP11-21,L19.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNG0083610] | ||
+ | |CD44-AS1 | ||
+ | |RP1-68D18.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNG0127560] | ||
+ | |LILRB1-AS1 | ||
+ | |AC009892.10 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289546 HSALNT0289546] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289546 HSALNG0141661] | ||
+ | |AC009892.10 | ||
+ | |LILRB1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |B cell lymphoma | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNG0137635] | ||
+ | |LINC01186 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNG0131657] | ||
+ | |MHENCR | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNG0034801] | ||
+ | |LINC02232 | ||
+ | |RP11-707A18.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNG0038220] | ||
+ | |LINC02233 | ||
+ | |RP11-6C14.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNG0039930] | ||
+ | |LINC02236 | ||
+ | |RP11-332J15.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNG0043678] | ||
+ | |LINC02234 | ||
+ | |RP11-455B3.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNG0066607] | ||
+ | |LINC02235 | ||
+ | |RP11-354A14.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNG0067779] | ||
+ | |LINC02237 | ||
+ | |RP11-1101K5.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNG0111295] | ||
+ | |LINC02179 | ||
+ | |RP11-189E14.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNG0132340] | ||
+ | |LINC01689 | ||
+ | |AP000469.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNG0091963] | ||
+ | |LINC02231 | ||
+ | |RP11-766N7.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Esophageal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNG0105903] | ||
+ | |MIR4713HG | ||
+ | |RP11-108K3.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNG0037858] | ||
+ | |FAM160A1-DT | ||
+ | |RP11-610P16.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNG0021423] | ||
+ | |SATB2-AS1 | ||
+ | |NA | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNG0141623] | ||
+ | |LINC01826 | ||
+ | |lnc-MKI67IP-3 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |atherosclerosis | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNG0104253] | ||
+ | |LINC00226 | ||
+ | |C14orf97,NCRNA00226 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic ductaladenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNG0039173] | ||
+ | |F11-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNG0105295] | ||
+ | |SPINT1-AS1 | ||
+ | |RP11-532F12.5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNG0088950] | ||
+ | |MIR200CHG | ||
+ | |U47924.27 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNG0031153] | ||
+ | |LINC00888 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNG0116205] | ||
+ | |LINC00672 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNG0085691] | ||
+ | |P4HA3-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |parkinson's disease | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNG0095075] | ||
+ | |TMEM132D-AS1 | ||
+ | |LOC283352 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |human dermal fibroblasts | ||
+ | |Cell Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNG0113128] | ||
+ | |ATP2C2-AS1 | ||
+ | |RP11-517C16.2-001 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNG0112863] | ||
+ | |WWOX-AS1 | ||
+ | |RP11-190D6.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNG0061246] | ||
+ | |FLNC-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical squamous cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNG0142004] | ||
+ | |LIF-AS1 | ||
+ | |Lnc-LIF-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical squamous cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNG0005428] | ||
+ | |DPYD-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical squamous cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNG0141951] | ||
+ | |FLICR | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |autoimmune diabete | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNG0090563] | ||
+ | |LINC02402 | ||
+ | |ENST00000550337.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diabetes | ||
+ | |Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNG0065453] | ||
+ | |CERNA3 | ||
+ | |CTA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNG0043312] | ||
+ | |LINC02488 | ||
+ | |CTD-2316B1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNG0083979] | ||
+ | |LINC02489 | ||
+ | |CTD-2589M5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNG0105991] | ||
+ | |LINC02490 | ||
+ | |RP11-209E8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNG0045650] | ||
+ | |STK32A-AS1 | ||
+ | |CTC-255N20 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNG0055190] | ||
+ | |LINC02487 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNG0045503] | ||
+ | |SPRY4-AS1 | ||
+ | |THCAT68 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNG0090908] | ||
+ | |DDN-AS1 | ||
+ | |CAT1507 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNG0006150] | ||
+ | |SLC16A1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute myocardial infarction | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNG0000276] | ||
+ | |TNFRSF14-AS1 | ||
+ | |ENST00000416860.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute myocardial infarction | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNG0125745] | ||
+ | |LINC00665 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNG0019085] | ||
+ | |DARS-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal disease | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNG0125425] | ||
+ | |CEBPA-AS1 | ||
+ | |CEBPA-DT | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNG0057479] | ||
+ | |INHBA-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNG0067472] | ||
+ | |GASAL1 | ||
+ | |GASL1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNG0021881] | ||
+ | |LINC01857 | ||
+ | |AC079767.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tuberculosis | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNG0004949] | ||
+ | |LINC01140 | ||
+ | |FLJ41676 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNG0137521] | ||
+ | |PINCR | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNG0139543] | ||
+ | |LINC00890 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leiomyoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNG0009573] | ||
+ | |LINC00862 | ||
+ | |C1orf98,SMIM16 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNG0035237] | ||
+ | |LINC02562 | ||
+ | |RP11-44F21.5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNG0127961] | ||
+ | |LINC02560 | ||
+ | |CTD-2619J13.13 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNG0088252] | ||
+ | |LINC02551 | ||
+ | |RP11-890B15.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNG0078773] | ||
+ | |DDIT4-AS1 | ||
+ | |RP11-442H21.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic Fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNG0089423] | ||
+ | |GPRC5D-AS1 | ||
+ | |RP11-392P7.6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNG0015768] | ||
+ | |PCBP1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNG0044141] | ||
+ | |STARD4-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNG0097004] | ||
+ | |LINC00462 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNG0099453] | ||
+ | |SOX1-OT | ||
+ | |LINC00403 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNG0001107] | ||
+ | |SLC25A34-AS1 | ||
+ | |RP11-169K16.4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNG0075163] | ||
+ | |PPP1R26-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNG0064310] | ||
+ | |LINC00589 | ||
+ | |C8orf75,TSLNC8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNG0141627] | ||
+ | |TPM1-AS | ||
+ | |TPM1-AS1 | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNG0141631] | ||
+ | |LINC01101 | ||
+ | |FLJ14816 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |HPV-induced cervical neoplasia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNG0018748] | ||
+ | |LINC02572 | ||
+ | |AC079776.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNG0046188] | ||
+ | |LINC02202 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNG0027511] | ||
+ | |LINC00973 | ||
+ | |CTD-2021J15.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNG0141401] | ||
+ | |TTTY10 | ||
+ | |NCRNA00133 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNG0133418] | ||
+ | |LINC00319 | ||
+ | |C21orf125,NCRNA00319,PRED49,FLJ38036 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNG0007394] | ||
+ | |IL6R-AS1 | ||
+ | |RP11-350G8.5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNG0043020] | ||
+ | |CKMT2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNG0006203] | ||
+ | |HIPK1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNG0050214] | ||
+ | |POLH-AS1 | ||
+ | |RP3-337H4.8 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNG0053237] | ||
+ | |TRDN-AS1 | ||
+ | |HRAT13 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNG0069213] | ||
+ | |LY6E-DT | ||
+ | |LOC100133669 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNT0289434] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNG0040409] | ||
+ | |BASP1-AS1 | ||
+ | |LOC285696 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNG0069691] | ||
+ | |GLIS3-AS1 | ||
+ | |C9orf70,MGC16153 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNG0070213] | ||
+ | |BNC2-AS1 | ||
+ | |RP11-62F24.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNG0078947] | ||
+ | |ZNF503-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |age-related macular degeneration | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNG0076434] | ||
+ | |VIM-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNG0011058] | ||
+ | |ACBD3-AS1 | ||
+ | |RP11-275I14.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNG0005074] | ||
+ | |LRRC8C-DT | ||
+ | |FLJ27354 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNG0058889] | ||
+ | |ELN-AS1 | ||
+ | |CTB-51J22.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNG0036645] | ||
+ | |LINC02264 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNG0044495] | ||
+ | |LINC02201 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNG0132198] | ||
+ | |LINC02573 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNG0015785] | ||
+ | |LINC01816 | ||
+ | |LOC100133985 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNG0091335] | ||
+ | |LINC02381 | ||
+ | |LOC400043 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNG0029874] | ||
+ | |MBNL1-AS1 | ||
+ | |LOC401093 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNG0141624] | ||
+ | |MIR4697HG | ||
+ | |LINC00947,LOC283174 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNG0065480] | ||
+ | |LINC00968 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNG0053963] | ||
+ | |NMBR-AS1 | ||
+ | |RP11-137J7.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-melanoma skin cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNG0077499] | ||
+ | |LINC01518 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-melanoma skin cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNG0002009] | ||
+ | |LINC02574 | ||
+ | |RP11-288L9.1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNT0032721] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNG0015486] | ||
+ | |LINC02579 | ||
+ | |AC007365.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNG0014519] | ||
+ | |LINC02580 | ||
+ | |AC093609.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNT0032808] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNG0015519] | ||
+ | |LINC02576 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNG0060386] | ||
+ | |LINC02577 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNG0074062] | ||
+ | |LINC02578 | ||
+ | |RP11-127L21.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNG0084388] | ||
+ | |FAM111A-DT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNG0133545] | ||
+ | |LINC02575 | ||
+ | |AP001065.15 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |UVB-irradiated KC & non-melanoma skin cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNT0025249] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNG0012143] | ||
+ | |KIF26B-AS1 | ||
+ | |RP11-62I21.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNG0085146] | ||
+ | |RPS6KB2-AS1 | ||
+ | |AP003419.16 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |agingâassociated idiopathic pulmonary fibrosis | ||
+ | |Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNG0090150] | ||
+ | |LINC00941 | ||
+ | |lncRNA-MUF | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNG0075045] | ||
+ | |LINC00094 | ||
+ | |FLJ35348,bA374P20.3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNG0053894] | ||
+ | |FILNC1 | ||
+ | |NA | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |renal tumor | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNG0128600] | ||
+ | |PARAL1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |obesity | ||
+ | |Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244832 HSALNT0244832] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244832 HSALNG0118528] | ||
+ | |SOX9-AS1 | ||
+ | |FLJ37644 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNT0289236] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNG0118528] | ||
+ | |ROCR | ||
+ | |LINC02095 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNG0027060] | ||
+ | |LINC02027 | ||
+ | |LOC728290 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNT0289424] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNG0141124] | ||
+ | |TTTY22 | ||
+ | |NCRNA00147 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNG0030090] | ||
+ | |LINC00880 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNG0122396] | ||
+ | |LINC02582 | ||
+ | |CTD-2354A18.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNG0097712] | ||
+ | |LINC00364 | ||
+ | |LncRNA00364 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNG0029189] | ||
+ | |NCK1-DT | ||
+ | |NCK1-AS1,SLC35G2-AS1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNG0067505] | ||
+ | |BAALC-AS1 | ||
+ | |lncFZD6,FZD6-DT | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNG0021972] | ||
+ | |CPS1-IT1 | ||
+ | |CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNG0059740] | ||
+ | |DLX6-AS1 | ||
+ | |DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |split hand/split foot malformation disorder;lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNG0142006] | ||
+ | |LINC00114 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNG0138601] | ||
+ | |TSIX | ||
+ | |LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |systemic sclerosis | ||
+ | |Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNG0104503] | ||
+ | |MKRN3-AS1 | ||
+ | |ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNG0142371] | ||
+ | |SRA | ||
+ | |lnc-SRA1-1:1,SRA1,ENSG00000213523 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNG0049271] | ||
+ | |HCP5 | ||
+ | |6S2650E,D6S2650E,P5-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |AIDS | ||
+ | |Immune System Diseases;Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNG0083476] | ||
+ | |WT1-AS | ||
+ | |WIT1,WIT-1,WT1A, WT1-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNG0082235] | ||
+ | |KCNQ1OT1 | ||
+ | |KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNG0128372] | ||
+ | |PCNA-AS1 | ||
+ | |PCNAA, PCNA-AS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer;hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNG0049107] | ||
+ | |HCG9 | ||
+ | |PERB11,HCGIX,HCGIX4,HCGIX-4 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNG0103448] | ||
+ | |TCL6 | ||
+ | |TCL6e1,TNG2,TNG1 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |renal cell cancer;leukemia | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNG0072040] | ||
+ | |PCA3 | ||
+ | |DD3,NCRNA00019,PCAT3 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNG0082178] | ||
+ | |H19 | ||
+ | |ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |developmental process;pathogenic process | ||
+ | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | ||
+ | |Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNG0097105] | ||
+ | |DLEU1 | ||
+ | |BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNG0141604] | ||
+ | |DBH-AS1 | ||
+ | |NCRNA00118,BPR | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNG0042101] | ||
+ | |PART1 | ||
+ | |DKFZP586D0823,NCRNA00206 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioblastoma | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNG0082197] | ||
+ | |IGF2-AS | ||
+ | |IGF2A,PEG8,IGF2-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | ||
+ | |Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNG0131285] | ||
+ | |GNAS-AS1 | ||
+ | |GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;pseudohypoparathyroidism type Ib | ||
+ | |Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNG0051709] | ||
+ | |SNHG5 | ||
+ | |C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;lymphoma;melanoma | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNG0011462] | ||
+ | |DISC2 | ||
+ | |DISC1-AS1,DISC1O, NCRNA00015 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | ||
+ | |Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNG0097806] | ||
+ | |ATXN8OS | ||
+ | |SCA8,KLHL1A,NCRNA00003 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia;spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNG0142427] | ||
+ | |TRAF3IP2-AS1 | ||
+ | |C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |schizophrenia;cocaine abuse | ||
+ | |Chemically-Induced Disorders;Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNG0054049] | ||
+ | |HYMAI | ||
+ | |NCRNA00020 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |transient neonatal diabetes | ||
+ | |Nutritional and Metabolic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNG0071146] | ||
+ | |FAM201A | ||
+ | |C9orf122 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |leukemia | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNG0093910] | ||
+ | |FAM222A-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNG0138575] | ||
+ | |FAM226A | ||
+ | |CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNG0141608] | ||
+ | |FAM215A | ||
+ | |C17orf88,APR-2,LINC00530 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;leukemia | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNG0025991] | ||
+ | |RBM5-AS1 | ||
+ | |LUST | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |tumor | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNG0001554] | ||
+ | |LINC00339 | ||
+ | |NCRNA00339,HSPC157 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNG0068615] | ||
+ | |ASAP1-IT1 | ||
+ | |ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNG0021208] | ||
+ | |PCGEM1 | ||
+ | |NCRNA00071,LINC00071,PCAT9 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis;prostate cancer;glioma | ||
+ | |Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNG0082243] | ||
+ | |KCNQ1DN | ||
+ | |BWRT,HSA404617 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |aging;Wilms' tumor | ||
+ | |Physiological Phenomena;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNG0097101] | ||
+ | |DLEU2 | ||
+ | |DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNG0104558] | ||
+ | |PWAR4 | ||
+ | |PAR4,PAR-4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome and Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNG0103778] | ||
+ | |MEG8 | ||
+ | |SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome and Angelman syndrome;temple syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNG0133856] | ||
+ | |CECR7 | ||
+ | |SAHL1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNG0035451] | ||
+ | |PCAT4 | ||
+ | |GDEP,PCAN1,PCA4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNG0029318] | ||
+ | |PISRT1 | ||
+ | |NCRNA00195 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |blepharophimosis syndrome | ||
+ | |Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNG0092137] | ||
+ | |IFNG-AS1 | ||
+ | |Tmevpg1,LincR-Ifng-3'A, NEST | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | ||
+ | |Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNG0018067] | ||
+ | |FAM138B | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNG0069515] | ||
+ | |FAM138C | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNG0000006] | ||
+ | |FAM138A | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNG0088434] | ||
+ | |FAM138D | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNG0108677] | ||
+ | |FAM138E | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNG0122829] | ||
+ | |FAM138F | ||
+ | |F379 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNG0141632] | ||
+ | |LINC00312 | ||
+ | |LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNG0054798] | ||
+ | |AIRN | ||
+ | |AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNG0123415] | ||
+ | |MIR7-3HG | ||
+ | |C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |liver cancer;hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNG0089375] | ||
+ | |LOH12CR2 | ||
+ | |LOH2CR12 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pre-B acute lymphoblastic leukaemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNG0133055] | ||
+ | |DSCR8 | ||
+ | |C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Down syndrome;melanoma | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNG0133422] | ||
+ | |LINC00313 | ||
+ | |C21orf84,NCRNA00313, | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNG0132830] | ||
+ | |LINC00310 | ||
+ | |C21orf82,NCRNA00310 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNG0132500] | ||
+ | |LINC00161 | ||
+ | |C21orf100,NCRNA00161 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNG0132027] | ||
+ | |MIR99AHG | ||
+ | |C21orf35,FLJ38295,C21orf34,LINC00478,MONC | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myeloid leukemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNG0056865] | ||
+ | |HOXA11-AS | ||
+ | |HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNG0093342] | ||
+ | |RMST | ||
+ | |NCRM, NCRNA00054,LINC00054 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |breast cancer;rhabdomyosarcoma | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNG0142194] | ||
+ | |ncR-PAR | ||
+ | |NCRUPAR,ENSG00000225407 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |gastric cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNG0061370] | ||
+ | |MESTIT1 | ||
+ | |MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Silver-Russell syndrome | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNG0133168] | ||
+ | |DSCAM-AS1 | ||
+ | |M41 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |adolescent idiopathic scoliosis;breast cancer | ||
+ | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNG0104546] | ||
+ | |PWARSN | ||
+ | |PAR-SN,PARSN | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNG0060774] | ||
+ | |ST7-AS1 | ||
+ | |ST7OT1,ST7AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma;autism | ||
+ | |Mental Disorders;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNG0099122] | ||
+ | |DAOA-AS1 | ||
+ | |DAOAA, DAOA-A,G30 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |panic disorder;schizophrenia;bipolar disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNG0080104] | ||
+ | |OLMALINC | ||
+ | |C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNG0012802] | ||
+ | |LINC00299 | ||
+ | |C2orf46,NCRNA00299,FLJ45673 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |intellectual and developmental disability;neurodevelopmental disabilities | ||
+ | |Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNG0039816] | ||
+ | |LINC01020 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNG0048016] | ||
+ | |LINC00518 | ||
+ | |C6orf218,MGC40222 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNG0039909] | ||
+ | |LINC01018 | ||
+ | |SRHC | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNG0031463] | ||
+ | |LPP-AS2 | ||
+ | |MYCLo-5,MYCLo-6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNG0068292] | ||
+ | |LINC00964 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNG0094063] | ||
+ | |MAPKAPK5-AS1 | ||
+ | |C12orf47,FLJ39616 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNG0027872] | ||
+ | |LINC00635 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNG0141633] | ||
+ | |LINC00636 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNG0127758] | ||
+ | |ZNF582-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNG0000022] | ||
+ | |LINC00115 | ||
+ | |NCRNA00115,FLJ22639 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNG0075291] | ||
+ | |SNHG7 | ||
+ | |MGC16037,NCRNA00061 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNG0020412] | ||
+ | |MAP3K20-AS1 | ||
+ | |MLK7-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNG0069280] | ||
+ | |RHPN1-AS1 | ||
+ | |C8orf51,MGC3113 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNG0138602] | ||
+ | |XIST | ||
+ | |DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNG0128330] | ||
+ | |PRNT | ||
+ | |M8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNG0080912] | ||
+ | |EMX2OS | ||
+ | |NCRNA00045,EMX2-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNG0096546] | ||
+ | |LINC00598 | ||
+ | |TTL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNG0141628] | ||
+ | |TTTY17A | ||
+ | |NCRNA00140 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNG0013206] | ||
+ | |MYCNOS | ||
+ | |NCYM,N-CYM,MYCN-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNG0022192] | ||
+ | |DIRC3 | ||
+ | |FLJ14199 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |familial renal cell cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNG0084905] | ||
+ | |MALAT1 | ||
+ | |PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | ||
+ | |splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | ||
+ | |Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNG0141859] | ||
+ | |DLG2-AS1 | ||
+ | |DLG2A, DLG2-A,PSZA11q14,SZ-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |schizophrenia;myotonic dystrophy type 1;heart failure | ||
+ | |Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNG0103778] | ||
+ | |MEG3 | ||
+ | |FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | ||
+ | |translational control;transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | ||
+ | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNG0142413] | ||
+ | |TERC | ||
+ | |DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;dyskeratosis congenita;lung squamous cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNG0080948] | ||
+ | |CASC2 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNG0098601] | ||
+ | |MIR17HG | ||
+ | |C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma;syndromic developmental defect;cancer | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNG0141456] | ||
+ | |TTTY6 | ||
+ | |TTY6,TTTY6A,LINC00127 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNG0141468] | ||
+ | |TTTY4 | ||
+ | |TTY4,TTTY4A,LINC00123 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNG0141548] | ||
+ | |TTTY3 | ||
+ | |TTY3,TTTY3A,LINC00121 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNG0141450] | ||
+ | |TTTY5 | ||
+ | |TTY5,LINC00126 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNG0036656] | ||
+ | |SNHG8 | ||
+ | |NCRNA00060,LINC00060 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;malignant pleural mesothelioma | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNG0141597] | ||
+ | |BCYRN1 | ||
+ | |BC200,BC200a,NCRNA00004,LINC00004 | ||
+ | |splicing regulation;translational control | ||
+ | |pathogenic process | ||
+ | |aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNG0068805] | ||
+ | |ZFAT-AS1 | ||
+ | |ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autoimmune disease | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNG0077083] | ||
+ | |ZEB1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | ||
+ | |Immune System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNG0135987] | ||
+ | |MIRLET7BHG | ||
+ | |linc-Ppara | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNG0116616] | ||
+ | |NBR2 | ||
+ | |NCRNA00192 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer;breast cancer;cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNG0134930] | ||
+ | |TUG1 | ||
+ | |FLJ20618,NCRNA00080,LINC00080 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNG0079552] | ||
+ | |FAS-AS1 | ||
+ | |FASA, FAS-A,SAF | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |ataxia telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNG0068110] | ||
+ | |HAS2-AS1 | ||
+ | |HAS2A, HAS2-A,HASNT,NCRNA00077 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNG0049245] | ||
+ | |PSORS1C3 | ||
+ | |NCRNA00196 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis;psoriasis | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNG0141983] | ||
+ | |HLA-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |psoriasis;liver injury;multiple sclerosis;AIDS | ||
+ | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNG0142269] | ||
+ | |PRINS | ||
+ | |NCRNA00074 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |psoriasis;prostate cancer | ||
+ | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNG0127790] | ||
+ | |PEG3-AS1 | ||
+ | |PEG3AS,PEG3-AS,APEG3,NCRNA00155 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNG0141648] | ||
+ | |7SL | ||
+ | |7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | ||
+ | |protein localization | ||
+ | |pathogenic process | ||
+ | |AIDS;Leishmaniasis;dermatomyositis;polymyositis | ||
+ | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNG0142196] | ||
+ | |NDM29 | ||
+ | |29A,lnc-C11orf16-1:1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNG0074439] | ||
+ | |NRON | ||
+ | |NCRNA00194 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |AIDS;Down syndrome;HIV | ||
+ | |Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNG0065926] | ||
+ | |SNHG6 | ||
+ | |U87HG,HBII-276HG,NCRNA00058 | ||
+ | |translational control;ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNG0141768] | ||
+ | |Beta-globin transcript | ||
+ | |AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNG0142513] | ||
+ | |Zfhx2as | ||
+ | |Zfh-5AS,ENSG00000157306,ENST00000554403.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNG0005433] | ||
+ | |MIR137HG | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |schizophrenia;lung cancer;malignant lymphoma | ||
+ | |Respiratory Tract Diseases;Mental Disorders;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNG0056858] | ||
+ | |HOXA-AS3 | ||
+ | |HOXA6as | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNG0068551] | ||
+ | |CCDC26 | ||
+ | |MGC27434,RAM | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNG0142008] | ||
+ | |LINC00271 | ||
+ | |C6orf217,NCRNA00271 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes;schizophrenia | ||
+ | |Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNG0109621] | ||
+ | |BCAR4 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;breast cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNG0142005] | ||
+ | |LINC00032 | ||
+ | |C9orf14,NCRNA00032 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |narcolepsy;melanoma | ||
+ | |Mental Disorders;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNG0133591] | ||
+ | |PICSAR | ||
+ | |C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | ||
+ | |Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNG0124398] | ||
+ | |UCA1 | ||
+ | |CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |developmental process;pathogenic process | ||
+ | |oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNT0003871] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNG0002066] | ||
+ | |SNHG3 | ||
+ | |NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease | ||
+ | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNG0131591] | ||
+ | |HAR1A | ||
+ | |HAR1F,NCRNA00064,LINC00064 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Huntington disease;Alzheimer's disease | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNG0131589] | ||
+ | |HAR1B | ||
+ | |HAR1R,NCRNA00065,LINC00065 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNG0044150] | ||
+ | |EPB41L4A-AS1 | ||
+ | |C5orf26,NCRNA00219,TIGA1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer;cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNG0134655] | ||
+ | |MIAT | ||
+ | |C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | ||
+ | |splicing regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | ||
+ | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNG0047947] | ||
+ | |HULC | ||
+ | |NCRNA00078,LINC00078,HCCAT1 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | ||
+ | |Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNG0023880] | ||
+ | |EGOT | ||
+ | |EGO,NCRNA00190 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |prostate cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNG0001461] | ||
+ | |PINK1-AS | ||
+ | |PINK1-AS1,FLJ00387,PINK1A, naPINK1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |glucose metabolism disorder;Parkinson's disease;diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNG0068477] | ||
+ | |PVT1 | ||
+ | |NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | ||
+ | |transcriptional regulation;translational control | ||
+ | |pathogenic process | ||
+ | |murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNG0073233] | ||
+ | |NAMA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNG0119442] | ||
+ | |NARF-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNG0070397] | ||
+ | |CDKN2B-AS1 | ||
+ | |CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | ||
+ | |siRNA;transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | ||
+ | |Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNG0024099] | ||
+ | |GHRLOS | ||
+ | |NCRNA00068,GHRL-AS1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNG0026279] | ||
+ | |ESRG | ||
+ | |HESRG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |embryonal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNG0140560] | ||
+ | |FMR1-AS1 | ||
+ | |FMR1A, FMR1-A,ASFMR1,FMR4 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |fragile X syndrome;neurological disorder | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNG0141610] | ||
+ | |HCG4 | ||
+ | |HCGIV-10,HCGIV.9 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNG0038609] | ||
+ | |HAND2-AS1 | ||
+ | |DEIN,NBLA00301,FLJ11539 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNG0019362] | ||
+ | |ZEB2-AS1 | ||
+ | |ZEB2A, ZEB2-A,ZEB2NAT | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer;hepatocellular cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNG0008545] | ||
+ | |GAS5 | ||
+ | |SNHG2,NCRNA00030 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNG0087449] | ||
+ | |BACE1-AS | ||
+ | |BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | ||
+ | |translational control;transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;colorectal cancer;Alzheimer's disease | ||
+ | |Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNG0133533] | ||
+ | |TRPM2-AS | ||
+ | |TRPM2-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma;prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNG0008462] | ||
+ | |DNM3OS | ||
+ | |DNM3-AS1,MIR199A2HG | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNG0133982] | ||
+ | |DGCR5 | ||
+ | |NCRNA00037,LINC00037 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNG0083307] | ||
+ | |BDNF-AS | ||
+ | |BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | ||
+ | |siRNA;transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |Huntington disease;schizophrenia;psychiatric disease;obesity | ||
+ | |Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNG0056850] | ||
+ | |HOTAIRM1 | ||
+ | |HOXA-AS1,NCRNA00179,HOXA1-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process;developmental process | ||
+ | |colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNG0142273] | ||
+ | |PTCSC1 | ||
+ | |PTCSC,AK023948,NCRNA00197 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNG0091318] | ||
+ | |HOTAIR | ||
+ | |HOXC-AS4,HOXC11-AS1,NCRNA00072 | ||
+ | |siRNA;transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNG0084892] | ||
+ | |NEAT1 | ||
+ | |NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNG0045213] | ||
+ | |SNHG4 | ||
+ | |U19H,NCRNA00059 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |myelodysplastic syndrome | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNG0118855] | ||
+ | |SNHG16 | ||
+ | |ncRAN,Nbla12061,Nbla10727 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNG0023698] | ||
+ | |BOK-AS1 | ||
+ | |BOKA,NCRNA00151,NAToB | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;testicular cancer;cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNG0141647] | ||
+ | |7SK | ||
+ | |7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | ||
+ | |Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNG0017872] | ||
+ | |MIR4435-2HG | ||
+ | |MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNG0016500] | ||
+ | |PARTICL | ||
+ | |PARTICLE | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |low-dose irradiation | ||
+ | |Disorders of Environmental Origin | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNG0069266] | ||
+ | |MINCR | ||
+ | |LINC01604,TCONS_00015189 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;Burkitt lymphoma | ||
+ | |Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNG0000905] | ||
+ | |NPPA-AS1 | ||
+ | |NPPAA, NPPA-AS | ||
+ | |splicing regulation | ||
+ | |pathogenic process | ||
+ | |cardiovascular disease | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNG0142345] | ||
+ | |RRP1B | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNG0093062] | ||
+ | |CLLU1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNG0087764] | ||
+ | |MIR100HG | ||
+ | |AGD1,lncRNA-N2,linc-NeD125 | ||
+ | |NA | ||
+ | |developmental process;pathogenic process | ||
+ | |myeloid leukemia;myopia;cervical cancer;neuroblastoma | ||
+ | |Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNG0028235] | ||
+ | |TUSC7 | ||
+ | |LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | ||
+ | |Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNG0141762] | ||
+ | |BC040587 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNG0028242] | ||
+ | |LINC00901 | ||
+ | |LSAMP-AS4,TCONS_00005428,BC040587 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;gastric cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNG0112604] | ||
+ | |HCCAT5 | ||
+ | |HTA,FJ222407 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNG0142155] | ||
+ | |LSINCT5 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNG0086377] | ||
+ | |DISC1FP1 | ||
+ | |Boymaw | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |schizophrenia | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNG0104567] | ||
+ | |SNHG14 | ||
+ | |115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome;cerebral infarction;Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNG0000343] | ||
+ | |TP73-AS1 | ||
+ | |KIAA0495,PDAM | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | ||
+ | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNG0142426] | ||
+ | |TP53COR1 | ||
+ | |Trp53cor1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNG0068414] | ||
+ | |PRNCR1 | ||
+ | |CARLo-3,PCAT8 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer;prostate cancer;glioma;colorectal cancer | ||
+ | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNG0009743] | ||
+ | |PCAT6 | ||
+ | |KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer;triple-negative breast cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNG0130723] | ||
+ | |TRERNA1 | ||
+ | |LINC00651,ncRNA-a7,treRNA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNG0007045] | ||
+ | |FALEC | ||
+ | |LINC00568,ncRNA-a1,FAL1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;thyroid cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNG0142123] | ||
+ | |LOC100887755 | ||
+ | |Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNG0142363] | ||
+ | |snaR | ||
+ | |EU035784.1,lnc-BSPH1-1:1 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNG0138609] | ||
+ | |JPX | ||
+ | |NCRNA00183,ENOX,LINC00183,DCBALD06 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNT0289231] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNG0001716] | ||
+ | |RCAN3AS | ||
+ | |TCONS_00001428 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNG0069631] | ||
+ | |VLDLR-AS1 | ||
+ | |lincRNA-VLDLR | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNG0138614] | ||
+ | |FTX | ||
+ | |NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNG0043383] | ||
+ | |MEF2C-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;Prader-Willi syndrome and Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNG0091277] | ||
+ | |PCBP2-OT1 | ||
+ | |TUC338 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;tongue squamous cell cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNG0142488] | ||
+ | |WRAP53 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;cancer;dyskeratosis congenita | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNG0049949] | ||
+ | |TDRG1 | ||
+ | |LINC00532,lincRNA-NRNA024015 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | ||
+ | |Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNG0132382] | ||
+ | |MIR155HG | ||
+ | |MIRHG2,BIC,NCRNA00172 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | ||
+ | |Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNG0024293] | ||
+ | |LINC00620 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNG0056871] | ||
+ | |HOTTIP | ||
+ | |NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNG0130661] | ||
+ | |ZFAS1 | ||
+ | |C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNG0045502] | ||
+ | |SPRY4-IT1 | ||
+ | |SPRIGHTLY | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNG0049759] | ||
+ | |PANDAR | ||
+ | |PANDA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNG0032415] | ||
+ | |HTT-AS | ||
+ | |HTT-AS1,HTTAS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Huntington disease | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNG0047200] | ||
+ | |HEIH | ||
+ | |LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNG0107117] | ||
+ | |NPTN-IT1 | ||
+ | |lncRNA-LET | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | ||
+ | |Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNG0141862] | ||
+ | |DQ786243 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |crohn's disease;colorectal cancer;hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNG0068414] | ||
+ | |PCAT1 | ||
+ | |PCAT-1,PCA1 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNG0134403] | ||
+ | |PCAT14 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNG0101780] | ||
+ | |HIF1A-AS2 | ||
+ | |3'aHIF-1A,aHIF | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNG0101776] | ||
+ | |HIF1A-AS1 | ||
+ | |5'aHIF-1A,5'aHIF1alpha | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNG0031034] | ||
+ | |SOX2-OT | ||
+ | |SOX2OT,DKFZp761J1324,NCRNA00043 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | ||
+ | |Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNG0141815] | ||
+ | |CDR1-AS | ||
+ | |CDR1NAT,ciRS-7,CDR1as | ||
+ | |ceRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNG0050599] | ||
+ | |LINCMD1 | ||
+ | |MIR133BHG,LINC-MD1 | ||
+ | |ceRNA | ||
+ | |developmental process;pathogenic process | ||
+ | |Duchenne muscular dystrophy | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNG0082362] | ||
+ | |BGLT3 | ||
+ | |LINC01083,BGL3,lncRNA-BGL3 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |chronic myeloid leukemia | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNG0055058] | ||
+ | |LINC00473 | ||
+ | |C6orf176,bA142J11.1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;renal cell cancer | ||
+ | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNG0048223] | ||
+ | |LINC01108 | ||
+ | |LncRNA-ES1 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNG0103465] | ||
+ | |TUNAR | ||
+ | |LINC00617,TUNA,HI-LNC78 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNG0105343] | ||
+ | |OIP5-AS1 | ||
+ | |cyrano,linc-OIP5 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNG0048515] | ||
+ | |LINC00581 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |West Syndrome;West syndrome | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNG0141771] | ||
+ | |BX118339 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |West syndrome | ||
+ | |Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNG0010465] | ||
+ | |LINC00538 | ||
+ | |Yiya,PROX1UT | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNG0132926] | ||
+ | |CBR3-AS1 | ||
+ | |PlncRNA-1,PlncRNA1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNG0070363] | ||
+ | |MIR31HG | ||
+ | |LOC554202,hsa-lnc-31,LncHIFCAR | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNG0034419] | ||
+ | |DANCR | ||
+ | |KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNG0142444] | ||
+ | |uc.388 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNG0141957] | ||
+ | |FR0348383 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNG0141211] | ||
+ | |TTTY15 | ||
+ | |DKFZP434I143,NCRNA00138 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNG0141833] | ||
+ | |CRNDE | ||
+ | |LOC643911,LINC00180,CRNDEP | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | ||
+ | |Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNG0141800] | ||
+ | |CCND1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |tumor;cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNG0142050] | ||
+ | |lincRNA-p21 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |lung cancer;cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNG0142249] | ||
+ | |PCNCR1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNG0141603] | ||
+ | |DBET | ||
+ | |DBE-T,DUX4L30 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |facioscapulohumeral muscular dystrophy | ||
+ | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNG0071734] | ||
+ | |BANCR | ||
+ | |LINC00586 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNG0100636] | ||
+ | |PTCSC3 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer;thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290063 HSALNT0290063] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290063 HSALNG0142178] | ||
+ | |MVIH | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNG0052921] | ||
+ | |LINC01268 | ||
+ | |LOC285758 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNG0031716] | ||
+ | |LINC00887 | ||
+ | |linc-ATP13A4-8,HEIRCC | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNG0100075] | ||
+ | |DHRS4-AS1 | ||
+ | |C14orf167,PRO1488,AS1DHRS4 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNG0113304] | ||
+ | |FENDRR | ||
+ | |FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | ||
+ | |transcriptional regulation | ||
+ | |developmental process;pathogenic process | ||
+ | |osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNG0050235] | ||
+ | |LINC01512 | ||
+ | |LOC100132354,TCONS_00011120,HI-LNC77 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;type 2 diabetes | ||
+ | |Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNG0118547] | ||
+ | |LINC00673 | ||
+ | |HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNG0128306] | ||
+ | |LINC01433 | ||
+ | |LOC728228 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNG0068424] | ||
+ | |CCAT1 | ||
+ | |CARLo-5,onco-lncRNA-40 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNG0123467] | ||
+ | |TINCR | ||
+ | |ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | ||
+ | |translational control | ||
+ | |pathogenic process;developmental process | ||
+ | |bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNG0060113] | ||
+ | |LNCPRESS1 | ||
+ | |lncPRESS1 | ||
+ | |translational control | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNG0075843] | ||
+ | |LINC02561 | ||
+ | |RP11-445P17.8 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |cystic fibrosis | ||
+ | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNG0140616] | ||
+ | |LINC00850 | ||
+ | |KUCG1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Duchenne muscular dystrophy | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNG0032699] | ||
+ | |AFAP1-AS1 | ||
+ | |AFAP1A, AFAP1-A,MGC10981 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNG0141630] | ||
+ | |XACT | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNG0120344] | ||
+ | |GATA6-AS1 | ||
+ | |locus5689,BM742401 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;chronic lymphocytic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNG0073144] | ||
+ | |PTCSC2 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNG0141770] | ||
+ | |BTG3-AS1 | ||
+ | |ASBEL | ||
+ | |translational control | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;colorectal cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNG0070801] | ||
+ | |PTENP1 | ||
+ | |NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | ||
+ | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNG0142244] | ||
+ | |PAN | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Kaposi's sarcoma | ||
+ | |Neoplasms;Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNG0142054] | ||
+ | |LINC-ROR | ||
+ | |lincRNA-RoR,lincRNA-ST8SIA3,ROR | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNG0142437] | ||
+ | |UBE3A-ATS | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNG0043367] | ||
+ | |LINC00461 | ||
+ | |EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |retinal and visual function | ||
+ | |Eye Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNG0141602] | ||
+ | |CTBP1-AS | ||
+ | |PCAT10 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |chronic hepatitis C;prostate cancer;polycystic ovary syndrome | ||
+ | |Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNG0017694] | ||
+ | |GACAT1 | ||
+ | |LINC00876,AC096655.1-002 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNG0056854] | ||
+ | |HOXA-AS2 | ||
+ | |HOXA3as | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |promyelocytic leukemia;gastric cancer | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNG0043441] | ||
+ | |LUCAT1 | ||
+ | |SCAL1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNG0009941] | ||
+ | |BLACAT1 | ||
+ | |linc-UBC1,LINC00912,onco-lncRNA-30 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer;gastric cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNG0071221] | ||
+ | |GLIDR | ||
+ | |LINC01172,MGC21881,TCONS_00015562 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNG0104548] | ||
+ | |PWAR5 | ||
+ | |PAR5,PAR-5 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNG0059377] | ||
+ | |TP53TG1 | ||
+ | |TP53AP1,H_RG012D21.9,LINC00096 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;ataxia telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNG0141713] | ||
+ | |AK126698 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNG0104558] | ||
+ | |IPW | ||
+ | |NCRNA00002 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNG0068443] | ||
+ | |CCAT2 | ||
+ | |NCCP1,LINC00873 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNG0129180] | ||
+ | |LINC00261 | ||
+ | |C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer;non-small cell lung cancer;gastric cancer | ||
+ | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNG0000303] | ||
+ | |LINC00982 | ||
+ | |FLJ42875 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNG0142197] | ||
+ | |NEAT1_2 | ||
+ | |NEAT1_2 | ||
+ | |protein localization | ||
+ | |pathogenic process | ||
+ | |amyotrophic lateral sclerosis | ||
+ | |Nutritional and Metabolic Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNG0076040] | ||
+ | |GATA3-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNG0004297] | ||
+ | |GNG12-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNG0142510] | ||
+ | |YAM1 | ||
+ | |Yam-1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process;developmental process | ||
+ | |skeletal myogenesis | ||
+ | |Musculoskeletal Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNG0018036] | ||
+ | |PAX8-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |malignant pleural mesothelioma;cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNG0026023] | ||
+ | |RASSF1-AS1 | ||
+ | |ANRASSF1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNG0142376] | ||
+ | |SUMO1P3 | ||
+ | |SUMO1P3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;gastric cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNG0094549] | ||
+ | |HNF1A-AS1 | ||
+ | |C12orf27,NCRNA00262,FLJ38690,HAS1 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNG0041218] | ||
+ | |NIPBL-AS1 | ||
+ | |NIPBL-DT,NIPBL-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |autism spectrum disorder | ||
+ | |Mental Disorders | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNG0057702] | ||
+ | |SNHG15 | ||
+ | |C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNG0113835] | ||
+ | |MIR22HG | ||
+ | |C17orf91,MGC14376,DKFZp686O06159 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNG0113835] | ||
+ | |MIR22HG | ||
+ | |C17orf91,MGC14376,DKFZp686O06159 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNG0119881] | ||
+ | |GACAT2 | ||
+ | |MTCL1-AS1,HMlincRNA717 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer;non-small cell lung cancer;gastric cancer | ||
+ | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNG0134448] | ||
+ | |MIF-AS1 | ||
+ | |LOC284889,MIF-AS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |malaria;nephrolithiasis | ||
+ | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNG0061385] | ||
+ | |LINC-PINT | ||
+ | |MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;heart failure | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNG0020769] | ||
+ | |SCHLAP1 | ||
+ | |LINC00913,SChLAP1,PCAT11 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |bladder cancer;prostate cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNG0093119] | ||
+ | |SOCS2-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNG0066261] | ||
+ | |CASC9 | ||
+ | |ESCCAL-1,ESSCAL1,LINC00981 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNG0130306] | ||
+ | |HNF4A-AS1 | ||
+ | |uc002xlx | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNG0131196] | ||
+ | |NKILA | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNG0088539] | ||
+ | |LINC00942 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;autism spectrum disorder | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNG0062700] | ||
+ | |MNX1-AS1 | ||
+ | |CCAT5,LOC645249 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;colorectal cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNG0141629] | ||
+ | |VPS9D1-AS1 | ||
+ | |MYU | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;colorectal cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNG0142381] | ||
+ | |TC0101441 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |epithelial ovarian cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNG0009856] | ||
+ | |ERLNC1 | ||
+ | |TC0101441,ElncRNA1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNG0142165] | ||
+ | |Mdgt | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNG0020594] | ||
+ | |HAGLR | ||
+ | |HOXD-AS1,Mdgt | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;neuroblastoma | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNG0017541] | ||
+ | |LINC01158 | ||
+ | |PANTR1,linc-Brn1a,linc-POU3F3 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process;developmental process | ||
+ | |esophageal squamous cell cancer;gastric cancer;glioma | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNG0062110] | ||
+ | |GHET1 | ||
+ | |lncRNA-GHET1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;gastric cancer;colorectal cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNG0141625] | ||
+ | |PEG13 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |intellectual disabilities | ||
+ | |Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNG0140233] | ||
+ | |MIR503HG | ||
+ | |MGC16121,H19X | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |choriocarcinoma | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNG0083445] | ||
+ | |PAUPAR | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process;developmental process | ||
+ | |uveal melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNG0094171] | ||
+ | |LINC01234 | ||
+ | |LCAL84,onco-lncRNA-32 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |oesophageal squamous cell cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNG0016642] | ||
+ | |CYTOR | ||
+ | |C2orf59,NCRNA00152,MGC4677 | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNG0141821] | ||
+ | |CHRF | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |cardiac hypertrophy;silicosis | ||
+ | |Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNG0068436] | ||
+ | |CASC8 | ||
+ | |LINC00860,CARLo-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNG0068465] | ||
+ | |CASC11 | ||
+ | |TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNG0133191] | ||
+ | |LINC00323 | ||
+ | |PRED42,FLJ37173 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer;hereditary haemorrhagic telangiectasia | ||
+ | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNG0011845] | ||
+ | |LINC01139 | ||
+ | |LINK-A,TCONS_00000027 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNG0036270] | ||
+ | |LEF1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia;colorectal cancer | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNG0119753] | ||
+ | |LINC00667 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hereditary haemorrhagic telangiectasia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNG0142260] | ||
+ | |POU3F3 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNG0096112] | ||
+ | |LINC00426 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |primary Sjögren's syndrome | ||
+ | |Immune System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNG0074744] | ||
+ | |LINC00963 | ||
+ | |MetaLnc9 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNG0086124] | ||
+ | |PCF11-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNG0141649] | ||
+ | |91H | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNG0055679] | ||
+ | |ELFN1-AS1 | ||
+ | |MYCLo-2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNG0079547] | ||
+ | |ACTA2-AS1 | ||
+ | |uc001kfo.1,ZXF1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNG0059132] | ||
+ | |APTR | ||
+ | |RSBN1L-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |liver fibrosis;glioblastoma | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNG0142101] | ||
+ | |lncRNA-MVIH | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNG0142092] | ||
+ | |lncRNA-ATB | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNG0141737] | ||
+ | |ATB | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | ||
+ | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNG0141701] | ||
+ | |AK057054 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNG0135702] | ||
+ | |LINC01315 | ||
+ | |lnc-C22orf32-1,C22orf32-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNG0026583] | ||
+ | |ADAMTS9-AS2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;glioma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNG0009103] | ||
+ | |PACERR | ||
+ | |PACER,PTGS2-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;osteoarthritis;inflammation and cancer | ||
+ | |Musculoskeletal Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNG0010604] | ||
+ | |TGFB2-OT1 | ||
+ | |FLJ11812 | ||
+ | |ceRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNG0027860] | ||
+ | |DUBR | ||
+ | |LINC00883 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |asthma and chronic obstructive pulmonary disease | ||
+ | |Respiratory Tract Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNT0290147] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNG0142262] | ||
+ | |POXCUT | ||
+ | |TCONS_00011636 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNG0047407] | ||
+ | |FOXCUT | ||
+ | |LINC01379,TCONS_00011636 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNG0059521] | ||
+ | |CYP51A1-AS1 | ||
+ | |ENST00000453068,LRRD1-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |renal cell cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNG0036288] | ||
+ | |RPL34-AS1 | ||
+ | |FLJ37673,RP11-462C24.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNG0045015] | ||
+ | |C5orf66-AS1 | ||
+ | |CTC-276P9.1,Epist | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNG0006924] | ||
+ | |LINC00623 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |nasopharyngeal cancer | ||
+ | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNG0141946] | ||
+ | |FER1L4 | ||
+ | |FER1L4 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;endometrial cancer;colorectal cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNG0013215] | ||
+ | |GACAT3 | ||
+ | |LINC01458,lncRNA-AC130710 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;gastric cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNG0058863] | ||
+ | |ABHD11-AS1 | ||
+ | |WBSCR26,LINC00035,NCRNA00035 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;mutant huntingtin | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNG0137651] | ||
+ | |ZNF674-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNG0106864] | ||
+ | |PCAT29 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNG0141787] | ||
+ | |CADM1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNG0007253] | ||
+ | |LINC01527 | ||
+ | |lnc-SPRR2D-1,RP1-13P20.6 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNG0108520] | ||
+ | |LUNAR1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | ||
+ | |Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNG0141945] | ||
+ | |FAR2P1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNG0053580] | ||
+ | |TARID | ||
+ | |EYA4-AS1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |kidney clear cell sarcoma | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNG0069286] | ||
+ | |MAFA-AS1 | ||
+ | |RP11-909N17.3,TCONS_00014882 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNG0142344] | ||
+ | |RPLP0P2 | ||
+ | |RPLP0P2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNG0133273] | ||
+ | |ZNF295-AS1 | ||
+ | |C21orf121,NCRNA00318,PRED87 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;epithelial ovarian cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNG0040150] | ||
+ | |LINC01513 | ||
+ | |RP11-1C1.7,TCONS_00009352 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNG0108507] | ||
+ | |IRAIN | ||
+ | |IGF1R-AS | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNG0142517] | ||
+ | |ZNRD1-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;lung cancer;cervical cancer | ||
+ | |Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNG0141615] | ||
+ | |LCAL1 | ||
+ | |onco-lncRNA-27 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNG0100038] | ||
+ | |MHRT | ||
+ | |Myheart | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |heart hypertrophy;acute myocardial infarction | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNG0141974] | ||
+ | |HA117 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hirschsprung disease | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNG0012722] | ||
+ | |NRIR | ||
+ | |lncRNA-CMPK2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |chronic hepatitis C;HCV | ||
+ | |Digestive System Diseases;Virus Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNG0142002] | ||
+ | |LET | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | ||
+ | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNG0004023] | ||
+ | |NFIA-AS1 | ||
+ | |RP5-833A20.1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |atherosclerosis;glioma | ||
+ | |Cardiovascular Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNG0119710] | ||
+ | |GAPLINC | ||
+ | |LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | ||
+ | |siRNA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNG0079313] | ||
+ | |CERNA2 | ||
+ | |HOST2,lncRNA-HOST2 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;epithelial ovarian cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNG0050689] | ||
+ | |LINC01564 | ||
+ | |TCONS_00011314 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNG0012685] | ||
+ | |LINC01105 | ||
+ | |FLJ30594,LOC150622 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer;leukemia and neuroblastoma | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNG0091650] | ||
+ | |AGAP2-AS1 | ||
+ | |LOC100130776,PUNISHER | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;glioma;leukemia and neuroblastoma | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNG0106834] | ||
+ | |EWSAT1 | ||
+ | |TMEM84,NCRNA00277,LINC00277,FLJ33768 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |Ewing sarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNG0074573] | ||
+ | |SLC25A25-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNG0130331] | ||
+ | |KCNK15-AS1 | ||
+ | |RP11-445H22.4 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis;breast cancer | ||
+ | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNG0141979] | ||
+ | |HIF2PUT | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNG0019370] | ||
+ | |TEX41 | ||
+ | |DKFZp686O1327,LINC00953 | ||
+ | |transcriptional regulation | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNG0142476] | ||
+ | |UFC1 | ||
+ | |NA | ||
+ | |transcriptional regulation;ceRNA | ||
+ | |pathogenic process | ||
+ | |osteoarthritis;hepatocellular cancer | ||
+ | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNG0142001] | ||
+ | |LEIGC | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNG0049188] | ||
+ | |MDC1-AS1 | ||
+ | |MDC1-AS | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer;glioma | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNG0048542] | ||
+ | |NBAT1 | ||
+ | |CASC14,NBAT-1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |breast cancer;renal clear cell cancer;neuroblastoma | ||
+ | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNG0113287] | ||
+ | |LINC00917 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration;breast cancer | ||
+ | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNG0094327] | ||
+ | |LINC00173 | ||
+ | |NCRNA00173,FLJ42957 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |HIV-1-infected;hepatocelluar cancer | ||
+ | |Virus Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNG0142253] | ||
+ | |PEG10 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diffuse large B-cell lymphoma;esophageal cancer | ||
+ | |Neoplasms;Hemic and Lymphatic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNG0041549] | ||
+ | |LINC02224 | ||
+ | |BRCAT107,ENST00000505706 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |active tuberculosis | ||
+ | |Bacterial Infections and Mycoses | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNG0141981] | ||
+ | |HIT | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNG0002075] | ||
+ | |SNHG12 | ||
+ | |ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma;endometrial cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNG0002236] | ||
+ | |LINC01225 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNG0142162] | ||
+ | |MALAT2 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNG0084672] | ||
+ | |SNHG1 | ||
+ | |LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNG0044933] | ||
+ | |WSPAR | ||
+ | |TCONS_00009511-XLOC_004555,lncTCF7 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;liver cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNG0118552] | ||
+ | |LINC00511 | ||
+ | |onco-lncRNA-12 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNG0069321] | ||
+ | |FAM83H-AS1 | ||
+ | |onco-lncRNA-3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNG0051162] | ||
+ | |LINC00472 | ||
+ | |C6orf155,dJ288M22.3,FLJ13189 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNG0142040] | ||
+ | |linc-ITGB1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNG0007801] | ||
+ | |LINC01133 | ||
+ | |lncRNA-PAGBC | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNG0141600] | ||
+ | |CCEPR | ||
+ | |CCHE1,lncRNA-CCHE1 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;cervical cancer | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNG0098682] | ||
+ | |SOX21-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;oral squamous cell cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNG0048533] | ||
+ | |CASC15 | ||
+ | |LINC00340,lnc-SOX4-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |basal cell cancer;melanoma;neuroblastoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNG0141670] | ||
+ | |AC104699.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNG0045923] | ||
+ | |CLMAT3 | ||
+ | |SPARC-AS1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNG0043698] | ||
+ | |RGMB-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung adenocarcinoma;non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNG0142023] | ||
+ | |LINC01419 | ||
+ | |LVCAT7,TCONS_00014497 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNG0141656] | ||
+ | |AB209630 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hypopharyngeal squamous cell cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNG0141723] | ||
+ | |AOC4P | ||
+ | |AOC4P | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer;hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNG0040781] | ||
+ | |PURPL | ||
+ | |LINC01021,LOC643401,RP11-46C20.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNG0094605] | ||
+ | |LINC01089 | ||
+ | |LIMT | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer;astrocytoma | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNG0058166] | ||
+ | |EGFR-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNG0141654] | ||
+ | |AB073614 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;glioma | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNG0117322] | ||
+ | |CACNA1G-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |keloid | ||
+ | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNG0081992] | ||
+ | |MIR210HG | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hypoxic and inflammatory stress | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNG0113319] | ||
+ | |FOXC2-AS1 | ||
+ | |ODRUL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |osteosarcoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNG0132865] | ||
+ | |LINC00160 | ||
+ | |C21orf52,NCRNA00160 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNG0049582] | ||
+ | |LINC01016 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNG0045753] | ||
+ | |CARMN | ||
+ | |MIR143HG,CARMEN | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |cardiac differentiation | ||
+ | |Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNG0121579] | ||
+ | |LINC01630 | ||
+ | |LOC100287225 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNG0104253] | ||
+ | |FAM30A | ||
+ | |C14orf110,KIAA0125,HSPC053 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |gallbladder cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNG0141617] | ||
+ | |LINC00346 | ||
+ | |C13orf29,NCRNA00346 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNG0141758] | ||
+ | |BC032469 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNG0141695] | ||
+ | |AK024171 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |intervertebral disc degeneration;gastric cancer | ||
+ | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNG0142302] | ||
+ | |RP11-284N8.3.1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNG0141954] | ||
+ | |FMR6 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |fragile X syndrome;fragile X-associated premature ovarian insufficiency | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNG0142267] | ||
+ | |PRAL | ||
+ | |lncRNA-PRAL | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNG0129818] | ||
+ | |NORAD | ||
+ | |LINC00657 | ||
+ | |transcriptional regulation;translational control | ||
+ | |pathogenic process | ||
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNG0041283] | ||
+ | |LIFR-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |preterm | ||
+ | |Female Urogenital Diseases and Pregnancy Complications | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNG0036373] | ||
+ | |PANCR | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |atrial fibrillation | ||
+ | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNG0060982] | ||
+ | |FEZF1-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNG0115230] | ||
+ | |CCDC144NL-AS1 | ||
+ | |NA | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;cardiac hypertrophy | ||
+ | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNG0142217] | ||
+ | |NR_026689 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNG0075559] | ||
+ | |ADARB2-AS1 | ||
+ | |C10orf109,NCRNA00168,bA466B20.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer;pancreatic ductal adenocarcinoma | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNG0018139] | ||
+ | |DPP10-AS1 | ||
+ | |BC032913 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |breast cancer;colorectal cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNG0113682] | ||
+ | |GAS8-AS1 | ||
+ | |C16orf3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNG0075802] | ||
+ | |MANCR | ||
+ | |LINC00704 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNG0026715] | ||
+ | |SAMMSON | ||
+ | |LINC01212 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |melanoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNG0007238] | ||
+ | |LINC00302 | ||
+ | |C1orf46,NCRNA00302,XP33 | ||
+ | |NA | ||
+ | |developmental process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNG0118895] | ||
+ | |SNHG20 | ||
+ | |C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNG0007463] | ||
+ | |DCST1-AS1 | ||
+ | |RP11-307C12.11 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNG0071682] | ||
+ | |PGM5-AS1 | ||
+ | |FAM233A,LOC572558 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNG0142351] | ||
+ | |SBF2-AS1 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNG0142440] | ||
+ | |uc.338 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNT0289973] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNG0142088] | ||
+ | |LNCRI | ||
+ | |lnc-RI | ||
+ | |ceRNA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNG0142117] | ||
+ | |LOC100130476 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal squamous cell cancer;gastric cardia adenocarcinoma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNG0063356] | ||
+ | |LINC00599 | ||
+ | |Rncr3 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |diabetes | ||
+ | |Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNG0009871] | ||
+ | |LINC00628 | ||
+ | |NA | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |gastric cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNG0133031] | ||
+ | |DSCR4 | ||
+ | |DCRB | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Down syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNG0008546] | ||
+ | |GAS5-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |oral submucous fibrosis;non-small cell lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNG0048782] | ||
+ | |HCG11 | ||
+ | |bK14H9.3,FLJ14049,FLJ30357 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNG0064314] | ||
+ | |LINC02099 | ||
+ | |AC145110.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |rheumatoid arthritis;breast cancer | ||
+ | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNG0100348] | ||
+ | |G2E3-AS1 | ||
+ | |CAT1647 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |bladder cancer | ||
+ | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNG0015506] | ||
+ | |LINC02245 | ||
+ | |lnc-SERTAD2-3,AC007386.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNG0004109] | ||
+ | |FOXD3-AS1 | ||
+ | |pasFOXD3 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNG0060638] | ||
+ | |LINC00998 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |major depression disorder | ||
+ | |Behavior and Behavior Mechanisms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNG0041522] | ||
+ | |NNT-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNG0026555] | ||
+ | |PSMD6-AS1 | ||
+ | |ENST00000462717,lnc00462717 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer;glioma | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNG0119047] | ||
+ | |LINC02081 | ||
+ | |CTD-2357A8.3,XLOC_012582 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |esophageal cancer | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNG0107939] | ||
+ | |LINC00052 | ||
+ | |TMEM83,NCRNA00052,FLJ31461 | ||
+ | |ceRNA | ||
+ | |pathogenic process | ||
+ | |hepatocellular cancer;breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNG0095970] | ||
+ | |PLUT | ||
+ | |PDX1-AS1,PLUTO,HI-LNC71 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNG0073476] | ||
+ | |LINC01505 | ||
+ | |RP11-308N19.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNG0020625] | ||
+ | |LINC01116 | ||
+ | |TALNEC2 | ||
+ | |transcriptional regulation | ||
+ | |pathogenic process | ||
+ | |prostate cancer;glioblastoma | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNG0003395] | ||
+ | |FOXD2-AS1 | ||
+ | |MGC12982 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNG0122085] | ||
+ | |LINC00305 | ||
+ | |C18orf20,NCRNA00305,MGC39571,HsT1235 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNG0110794] | ||
+ | |FBXL19-AS1 | ||
+ | |NCRNA00095,MGC125469,MGC125470,MGC125472 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNG0090479] | ||
+ | |LINC02555 | ||
+ | |AC079630.2 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNG0121679] | ||
+ | |LINC01929 | ||
+ | |CTD-2171N6.1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |papillary thyroid cancer | ||
+ | |Endocrine System Diseases;Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNG0118529] | ||
+ | |LINC01152 | ||
+ | |TCONS_00025128,CMPD | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNG0139113] | ||
+ | |DIAPH2-AS1 | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Hodgkin's disease | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNG0104558] | ||
+ | |PWAR1 | ||
+ | |PAR1,PAR-1 | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |Prader-Willi syndrome and Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNG0070961] | ||
+ | |LINC00950 | ||
+ | |FP588 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNG0141855] | ||
+ | |DGCR12 | ||
+ | |DGS-E | ||
+ | |NA | ||
+ | |pathogenic process;developmental process | ||
+ | |DiGeorge syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNG0133987] | ||
+ | |DGCR9 | ||
+ | |DGS-A,POM121L5P | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |DiGeorge syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNG0133982] | ||
+ | |DGCR10 | ||
+ | |DGS-B | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494] | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNG0141605] | ||
+ | |DGCR11 | ||
+ | |DGS-D | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |} |
Revision as of 03:15, 26 August 2019
Transcript ID | Gene ID | Symbol | Synonyms | Functional Mechanism | Biological Process | Disease | Mesh Ontology |
---|---|---|---|---|---|---|---|
HSALNT0289501 | HSALNG0141612 | HPVC1 | PE5L,HPV18E5L | NA | pathogenic process | NA | NA |
HSALNT0289605 | HSALNG0141720 | Alpha 250/ Alpha 280 | NONHSAT104559,lnc-C9orf53-2:1 | NA | NA | NA | NA |
HSALNT0199632 | HSALNG0096226 | N4BP2L2-IT2 | CG030 | NA | NA | NA | NA |
HSALNT0171094 | HSALNG0082161 | LINC01150 | 2G7,TCONS_00019134 | NA | pathogenic process | Wilms' tumor | Neoplasms |
HSALNT0289115 | HSALNG0032599 | LINC01587 | C4orf6,aC1 | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0290105 | HSALNG0142220 | NTT | NONHSAT115106 | NA | NA | NA | NA |
HSALNT0289234 | HSALNG0053252 | RNF217-AS1 | STL | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0280481 | HSALNG0136795 | INE2 | NCRNA00011 | NA | NA | NA | NA |
HSALNT0289485 | HSALNG0137683 | INE1 | NCRNA00010 | NA | NA | NA | NA |
HSALNT0289511 | HSALNG0141622 | LINC01565 | C3orf27,GR6 | NA | pathogenic process | leukemia | Neoplasms |
HSALNT0289068 | HSALNG0006924 | LINC00869 | KIAA0493 | NA | NA | NA | NA |
HSALNT0289430 | HSALNG0026312 | ERC2-IT1 | C1orf1,C3orf51,Po42 | NA | pathogenic process | NA | NA |
HSALNT0290394 | HSALNG0142509 | Y RNAs | lnc-PDIA4-1:1 | NA | NA | NA | NA |
HSALNT0289195 | HSALNG0032409 | NOP14-AS1 | C4orf10,RES4-24 | NA | NA | NA | NA |
HSALNT0290309 | HSALNG0142424 | TncRNA | NONHSAT022116,AF080092,TSU | NA | developmental process | NA | NA |
HSALNT0289243 | HSALNG0045080 | SMAD5-AS1 | SMAD5O,DAMS | NA | pathogenic process | malignant hematopoietic | Cell Physiological Phenomena |
HSALNT0289025 | HSALNG0062672 | LINC00244 | C7orf4,NCRNA00244 | NA | pathogenic process | preaxial polydactyly | NA |
HSALNT0289017 | HSALNG0055219 | KIF25-AS1 | C6orf54,NCRNA00300,HGC6.1.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289332 | HSALNG0055207 | LINC01558 | C6orf123,LINC01557,HGC6.2,dJ431P23.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289438 | HSALNG0055209 | AFDN-AS1 | C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | NA | pathogenic process | NA | NA |
HSALNT0289232 | HSALNG0135027 | RFPL3S | RFPL3-AS1,RFPL3-A, NCRNA00005 | NA | pathogenic process | opitz syndrome | NA |
HSALNT0289393 | HSALNG0134830 | RFPL1S | RFPL1-AS1,RFPL1-A, NCRNA00006 | NA | pathogenic process | NA | NA |
HSALNT0289500 | HSALNG0141611 | HCG4B | HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | NA | NA | NA | NA |
HSALNT0289894 | HSALNG0142009 | LINC00294 | NA | NA | NA | NA | NA |
HSALNT0289345 | HSALNG0140599 | LINC00893 | NA | NA | pathogenic process | hunter syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0290133 | HSALNG0142248 | PCBP3-OT1 | PCBP3-OT1,FLJ44028 | NA | NA | NA | NA |
HSALNT0289488 | HSALNG0141599 | BPESC1 | NCRNA00187 | NA | pathogenic process | blepharophimosis syndrome | Eye Diseases |
HSALNT0289712 | HSALNG0141827 | COPG2IT1 | CIT1,NCRNA00170,COPG2AS | NA | NA | NA | NA |
HSALNT0265040 | HSALNG0128978 | LINC00652 | HSPC072 | NA | developmental process | NA | NA |
HSALNT0289282 | HSALNG0108689 | WASIR2 | NCRNA00286A | NA | NA | NA | NA |
HSALNT0246856 | HSALNG0119601 | LINC00470 | C18orf2 | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
HSALNT0289507 | HSALNG0141618 | LINC00588 | C8orf71,DKFZP434F122 | NA | NA | NA | NA |
HSALNT0276604 | HSALNG0134754 | TTC28-AS1 | TTC28AS,TTC28-AS,KIAA1648 | NA | NA | NA | NA |
HSALNT0237577 | HSALNG0114754 | CDRT7 | NCRNA00025,LINC00025 | NA | NA | NA | NA |
HSALNT0288912 | HSALNG0114755 | CDRT8 | NA | NA | NA | NA | NA |
HSALNT0275048 | HSALNG0133887 | CECR3 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0288915 | HSALNG0133890 | CECR9 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0288998 | HSALNG0133878 | HDHD5-AS1 | CECR4,CECR5-AS1,NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0288914 | HSALNG0133878 | CECR5-AS1 | NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0288919 | HSALNG0029809 | CLRN1-AS1 | CLRN1O,UCRP | NA | pathogenic process | usher syndrome type 3 | NA |
HSALNT0289271 | HSALNG0082585 | TMEM9B-AS1 | C11orf18 | NA | NA | NA | NA |
HSALNT0289324 | HSALNG0133586 | LINC01547 | C21orf69,C21orf67 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0270409 | HSALNG0131587 | LINC00029 | C20orf51,NCRNA00029,bA305P22.4 | NA | NA | NA | NA |
HSALNT0289336 | HSALNG0141634 | LINC00529 | C8orf8 | NA | pathogenic process | keratolytic winter erythema | NA |
HSALNT0288978 | HSALNG0010403 | FLVCR1-AS1 | FLVCR1-DT,LQK1 | NA | NA | NA | NA |
HSALNT0238050 | HSALNG0114969 | SMCR2 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289401 | HSALNG0114982 | SMCR5 | NCRNA00034 | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290246 | HSALNG0142361 | SMCR6 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0274626 | HSALNG0133620 | LINC00205 | C21orf86,NCRNA00205, | NA | pathogenic process | NA | NA |
HSALNT0271512 | HSALNG0132117 | C21orf91-OT1 | NCRNA00285,D21S2089E | NA | NA | NA | NA |
HSALNT0272596 | HSALNG0132582 | LINC00307 | NCRNA00307,D21S2091E | NA | NA | NA | NA |
HSALNT0274502 | HSALNG0133549 | TSPEAR-AS2 | C21orf90 | NA | NA | NA | NA |
HSALNT0274807 | HSALNG0133721 | MCM3AP-AS1 | C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | NA | NA | NA | NA |
HSALNT0288888 | HSALNG0133144 | B3GALT5-AS1 | C21orf88 | NA | NA | NA | NA |
HSALNT0288898 | HSALNG0133127 | BRWD1-AS2 | C21orf87,NCRNA00257,BRWD1-IT2 | NA | NA | NA | NA |
HSALNT0289031 | HSALNG0133621 | LINC00315 | C21orf93,NCRNA00315 | NA | NA | NA | NA |
HSALNT0289033 | HSALNG0133612 | LINC00334 | C21orf89,NCRNA00334 | NA | NA | NA | NA |
HSALNT0289322 | HSALNG0132477 | LINC00314 | C21orf94,NCRNA00314 | NA | NA | NA | NA |
HSALNT0271821 | HSALNG0132261 | LINC00308 | C21orf74,NCRNA00308,PRED16 | NA | pathogenic process | NA | NA |
HSALNT0289023 | HSALNG0132537 | LINC00189 | C21orf109,NCRNA00189 | NA | pathogenic process | NA | NA |
HSALNT0289375 | HSALNG0042788 | NCRUPAR | ncR-uPAR,ncRuPAR,NCRNA00193 | transcriptional regulation | developmental process | NA | NA |
HSALNT0273467 | HSALNG0133048 | DSCR10 | NA | NA | NA | NA | NA |
HSALNT0289480 | HSALNG0132984 | DSCR9 | NCRNA00038 | NA | NA | NA | NA |
HSALNT0290051 | HSALNG0142166 | MDS2 | NA | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
HSALNT0127810 | HSALNG0060777 | ST7-AS2 | ST7OT2,ST7AS2 | NA | pathogenic process | autism | Mental Disorders |
HSALNT0127813 | HSALNG0060778 | ST7-OT3 | ST7OT3,NCRNA00026 | NA | pathogenic process | autism | Mental Disorders |
HSALNT0290258 | HSALNG0142373 | ST7-OT4 | NA | NA | pathogenic process | autism | Mental Disorders |
HSALNT0290257 | HSALNG0142372 | ST7OT | NONHSAT122926 | NA | NA | NA | NA |
HSALNT0289372 | HSALNG0074272 | MIR600HG | C9orf45,NCRNA00287,GL012,FLJ22161 | NA | NA | NA | NA |
HSALNT0013239 | HSALNG0006325 | ATP1A1-AS1 | C1orf203,ATP1A1OS,MGC16179 | NA | NA | NA | NA |
HSALNT0048563 | HSALNG0022910 | SPATA3-AS1 | NA | NA | NA | NA | NA |
HSALNT0050859 | HSALNG0024100 | LINC00852 | C3orf42,GHRLOS2,NAG73,GHRL-AS2 | NA | NA | NA | NA |
HSALNT0069395 | HSALNG0033002 | LINC01096 | NA | NA | NA | NA | NA |
HSALNT0072367 | HSALNG0034486 | LINC02260 | NA | NA | NA | NA | NA |
HSALNT0077259 | HSALNG0036896 | LINC01091 | NA | NA | NA | NA | NA |
HSALNT0096480 | HSALNG0046004 | SAP30L-AS1 | FLJ38109,GALNT10-AS1 | NA | NA | NA | NA |
HSALNT0098558 | HSALNG0046927 | PRR7-AS1 | NA | NA | NA | NA | NA |
HSALNT0099356 | HSALNG0047338 | LINC01622 | TCONS_00011202 | NA | NA | NA | NA |
HSALNT0113415 | HSALNG0053588 | LINC01312 | MGC34034 | NA | NA | NA | NA |
HSALNT0134652 | HSALNG0064240 | EXTL3-AS1 | C8orf50 | NA | NA | NA | NA |
HSALNT0138253 | HSALNG0065979 | C8orf34-AS1 | NA | NA | NA | NA | NA |
HSALNT0154876 | HSALNG0074139 | PSMD5-AS1 | NA | NA | NA | NA | NA |
HSALNT0163228 | HSALNG0078227 | LINC01553 | C10orf40,AC023904.2 | NA | NA | NA | NA |
HSALNT0175689 | HSALNG0084463 | LINC00301 | C11orf64,NCRNA00301,MGC39681 | NA | NA | NA | NA |
HSALNT0247235 | HSALNG0119722 | DLGAP1-AS3 | NA | NA | NA | NA | NA |
HSALNT0254200 | HSALNG0123001 | CIRBP-AS1 | C19orf23,MGC39338 | NA | NA | NA | NA |
HSALNT0257335 | HSALNG0124987 | LINC01785 | NA | NA | NA | NA | NA |
HSALNT0261582 | HSALNG0127139 | LINC01869 | MGC45922 | NA | NA | NA | NA |
HSALNT0269743 | HSALNG0131262 | LINC01711 | MGC4294 | NA | NA | NA | NA |
HSALNT0288468 | HSALNG0141311 | FAM41AY1 | FAM41AY | NA | NA | NA | NA |
HSALNT0288899 | HSALNG0045020 | C5orf66-AS2 | NA | NA | NA | NA | NA |
HSALNT0288922 | HSALNG0083517 | CSTF3-AS1 | CSTF3-DT | NA | NA | NA | NA |
HSALNT0288923 | HSALNG0014289 | CYP1B1-AS1 | C2orf58,MGC34824 | NA | NA | NA | NA |
HSALNT0288957 | HSALNG0025315 | ENTPD3-AS1 | FLJ36665 | NA | NA | NA | NA |
HSALNT0288970 | HSALNG0071511 | FAM27E3 | MGC42630 | NA | NA | NA | NA |
HSALNT0288972 | HSALNG0000046 | FAM41C | NA | NA | NA | NA | NA |
HSALNT0288977 | HSALNG0007223 | FLG-AS1 | NA | NA | NA | NA | NA |
HSALNT0288983 | HSALNG0105871 | GABPB1-IT1 | FLJ10038 | NA | NA | NA | NA |
HSALNT0289010 | HSALNG0123950 | ILF3-AS1 | ILF3-DT | NA | NA | NA | NA |
HSALNT0289034 | HSALNG0097943 | LINC00347 | NA | NA | NA | NA | NA |
HSALNT0289039 | HSALNG0004105 | LINC00466 | NA | NA | NA | NA | NA |
HSALNT0289040 | HSALNG0022951 | LINC00471 | C2orf52,MGC43122 | NA | NA | NA | NA |
HSALNT0289044 | HSALNG0119752 | LINC00526 | C18orf18,MGC17515,HsT959 | NA | NA | NA | NA |
HSALNT0289048 | HSALNG0106873 | LINC00593 | C15orf50,MGC42951 | NA | NA | NA | NA |
HSALNT0289050 | HSALNG0022320 | LINC00608 | NA | NA | NA | NA | NA |
HSALNT0289054 | HSALNG0104144 | LINC00638 | MGC23270 | NA | NA | NA | NA |
HSALNT0289056 | HSALNG0124410 | LINC00661 | NA | NA | NA | NA | NA |
HSALNT0289057 | HSALNG0125113 | LINC00662 | NA | NA | NA | NA | NA |
HSALNT0289062 | HSALNG0024755 | LINC00692 | NA | NA | NA | NA | NA |
HSALNT0289064 | HSALNG0075805 | LINC00705 | NA | NA | NA | NA | NA |
HSALNT0289067 | HSALNG0118878 | LINC00868 | C17orf52 | NA | NA | NA | NA |
HSALNT0130693 | HSALNG0062275 | LINC00996 | NA | NA | NA | NA | NA |
HSALNT0289101 | HSALNG0089327 | LINC01252 | NA | NA | NA | NA | NA |
HSALNT0289131 | HSALNG0113283 | LINC02135 | NA | NA | NA | NA | NA |
HSALNT0289193 | HSALNG0018445 | NIFK-AS1 | NA | NA | NA | NA | NA |
HSALNT0289244 | HSALNG0008972 | SMG7-AS1 | DKFZP564C196 | NA | NA | NA | NA |
HSALNT0235326 | HSALNG0113528 | SNAI3-AS1 | MGC23284 | NA | NA | NA | NA |
HSALNT0215205 | HSALNG0103442 | SNHG10 | C14orf62,FLJ40557,NCRNA00063,LINC00063 | NA | NA | NA | NA |
HSALNT0289290 | HSALNG0109122 | ZNF205-AS1 | MGC3771 | NA | NA | NA | NA |
HSALNT0289294 | HSALNG0009820 | LINC00260 | C1orf217,NCRNA00260,MGC5457 | NA | NA | NA | NA |
HSALNT0289295 | HSALNG0000511 | LINC00337 | C1orf211,NCRNA00337,MGC40168 | NA | NA | NA | NA |
HSALNT0289298 | HSALNG0076905 | WAC-AS1 | NA | NA | NA | NA | NA |
HSALNT0289299 | HSALNG0077486 | LINC00839 | NA | NA | NA | NA | NA |
HSALNT0289303 | HSALNG0089110 | LINC00612 | C12orf33,MGC40170,FLJ41814 | NA | NA | NA | NA |
HSALNT0289312 | HSALNG0124755 | LINC00663 | MGC39821 | NA | NA | NA | NA |
HSALNT0289320 | HSALNG0130611 | LINC00494 | NA | NA | NA | NA | NA |
HSALNT0289330 | HSALNG0039733 | LINC01019 | NA | NA | NA | NA | NA |
HSALNT0289333 | HSALNG0057380 | LINC00265 | NCRNA00265,NCRNA00265-1 | NA | NA | NA | NA |
HSALNT0289334 | HSALNG0062824 | LINC00689 | NA | NA | NA | NA | NA |
HSALNT0289337 | HSALNG0068847 | LINC01591 | NA | NA | NA | NA | NA |
HSALNT0289340 | HSALNG0072666 | LINC01501 | NA | NA | NA | NA | NA |
HSALNT0289346 | HSALNG0137712 | LINC01560 | CXorf24 | NA | NA | NA | NA |
HSALNT0289352 | HSALNG0045051 | LINC01959 | NA | NA | NA | NA | NA |
HSALNT0289353 | HSALNG0110333 | LINC02175 | NA | NA | NA | NA | NA |
HSALNT0289354 | HSALNG0064321 | LINC02209 | FAM183CP | NA | NA | NA | NA |
HSALNT0289359 | HSALNG0107406 | LINGO1-AS1 | NA | NA | NA | NA | NA |
HSALNT0289362 | HSALNG0119342 | MAFG-AS1 | MAFG-DT | NA | NA | NA | NA |
HSALNT0289373 | HSALNG0139326 | MORF4L2-AS1 | NA | NA | NA | NA | NA |
HSALNT0289381 | HSALNG0029035 | NPHP3-AS1 | NCRNA00119 | NA | NA | NA | NA |
HSALNT0289385 | HSALNG0062543 | PAXIP1-AS1 | NA | NA | NA | NA | NA |
HSALNT0289413 | HSALNG0082091 | TOLLIP-AS1 | NA | NA | NA | NA | NA |
HSALNT0289416 | HSALNG0113198 | LINC00311 | TMEM148,NCRNA00311,MGC22001 | NA | NA | NA | NA |
HSALNT0289422 | HSALNG0069500 | ZNF252P-AS1 | C8orf77 | NA | NA | NA | NA |
HSALNT0289423 | HSALNG0001624 | ZNF436-AS1 | C1orf213,FLJ90508 | NA | NA | NA | NA |
HSALNT0289429 | HSALNG0029047 | BFSP2-AS1 | MGC2848 | NA | NA | NA | NA |
HSALNT0289432 | HSALNG0032263 | CTBP1-AS1 | C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 | NA | NA | NA | NA |
HSALNT0289436 | HSALNG0039444 | EXOC3-AS1 | C5orf55 | NA | NA | NA | NA |
HSALNT0289441 | HSALNG0049246 | HCG27 | bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | NA | NA | NA | NA |
HSALNT0289450 | HSALNG0067505 | BAALC-AS2 | C8orf56,BAALCOS,MGC39526 | NA | NA | NA | NA |
HSALNT0289453 | HSALNG0062877 | FAM87A | NA | NA | NA | NA | NA |
HSALNT0289459 | HSALNG0078365 | JMJD1C-AS1 | NA | NA | NA | NA | NA |
HSALNT0289465 | HSALNG0092957 | ATP2B1-AS1 | LINC00936 | NA | NA | NA | NA |
HSALNT0289466 | HSALNG0093183 | CEP83-AS1 | CEP83-DT | NA | NA | NA | NA |
HSALNT0289470 | HSALNG0107054 | HEXA-AS1 | C15orf34,FLJ13315 | NA | NA | NA | NA |
HSALNT0289487 | HSALNG0141598 | BIN3-IT1 | FLJ14107 | NA | NA | NA | NA |
HSALNT0289490 | HSALNG0141601 | CSNK1G2-AS1 | C19orf34,MGC39696 | NA | NA | NA | NA |
HSALNT0289508 | HSALNG0141619 | LINC00634 | NA | NA | NA | NA | NA |
HSALNT0289510 | HSALNG0141621 | LINC00685 | CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | NA | NA | NA | NA |
HSALNT0289515 | HSALNG0141626 | SHANK2-AS3 | C11orf76 | NA | NA | NA | NA |
HSALNT0290073 | HSALNG0142188 | NCBP2-AS2 | NA | NA | NA | NA | NA |
HSALNT0289502 | HSALNG0141613 | KCNIP4-IT1 | NCRNA00099,UM9-5 | NA | NA | NA | NA |
HSALNT0289856 | HSALNG0141971 | GTSCR1 | NA | NA | pathogenic process | Gilles de la Tourette syndrome | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289325 | HSALNG0008917 | LINC00272 | C1orf120,NCRNA00272,RP1-223H12.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288512 | HSALNG0141348 | TTTY9B | NCRNA00132 | NA | NA | NA | NA |
HSALNT0290155 | HSALNG0142270 | Prion-associated RNAs | NA | NA | pathogenic process | prion disease | Nervous System Diseases |
HSALNT0289444 | HSALNG0062567 | BLACE | NA | NA | pathogenic process | acute B lymphoblastic leukemias | Hemic and Lymphatic Diseases |
HSALNT0060411 | HSALNG0028877 | H1FX-AS1 | C3orf47,FLJ34151 | NA | NA | NA | NA |
HSALNT0186668 | HSALNG0089868 | LINC00477 | C12orf67,FLJ32894,FAM191B | NA | NA | NA | NA |
HSALNT0275096 | HSALNG0133923 | LINC00528 | C22orf37,FLJ40542 | NA | NA | NA | NA |
HSALNT0287824 | HSALNG0140941 | ASMTL-AS1 | CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | NA | NA | NA | NA |
HSALNT0288887 | HSALNG0106820 | ANP32A-IT1 | C15orf28,NCRNA00321,FLJ11722,HsT18971 | NA | NA | NA | NA |
HSALNT0289370 | HSALNG0010128 | MIR29B2CHG | C1orf132,FLJ35650 | NA | NA | NA | NA |
HSALNT0289396 | HSALNG0007497 | RUSC1-AS1 | C1orf104,FLJ35976 | NA | NA | NA | NA |
HSALNT0084628 | HSALNG0040236 | LINC01194 | CT49,TAG | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289468 | HSALNG0103838 | DIO3OS | C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | NA | NA | NA | NA |
HSALNT0121060 | HSALNG0057178 | NPSR1-AS1 | AAA1,IMAGE:4827585 | NA | NA | NA | NA |
HSALNT0074370 | HSALNG0035535 | LINC00575 | C4orf11 | NA | pathogenic process | NA | NA |
HSALNT0137345 | HSALNG0065537 | LINC01602 | T1560 | NA | pathogenic process | NA | NA |
HSALNT0289433 | HSALNG0035768 | FAM13A-AS1 | FAM13A1OS,FAM13AOS,NCRNA00039 | NA | NA | NA | NA |
HSALNT0289186 | HSALNG0072891 | MIRLET7DHG | NA | NA | NA | NA | NA |
HSALNT0155254 | HSALNG0074353 | MIR181A2HG | NA | NA | NA | NA | NA |
HSALNT0289283 | HSALNG0035624 | WDFY3-AS2 | C4orf12,NCRNA00247,FBI4 | NA | NA | NA | NA |
HSALNT0154555 | HSALNG0073990 | PAPPA-AS1 | PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | NA | NA | NA | NA |
HSALNT0136307 | HSALNG0065020 | LINC00293 | BEYLA | NA | developmental process | NA | NA |
HSALNT0030983 | HSALNG0014614 | SIX3-AS1 | SIX3OS | NA | developmental process | NA | NA |
HSALNT0211503 | HSALNG0101546 | OTX2-AS1 | OTX2OS1 | NA | developmental process | NA | NA |
HSALNT0063422 | HSALNG0030360 | LINC01192 | CT64 | NA | NA | NA | NA |
HSALNT0217123 | HSALNG0104394 | LINC01193 | CT60,LOC348120 | NA | NA | NA | NA |
HSALNT0289664 | HSALNG0141779 | C1QTNF9B-AS1 | PCOTH | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289623 | HSALNG0141738 | ATP6V1G2-DDX39B | NA | NA | pathogenic process | dilated cardiomyopathy | Cardiovascular Diseases |
HSALNT0289498 | HSALNG0141609 | FAM226B | CXorf50B,NCRNA00246B,LINC00246B | NA | NA | NA | NA |
HSALNT0289321 | HSALNG0133590 | LINC00163 | C21orf134,NCRNA00163,NLC1-A,NLC1A | NA | pathogenic process | narcolepsy | Mental Disorders;Nervous System Diseases |
HSALNT0289505 | HSALNG0141616 | LINC00165 | C21orf135,NCRNA00165,NLC1-B | NA | NA | NA | NA |
HSALNT0290297 | HSALNG0142412 | TEA-ncRNAs | ENSG00000251002 | NA | NA | NA | NA |
HSALNT0274212 | HSALNG0133403 | LINC00322 | C21orf136,NCRNA00322,FLJ16545 | NA | NA | NA | NA |
HSALNT0289741 | HSALNG0141856 | DHFR upstream transcripts | DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | transcriptional regulation | NA | NA | NA |
HSALNT0289527 | HSALNG0141642 | 21A | ncRNA 21A,NONHSAT128494 | NA | NA | NA | NA |
HSALNT0289409 | HSALNG0080181 | TLX1NB | TD1,TDI,APT-B7 | NA | pathogenic process | leukemogenesis | Hemic and Lymphatic Diseases |
HSALNT0289662 | HSALNG0141777 | C15orf2 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290097 | HSALNG0142212 | NPAP1 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0217406 | HSALNG0104530 | PWRN2 | NCRNA00199 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289227 | HSALNG0104528 | PWRN1 | NCRNA00198 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0262816 | HSALNG0127793 | MIMT1 | MIM1,NCRNA00067,LINC00067 | NA | NA | NA | NA |
HSALNT0289180 | HSALNG0000682 | MIR34AHG | NA | NA | NA | NA | NA |
HSALNT0289357 | HSALNG0049203 | LINC02570 | XXbac-BPG27H4.8 | NA | pathogenic process | MHC-associated diseases | Immune System Diseases |
HSALNT0290177 | HSALNG0142292 | RNY1 | NA | NA | pathogenic process | cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0289378 | HSALNG0129114 | NKX2-2-AS1 | NKX2-2AS | transcriptional regulation | pathogenic process | NA | NA |
HSALNT0290151 | HSALNG0142266 | PR antisense transcripts | FJ515872.1,NONHSAT023851 | transcriptional regulation | NA | NA | NA |
HSALNT0180290 | HSALNG0086714 | PGR-AS1,PR antisense transcripts | AT1,AT2,AT3 | NA | NA | NA | NA |
HSALNT0289607 | HSALNG0141722 | anti-NOS2A | NA | NA | pathogenic process | meningioma;glioblastoma | Neoplasms;Nervous System Diseases |
HSALNT0289687 | HSALNG0141802 | CDKN1A-AS1 | p21NAT | transcriptional regulation | NA | NA | NA |
HSALNT0289166 | HSALNG0103805 | MEG9 | LINC00584 | NA | NA | NA | NA |
HSALNT0116668 | HSALNG0055114 | RPS6KA2-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289384 | HSALNG0073983 | PAPPA-AS2 | AGU1 | NA | NA | NA | NA |
HSALNT0262802 | HSALNG0127785 | ZIM2-AS1 | ZIM2as | NA | NA | NA | NA |
HSALNT0289824 | HSALNG0141939 | Evf2 | Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | transcriptional regulation | NA | NA | NA |
HSALNT0289481 | HSALNG0134495 | ADORA2A-AS1 | C22orf45,FLJ34651 | NA | NA | NA | NA |
HSALNT0290146 | HSALNG0142261 | POU5F1P4 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290033 | HSALNG0142148 | LSINCT1 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290034 | HSALNG0142149 | LSINCT10 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290035 | HSALNG0142150 | LSINCT11 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290036 | HSALNG0142151 | LSINCT12 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290037 | HSALNG0142152 | LSINCT2 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290038 | HSALNG0142153 | LSINCT3 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290039 | HSALNG0142154 | LSINCT4 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290041 | HSALNG0142156 | LSINCT6 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290042 | HSALNG0142157 | LSINCT7 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290043 | HSALNG0142158 | LSINCT8 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290044 | HSALNG0142159 | LSINCT9 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289676 | HSALNG0141791 | CAR Intergenic 10 | FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | transcriptional regulation | NA | NA | NA |
HSALNT0290032 | HSALNG0142147 | LRRC3DN | C21orf30,DKFZP434C128 | transcriptional regulation | NA | NA | NA |
HSALNT0266984 | HSALNG0129985 | SNHG11 | C20orf198,LINC00101,NCRNA00101 | NA | pathogenic process | obesity | Nutritional and Metabolic Diseases |
HSALNT0289880 | HSALNG0141995 | KRASP1 | NONHSAT113225,ENSG00000220635 | ceRNA | NA | NA | NA |
HSALNT0006368 | HSALNG0003376 | CYP4A22-AS1 | ncRNA-a3 | transcriptional regulation | NA | NA | NA |
HSALNT0027470 | HSALNG0013045 | LINC00570 | ncRNA-a5 | transcriptional regulation | NA | NA | NA |
HSALNT0289066 | HSALNG0003381 | LINC00853 | PDZK1IP1-AS1,ncRNA-a4 | transcriptional regulation | NA | NA | NA |
HSALNT0289936 | HSALNG0142051 | lincRNA-ROR | ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | NA | NA | NA | NA |
HSALNT0289705 | HSALNG0141820 | CHL1-AS2 | NA | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
HSALNT0076084 | HSALNG0036316 | SEC24B-AS1 | 1/2-SBSRNA4 | siRNA | NA | NA | NA |
HSALNT0290137 | HSALNG0142252 | PDZRN3-AS1 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0290237 | HSALNG0142352 | SCAANT1 | ATXN7-AS1 | transcriptional regulation | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289594 | HSALNG0141709 | AK123790 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289911 | HSALNG0142026 | LINC01451 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290401 | HSALNG0142516 | ZNF350-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289845 | HSALNG0141960 | GADD45G | NA | NA | pathogenic process | pituitary adenoma | Endocrine System Diseases;Neoplasms;Nervous System Diseases |
HSALNT0289410 | HSALNG0043357 | TMEM161B-AS1 | AK082072,linc-POLR3G-8,ENSG00000247828 | NA | NA | NA | NA |
HSALNT0289736 | HSALNG0141851 | DAPK1 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290048 | HSALNG0142163 | MAP3K14 | MAP3K14 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290150 | HSALNG0142265 | PPP3CB | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0151531 | HSALNG0072477 | DAPK1-IT1 | NA | NA | pathogenic process | NA | NA |
HSALNT0288990 | HSALNG0041256 | GDNF-AS1 | GDNFOS | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0029702 | HSALNG0014093 | BIRC6-AS2 | megamind | NA | developmental process | NA | NA |
HSALNT0029692 | HSALNG0014085 | BIRC6-AS1 | NA | NA | NA | NA | NA |
HSALNT0289310 | HSALNG0116623 | LINC00854 | NA | NA | NA | NA | NA |
HSALNT0290332 | HSALNG0142447 | uc.73 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289841 | HSALNG0141956 | FR0257520 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290104 | HSALNG0142219 | NRG1 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289689 | HSALNG0141804 | CDKN2B-AS11 | NA | NA | pathogenic process;developmental process | stroke | Cardiovascular Diseases;Nervous System Diseases |
HSALNT0289690 | HSALNG0141805 | CDKN2B-AS12 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289691 | HSALNG0141806 | CDKN2B-AS13 | NA | NA | pathogenic process | plexiform neurofibroma | Neoplasms;Nervous System Diseases |
HSALNT0289697 | HSALNG0141812 | CDKN2B-AS7 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289826 | HSALNG0141941 | FADS1 | NA | NA | pathogenic process | lipid metabolism disorder | Nutritional and Metabolic Diseases |
HSALNT0289698 | HSALNG0141813 | CDKN2B-AS8 | NA | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289696 | HSALNG0141811 | CDKN2B-AS6 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0289699 | HSALNG0141814 | CDKN2B-AS9 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289688 | HSALNG0141803 | CDKN2B-AS10 | NA | NA | pathogenic process | stroke | Cardiovascular Diseases;Nervous System Diseases |
HSALNT0288950 | HSALNG0031716 | ENST00000456816 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290021 | HSALNG0142136 | LOC389332 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290306 | HSALNG0142421 | TMEM72 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289641 | HSALNG0141756 | BC029135 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290374 | HSALNG0142489 | X91348 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289694 | HSALNG0141809 | CDKN2B-AS4 | NA | NA | pathogenic process | cancer | Neoplasms |
HSALNT0289692 | HSALNG0141807 | CDKN2B-AS2 | NA | NA | pathogenic process | coronary heart disease | Cardiovascular Diseases |
HSALNT0289693 | HSALNG0141808 | CDKN2B-AS3 | NA | NA | pathogenic process | intracranial aneurysm | Cardiovascular Diseases;Nervous System Diseases |
HSALNT0289695 | HSALNG0141810 | CDKN2B-AS5 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0290319 | HSALNG0142434 | T-UCRs | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0289530 | HSALNG0141645 | 51A | NA | splicing regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0290163 | HSALNG0142278 | RAB4B-EGLN2 | NA | NA | pathogenic process | cancer | Neoplasms |
HSALNT0290167 | HSALNG0142282 | RERT | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0265263 | HSALNG0129088 | LINC00237 | NCRNA00237 | NA | pathogenic process | macrocephaly;obesity | Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
HSALNT0267186 | HSALNG0130081 | LINC01370 | HI-LNC25,HILNC25 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0289114 | HSALNG0046884 | LINC01574 | HI-LNC12,TCONS_00009551 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0290159 | HSALNG0142274 | PTHLH | NA | NA | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0189394 | HSALNG0091306 | CISTR | CISTR-ACT,CISTRACT,re52431 | transcriptional regulation | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0289862 | HSALNG0141977 | HELLPAR | LINC-HELLP | NA | pathogenic process | HELLP syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289904 | HSALNG0142019 | LINC01125 | NA | NA | pathogenic process | uremia | Male Urogenital Diseases |
HSALNT0289544 | HSALNG0141659 | AC002511.1 | LINC01531 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
HSALNT0289609 | HSALNG0141724 | AP000688.29 | AP000688.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
HSALNT0289832 | HSALNG0141947 | FFAR2 | NA | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
HSALNT0290222 | HSALNG0142337 | RP4-620F22.3 | AC099063.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
HSALNT0290227 | HSALNG0142342 | RP5-843L14.1 | LINC01716 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
HSALNT0287285 | HSALNG0140617 | MAGEA8-AS1 | RP5-869M20.2 | NA | NA | NA | NA |
HSALNT0289019 | HSALNG0094159 | LHX5-AS1 | locus4010 | NA | NA | NA | NA |
HSALNT0288902 | HSALNG0023597 | CAPN10-AS1 | CAPN10-DT,locus959 | NA | NA | NA | NA |
HSALNT0289404 | HSALNG0076463 | STAM-AS1 | locus3182 | NA | NA | NA | NA |
HSALNT0148276 | HSALNG0070806 | PTENP1-AS | PTENpg1-asRNA | transcriptional regulation | NA | NA | NA |
HSALNT0289562 | HSALNG0141677 | AF116616 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289589 | HSALNG0141704 | AK094838 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289620 | HSALNG0141735 | ASLNC00339 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289629 | HSALNG0141744 | BC002350 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289651 | HSALNG0141766 | BC091525 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289652 | HSALNG0141767 | BE503655 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289753 | HSALNG0141868 | ENO1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289835 | HSALNG0141950 | FKBP10 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0290064 | HSALNG0142179 | MYHAS | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289985 | HSALNG0142100 | LncRNA-LALR1 | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289934 | HSALNG0142049 | lincRNA-LALR1 | NA | transcriptional regulation | pathogenic process | NA | NA |
HSALNT0091577 | HSALNG0043527 | NR2F1-AS1 | FLJ42709 | NA | NA | NA | NA |
HSALNT0289709 | HSALNG0141824 | CK19 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289943 | HSALNG0142058 | Llme23 | NA | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289553 | HSALNG0141668 | AC096655.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289178 | HSALNG0137593 | MIR222HG | Lnc-Ang362 | NA | pathogenic process | Ang II-associated cardiovascular disease | Cardiovascular Diseases |
HSALNT0289261 | HSALNG0032541 | STX18-AS1 | LOC100507266 | NA | pathogenic process | atrial septal defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289849 | HSALNG0141964 | GHSR | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289850 | HSALNG0141965 | GHSROS | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289210 | HSALNG0072923 | PCAT7 | PCAN-R2 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289702 | HSALNG0141817 | CES1P1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289892 | HSALNG0142007 | LINC00210 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290006 | HSALNG0142121 | LOC100506974 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290219 | HSALNG0142334 | RP3-508I15.14 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290243 | HSALNG0142358 | SLC6A6 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290342 | HSALNG0142457 | uc003bgl.1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289075 | HSALNG0008302 | LINC00970 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0211868 | HSALNG0101725 | SALRNA1 | SAL-RNA1,XLOC_023166 | NA | developmental process | NA | NA |
HSALNT0222267 | HSALNG0106957 | SALRNA3 | SAL-RNA3,XLOC_025918 | NA | developmental process | NA | NA |
HSALNT0222274 | HSALNG0106960 | SALRNA2 | SAL-RNA2,XLOC_025931 | NA | developmental process | NA | NA |
HSALNT0289428 | HSALNG0021790 | GPR1-AS | GPR1-AS1,GPR1AS | transcriptional regulation | NA | NA | NA |
HSALNT0226207 | HSALNG0108743 | LINC00235 | NA | NA | pathogenic process | anorexia nervosa | Mental Disorders |
HSALNT0289526 | HSALNG0141641 | 1B FGF-antisense transcripts | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0290171 | HSALNG0142286 | RNA polymerase III-dependent lncRNAs | NA | NA | pathogenic process | diffuse cerebral hypomyelination | NA |
HSALNT0290168 | HSALNG0142283 | REST/CoREST-regulated lncRNAs | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289606 | HSALNG0141721 | Alu lncRNAs | NA | NA | pathogenic process | macular degeneration | Eye Diseases |
HSALNT0290358 | HSALNG0142473 | UCH1LAS | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0290244 | HSALNG0142359 | SLC7A2-IT1A/B | NA | NA | pathogenic process | progressive encephalopathy with severe infantile anorexia | Nervous System Diseases |
HSALNT0289877 | HSALNG0141992 | Kcna2-AS | NA | NA | pathogenic process | neuropathic pain | Nervous System Diseases |
HSALNT0289191 | HSALNG0053305 | NCOA7-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0290020 | HSALNG0142135 | LOC389023 | NA | transcriptional regulation | pathogenic process | psychiatric disease | Nervous System Diseases |
HSALNT0175124 | HSALNG0084108 | PTPRJ-AS1 | NA | transcriptional regulation | NA | NA | NA |
HSALNT0289654 | HSALNG0141769 | BM742401 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289331 | HSALNG0049950 | LINC00951 | lincRNA-uc003opf.1,FLJ41649 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0290130 | HSALNG0142245 | PAWR | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0290264 | HSALNG0142379 | T-ALL-R-LncR1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289599 | HSALNG0141714 | AK130977 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0289625 | HSALNG0141740 | AX746718 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0289738 | HSALNG0141853 | DDR2 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0290003 | HSALNG0142118 | LOC100131831 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0290144 | HSALNG0142259 | POT1-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0290253 | HSALNG0142368 | SNORA17B | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
HSALNT0207421 | HSALNG0099625 | GAS6-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289838 | HSALNG0141953 | FMR5 | NA | NA | pathogenic process | fragile X syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0208907 | HSALNG0100287 | FOXG1-AS1 | FOXG1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
HSALNT0290263 | HSALNG0142378 | SYNGAP1-AS1 | SYNGAP1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
HSALNT0290176 | HSALNG0142291 | RNase MRP | NA | NA | pathogenic process | cartilage hair hypoplaisia | Cardiovascular Diseases |
HSALNT0289469 | HSALNG0105872 | GABPB1-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0289009 | HSALNG0075528 | IDI2-AS1 | C10orf110,IDI2-A,HT009,Em:AC022536.4 | NA | NA | NA | NA |
HSALNT0289093 | HSALNG0044716 | LINC01184 | FLJ33630 | NA | NA | NA | NA |
HSALNT0290108 | HSALNG0142223 | OGT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290077 | HSALNG0142192 | ncNRFR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290337 | HSALNG0142452 | uc001lsz | NA | NA | pathogenic process | gastric cancer;prostate cancer;liver cancer;lung cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289087 | HSALNG0021008 | LINC01090 | NA | NA | pathogenic process | post-traumatic stress disorder | Mental Disorders |
HSALNT0289746 | HSALNG0141861 | DQ786227 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289981 | HSALNG0142096 | lncRNA-DQ786227 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289876 | HSALNG0141991 | JADRR | LINC00915,lncRNA-JADE | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290254 | HSALNG0142369 | SOX2OT-S1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0290404 | HSALNG0142519 | SOX2OT-S2 | NA | NA | pathogenic process | NA | NA |
HSALNT0289870 | HSALNG0141985 | HOXA13 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0078946 | HSALNG0037661 | SMAD1-AS1 | ENST00000513542 | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0087329 | HSALNG0041545 | FGF10-AS1 | RP11-473L15.2 | transcriptional regulation | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0290318 | HSALNG0142433 | TUC339 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289819 | HSALNG0141934 | ERICD | LINC01130,TCONS_00014875,ERIC | transcriptional regulation | pathogenic process | retinoblastoma | Neoplasms |
HSALNT0289615 | HSALNG0141730 | ARA | NA | NA | pathogenic process | cancer | Neoplasms |
HSALNT0289822 | HSALNG0141937 | ESCCAL-5 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0290074 | HSALNG0142189 | ncC11orf49 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290076 | HSALNG0142191 | ncHDAC5 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290078 | HSALNG0142193 | ncRAB31 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290080 | HSALNG0142195 | ncSRPK1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0018253 | HSALNG0008819 | OVAAL | LINC01131,OVAL | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289884 | HSALNG0141999 | LALR | NA | transcriptional regulation | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289701 | HSALNG0141816 | CEACAMP8 | CEACAMP8 | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0290018 | HSALNG0142133 | LOC284100 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0290023 | HSALNG0142138 | LOC391533 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0189558 | HSALNG0091365 | LINC01154 | NA | NA | NA | NA | NA |
HSALNT0196616 | HSALNG0094870 | THRIL | BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | transcriptional regulation | pathogenic process | Kawasaki disease | Cardiovascular Diseases |
HSALNT0289235 | HSALNG0098080 | RNF219-AS1 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
HSALNT0289561 | HSALNG0141676 | AF086415 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289583 | HSALNG0141698 | AK056098 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289590 | HSALNG0141705 | AK095147 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289600 | HSALNG0141715 | AK294004 | NA | transcriptional regulation | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289612 | HSALNG0141727 | AP5M1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0290110 | HSALNG0142225 | ORAOV1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0290210 | HSALNG0142325 | RP1-179N16.3 | Z95152.1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0037026 | HSALNG0017545 | LINC01159 | linc-Brn1b | NA | developmental process | NA | NA |
HSALNT0289014 | HSALNG0137988 | KANTR | KDM5C adjacent non-coding transcript | NA | developmental process | NA | NA |
HSALNT0289905 | HSALNG0142020 | LINC01157 | TCONS_00010378,linc-Enc1 | NA | developmental process | NA | NA |
HSALNT0289460 | HSALNG0087416 | APOA1-AS | NA | transcriptional regulation | NA | NA | NA |
HSALNT0290400 | HSALNG0142515 | ZNF300P1 | ZNF300P1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289750 | HSALNG0141865 | EEF1A1P9 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289796 | HSALNG0141911 | ENST00000318333 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289797 | HSALNG0141912 | ENST00000374520 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289800 | HSALNG0141915 | ENST00000422362 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289808 | HSALNG0141923 | ENST00000455912 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289809 | HSALNG0141924 | ENST00000456007 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289810 | HSALNG0141925 | ENST00000456185 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289817 | HSALNG0141932 | EPOR | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289913 | HSALNG0142028 | LINC01550 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0290142 | HSALNG0142257 | PMS2P5 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0290269 | HSALNG0142384 | TCF7 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0290345 | HSALNG0142460 | uc003jfz.2 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289095 | HSALNG0018112 | LINC01191 | VIN,lnc-ACTR3 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
HSALNT0288976 | HSALNG0140165 | FIRRE | LINC01200 | transcriptional regulation | NA | NA | NA |
HSALNT0289097 | HSALNG0046284 | LINC01202 | NA | NA | NA | NA | NA |
HSALNT0290271 | HSALNG0142386 | TCONS_00014512 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290272 | HSALNG0142387 | TCONS_00014978 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290274 | HSALNG0142389 | TCONS_00024647 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290279 | HSALNG0142394 | TCONS_00090092_MEG3 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290280 | HSALNG0142395 | TCONS_l2_00000179 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290283 | HSALNG0142398 | TCONS_l2_00004424 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290284 | HSALNG0142399 | TCONS_l2_00006843 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290289 | HSALNG0142404 | TCONS_l2_00014091 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290291 | HSALNG0142406 | TCONS_l2_00018070 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290292 | HSALNG0142407 | TCONS_l2_00020565 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290293 | HSALNG0142408 | TCONS_l2_00021262 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0290296 | HSALNG0142411 | TCONS_l2_00030560 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
HSALNT0289927 | HSALNG0142042 | lincRNA1611 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290149 | HSALNG0142264 | Ppp3ca | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290265 | HSALNG0142380 | TC0100223 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0290267 | HSALNG0142382 | TC0101686 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0290268 | HSALNG0142383 | TC1500845 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289318 | HSALNG0128589 | LAMP5-AS1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0234022 | HSALNG0112916 | LINC01228 | lincRNA-DYNLRB2-2 | NA | pathogenic process | NA | NA |
HSALNT0162654 | HSALNG0077963 | SGMS1-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0289206 | HSALNG0126202 | PCAT19 | LOC100505495,LINC01190 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289521 | HSALNG0115583 | ABHD15-AS1 | linc-TP53I13,lnc-TP53I13 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
HSALNT0289100 | HSALNG0069570 | LINC01230 | linc-DMRT2,lnc-DRMT2,TCONS_00015639 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
HSALNT0249183 | HSALNG0120583 | PCAT18 | LINC01092 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290029 | HSALNG0142144 | LOC728606 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288956 | HSALNG0094171 | ENST00000547963.1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0289802 | HSALNG0141917 | ENST00000435885 | NA | NA | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
HSALNT0205898 | HSALNG0098920 | LINC01232 | FLJ41590,TCONS_00021520 | NA | pathogenic process | NA | NA |
HSALNT0257311 | HSALNG0124979 | LINC01233 | XLOC_013014 | NA | pathogenic process | NA | NA |
HSALNT0183247 | HSALNG0088110 | SENCR | FLI1-AS1 | NA | pathogenic process | vascular SMC phenotype | Cardiovascular Diseases |
HSALNT0289296 | HSALNG0010286 | LINC00467 | C1orf97,MGC14801 | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0143586 | HSALNG0068435 | CASC21 | LINC01244,CARLo-2 | NA | pathogenic process | NA | NA |
HSALNT0288906 | HSALNG0068424 | CASC19 | LINC01245,CARLo-6 | NA | pathogenic process | NA | NA |
HSALNT0289754 | HSALNG0141869 | ENSG00000135253.9 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289755 | HSALNG0141870 | ENSG00000147753.5 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289756 | HSALNG0141871 | ENSG00000196096 | AC079610.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289757 | HSALNG0141872 | ENSG00000197251.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289758 | HSALNG0141873 | ENSG00000203325 | AL445248.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289759 | HSALNG0141874 | ENSG00000206129 | AC006305.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289760 | HSALNG0141875 | ENSG00000215231.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289761 | HSALNG0141876 | ENSG00000215374.4 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289762 | HSALNG0141877 | ENSG00000215808.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289763 | HSALNG0141878 | ENSG00000226496.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289764 | HSALNG0141879 | ENSG00000229563.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289765 | HSALNG0141880 | ENSG00000230133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289766 | HSALNG0141881 | ENSG00000230544.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289767 | HSALNG0141882 | ENSG00000231133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289768 | HSALNG0141883 | ENSG00000231185 | AC010317.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289769 | HSALNG0141884 | ENSG00000232021.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289770 | HSALNG0141885 | ENSG00000232046.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289771 | HSALNG0141886 | ENSG00000232956.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289772 | HSALNG0141887 | ENSG00000233154.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289773 | HSALNG0141888 | ENSG00000233251 | AC007743.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289774 | HSALNG0141889 | ENSG00000235285.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289775 | HSALNG0141890 | ENSG00000237036.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289776 | HSALNG0141891 | ENSG00000237548.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289777 | HSALNG0141892 | ENSG00000240453.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289778 | HSALNG0141893 | ENSG00000241269.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289779 | HSALNG0141894 | ENSG00000245910.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289780 | HSALNG0141895 | ENSG00000248176 | AC109349.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289781 | HSALNG0141896 | ENSG00000249364 | AC112206.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289782 | HSALNG0141897 | ENSG00000249772 | AC026427.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289783 | HSALNG0141898 | ENSG00000250195 | AC109927.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289784 | HSALNG0141899 | ENSG00000250608 | AC010210.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289785 | HSALNG0141900 | ENSG00000254154 | AL359075.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289786 | HSALNG0141901 | ENSG00000255471 | AP001528.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289787 | HSALNG0141902 | ENSG00000256218 | AC007848.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289788 | HSALNG0141903 | ENSG00000259150.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289789 | HSALNG0141904 | ENSG00000259334.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289790 | HSALNG0141905 | ENSG00000259484.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289791 | HSALNG0141906 | ENSG00000259758.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289793 | HSALNG0141908 | ENSG00000263753.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289794 | HSALNG0141909 | ENSG00000264772 | AC016876.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289795 | HSALNG0141910 | ENSG00000266952.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289828 | HSALNG0141943 | FAM66B | FAM66E | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289895 | HSALNG0142010 | LINC00336 | C6orf227,NCRNA00336 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289899 | HSALNG0142014 | LINC00929 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289906 | HSALNG0142021 | LINC01204 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289912 | HSALNG0142027 | LINC01538 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289915 | HSALNG0142030 | LINC01721 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289916 | HSALNG0142031 | LINC01762 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289917 | HSALNG0142032 | LINC01798 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0290247 | HSALNG0142362 | SMIM2-IT1 | C13orf44-IT1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0290316 | HSALNG0142431 | TTTY7 | CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289872 | HSALNG0141987 | HTTAS_v1 | NA | transcriptional regulation | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290175 | HSALNG0142290 | RNA-a | NA | transcriptional regulation | pathogenic process | Opitz-Kaveggia syndrome | NA |
HSALNT0289525 | HSALNG0141640 | 116HG | NA | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nervous System Diseases |
HSALNT0290320 | HSALNG0142435 | U1 spliceosomal lncRNA | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0289102 | HSALNG0039360 | LINC01262 | TCONS_l2_00021807,RP11-462G22.1 | ceRNA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0289681 | HSALNG0141796 | CCAT1-L | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290062 | HSALNG0142177 | MT-LIPCAR | uc022bqs.1,LIPCAR | NA | pathogenic process | heart disease | Cardiovascular Diseases |
HSALNT0289941 | HSALNG0142056 | LIPCAR | NA | NA | pathogenic process | heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0200965 | HSALNG0096756 | TUSC8 | LINC01071,XLOC_010588 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0161787 | HSALNG0077519 | LINC01264 | RP11-124O11.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289733 | HSALNG0141848 | D4Z4 | NA | NA | pathogenic process;developmental process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289678 | HSALNG0141793 | CARL | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
HSALNT0289923 | HSALNG0142038 | linc-CBR1-2 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0243354 | HSALNG0117819 | WFDC21P | WAP four-disulfide core domain 21,pseudogene | transcriptional regulation | pathogenic process | DC dysfunction | NA |
HSALNT0290232 | HSALNG0142347 | RUNX1 | NA | NA | pathogenic process | acute myeloid leukemia | Neoplasms |
HSALNT0290234 | HSALNG0142349 | RUNXOR | NA | NA | pathogenic process | hematopoietic malignancies | Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289979 | HSALNG0142094 | lncRNA-CIR | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0290368 | HSALNG0142483 | VIM2P | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0289879 | HSALNG0141994 | KRAS1P | NA | NA | pathogenic process | cancer | Neoplasms |
HSALNT0290054 | HSALNG0142169 | MINA | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289270 | HSALNG0117279 | TMEM92-AS1 | RP11-893F2.9,lncRNA-508851,TCONS_00025237 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0288900 | HSALNG0054937 | CAHM | LINC00468 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289593 | HSALNG0141708 | AK123657 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289659 | HSALNG0141774 | BX648207 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289660 | HSALNG0141775 | BX649059 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289846 | HSALNG0141961 | GAS2L3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289633 | HSALNG0141748 | BC011663 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289867 | HSALNG0141982 | HIV1230 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290045 | HSALNG0142160 | M14574 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290245 | HSALNG0142360 | SLCO5A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290326 | HSALNG0142441 | uc.341 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290344 | HSALNG0142459 | uc003iqu | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290346 | HSALNG0142461 | uc003tfx | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289950 | HSALNG0142065 | lnc-AL355149.1-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0290001 | HSALNG0142116 | lnc-ZNF674-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0286909 | HSALNG0140423 | LINC00632 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289105 | HSALNG0014134 | LINC01317 | NA | NA | NA | NA | NA |
HSALNT0234804 | HSALNG0113279 | LINC01081 | TCONS_00024764 | transcriptional regulation | pathogenic process | alveolar capillary dysplasia | Respiratory Tract Diseases |
HSALNT0289840 | HSALNG0141955 | FOSB | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289587 | HSALNG0141702 | AK093543 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289732 | HSALNG0141847 | D16366 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289814 | HSALNG0141929 | ENST00000501583 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290273 | HSALNG0142388 | TCONS_00018278 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289907 | HSALNG0142022 | LINC01374 | TCONS_00018278 | NA | pathogenic process | NA | NA |
HSALNT0231106 | HSALNG0111452 | CASC22 | LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0058246 | HSALNG0027843 | LINC00882 | NA | ceRNA | pathogenic process | airway diseases | Respiratory Tract Diseases |
HSALNT0018288 | HSALNG0008840 | KIAA1614-AS1 | RP11-46A10.4 | ceRNA | pathogenic process | airway smooth muscle (ASM) disease | Respiratory Tract Diseases |
HSALNT0142310 | HSALNG0067913 | LINC00536 | NA | NA | pathogenic process | trichorhinophalangeal syndrome | NA |
HSALNT0034200 | HSALNG0016063 | LBX2-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0149799 | HSALNG0071679 | ENST00000414223 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290012 | HSALNG0142127 | LOC105374631 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290305 | HSALNG0142420 | TMEM179 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290315 | HSALNG0142430 | TSPAN8 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290334 | HSALNG0142449 | uc001aka.2 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290339 | HSALNG0142454 | uc001vjj.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290343 | HSALNG0142458 | uc003erl.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290354 | HSALNG0142469 | uc009wkz.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0027893 | HSALNG0013204 | MYCNUT | MYCNUN,lncUSMycN | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0273205 | HSALNG0132900 | LINC01436 | AP000688.8 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0266116 | HSALNG0129435 | MIR663AHG | RP3-410C9.1 | NA | pathogenic process | turner syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases |
HSALNT0289108 | HSALNG0080498 | LINC01435 | RP11-215N21.1,TCONS_00018040 | NA | pathogenic process | NA | NA |
HSALNT0289674 | HSALNG0141789 | CADM3-AS1 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289882 | HSALNG0141997 | KRT19P3 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290310 | HSALNG0142425 | TNXA | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0008750 | HSALNG0004412 | ZRANB2-AS2 | NA | NA | NA | NA | NA |
HSALNT0289745 | HSALNG0141860 | DMTF1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290059 | HSALNG0142174 | MRUL | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0185163 | HSALNG0089050 | FAM66C | NA | NA | NA | NA | NA |
HSALNT0289476 | HSALNG0132414 | CYYR1-AS1 | NA | NA | NA | NA | NA |
HSALNT0289535 | HSALNG0141650 | AA174084 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0266298 | HSALNG0129511 | ABALON | INXS | splicing regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290370 | HSALNG0142485 | VTRNA2-1 | CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289619 | HSALNG0141734 | ASK00420 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289749 | HSALNG0141864 | EBIC | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290299 | HSALNG0142414 | TI09485 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290300 | HSALNG0142415 | TI10124 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290301 | HSALNG0142416 | TI13831 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290302 | HSALNG0142417 | TI18318 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290303 | HSALNG0142418 | TI21327 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290304 | HSALNG0142419 | TI22687 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290307 | HSALNG0142422 | TMPOP2 | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289570 | HSALNG0141685 | AK021444 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289601 | HSALNG0141716 | AK307796 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289801 | HSALNG0141916 | ENST00000425785 | SEC63P1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289871 | HSALNG0141986 | HOXB-AS3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290367 | HSALNG0142482 | URHC | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289085 | HSALNG0098166 | LINC01080 | TCONS_00021856 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0289751 | HSALNG0141866 | EFNA3 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289798 | HSALNG0141913 | ENST00000395084 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289829 | HSALNG0141944 | FAM83A-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290164 | HSALNG0142279 | RAD1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289585 | HSALNG0141700 | AK056988 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289638 | HSALNG0141753 | BC017743 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290156 | HSALNG0142271 | PRR26 | C10orf108 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290349 | HSALNG0142464 | uc003yqb.1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289675 | HSALNG0141790 | CAI2 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0289673 | HSALNG0141788 | CADM1-AS1 | NA | transcriptional regulation | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290313 | HSALNG0142428 | TSLC1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0013359 | HSALNG0006378 | LINC01525 | lnc-MAN1A2-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
HSALNT0109106 | HSALNG0051540 | LINC01526 | Lnc-FAM46A-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
HSALNT0162774 | HSALNG0078013 | LINC01468 | lnc-MBL2-4 | NA | pathogenic process | squamous cell cancer | Neoplasms |
HSALNT0289110 | HSALNG0074718 | LINC01503 | lnc-PPP2R4-5 | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
HSALNT0289968 | HSALNG0142083 | lnc-MBL2-4:3 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
HSALNT0289993 | HSALNG0142108 | lnc-STXBP5-1 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
HSALNT0289563 | HSALNG0141678 | AF118081 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289597 | HSALNG0141712 | AK124939 | NA | NA | pathogenic process | pulmonary adenocarcinoma | Neoplasms |
HSALNT0290153 | HSALNG0142268 | PRAS | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290249 | HSALNG0142364 | SNAR-A1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289929 | HSALNG0142044 | lincRNA-BC2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289930 | HSALNG0142045 | lincRNA-BC4 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289931 | HSALNG0142046 | lincRNA-BC5 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289932 | HSALNG0142047 | lincRNA-BC8 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0083190 | HSALNG0039551 | LINC01511 | RP11-325I22.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290026 | HSALNG0142141 | LOC440905 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0083190 | HSALNG0039551 | LINC01511 | RP11-325I22.2 | NA | NA | NA | NA |
HSALNT0289552 | HSALNG0141667 | AC079776.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289720 | HSALNG0141835 | CTA-363E6.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289901 | HSALNG0142016 | LINC00987 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290185 | HSALNG0142300 | RP11-1C1.7 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290197 | HSALNG0142312 | RP11-445K13.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290199 | HSALNG0142314 | RP11-473M20.11 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290213 | HSALNG0142328 | RP11-893F2.6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290217 | HSALNG0142332 | RP13-514E23.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290218 | HSALNG0142333 | RP1-90D4.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290220 | HSALNG0142335 | RP4-575N6.5 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290226 | HSALNG0142341 | RP5-826L7.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290378 | HSALNG0142493 | XLOC_003286 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290379 | HSALNG0142494 | XLOC_003405 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290389 | HSALNG0142504 | XLOC_012255 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290056 | HSALNG0142171 | MIR21 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0289621 | HSALNG0141736 | ASncmtRNAs | NA | transcriptional regulation | pathogenic process | cancer | Neoplasms |
HSALNT0289316 | HSALNG0022090 | LINC01614 | LCAL4,TCONS_00003105 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289982 | HSALNG0142097 | lncRNA-FER1L4 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290016 | HSALNG0142131 | LOC283177 | NA | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
HSALNT0289003 | HSALNG0134860 | HORMAD2-AS1 | MTMR3-AS1,NONHSAG033653 | NA | pathogenic process | type 1 diabetes;bowel disease | Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0290372 | HSALNG0142487 | WNT4 | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289540 | HSALNG0141655 | AB074278 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290166 | HSALNG0142281 | RCCRT1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289043 | HSALNG0043862 | LINC00491 | BC008363 | NA | pathogenic process | pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0289632 | HSALNG0141747 | BC008363 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0289858 | HSALNG0141973 | H1.3 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289896 | HSALNG0142011 | LINC00582 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289301 | HSALNG0141635 | LINC01537 | RP11-169D4.1-001 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0289551 | HSALNG0141666 | AC026166.2 | MTCO1P5 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0290184 | HSALNG0142299 | RP11-169D4.1-001 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0289545 | HSALNG0141660 | AC006050.3 | NA | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289556 | HSALNG0141671 | AC138128.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289818 | HSALNG0141933 | ERCC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290061 | HSALNG0142176 | MT1DP | MT1DP | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289578 | HSALNG0141693 | AK023096 | NA | NA | pathogenic process | Wilmsâ tumor;uterine leiomyomas | Neoplasms |
HSALNT0289112 | HSALNG0003560 | LINC01562 | RP11-296A18.3 | transcriptional regulation | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0289567 | HSALNG0141682 | AK000974 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289579 | HSALNG0141694 | AK024118 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289645 | HSALNG0141760 | BC040204 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290321 | HSALNG0142436 | U79277 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289869 | HSALNG0141984 | HOST2 | NA | ceRNA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0289368 | HSALNG0135509 | MGAT3-AS1 | TapSAKI | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289624 | HSALNG0141739 | ATXN7L3B | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289990 | HSALNG0142105 | lnc-SCA7 | NA | ceRNA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290004 | HSALNG0142119 | LOC100287482 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290383 | HSALNG0142498 | XLOC_007697 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290384 | HSALNG0142499 | XLOC_008559 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290385 | HSALNG0142500 | XLOC_009911 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289813 | HSALNG0141928 | ENST00000480739 | RPL13AP23 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290111 | HSALNG0142226 | OS9 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0290324 | HSALNG0142439 | uc.283-plus | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289117 | HSALNG0051652 | LINC01611 | RP1-90L14.1,TCONS_l2_00025430 | NA | pathogenic process | diabetic retinopathy | Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases |
HSALNT0289529 | HSALNG0141644 | 2900055J20Rik | 2900055J20Rik | NA | pathogenic process | left ventricular hypertrophy | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0289792 | HSALNG0141907 | ENSG00000261777 | AC012184.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289618 | HSALNG0141733 | Asb3 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
HSALNT0289703 | HSALNG0141818 | Chac2 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
HSALNT0290139 | HSALNG0142254 | Pex11b | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
HSALNT0290255 | HSALNG0142370 | Sp5 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
HSALNT0211639 | HSALNG0101614 | PSMA3-AS1 | FLJ31306 | NA | pathogenic process | NA | NA |
HSALNT0289319 | HSALNG0141639 | LINC00493 | LOC388789 | NA | pathogenic process | NA | NA |
HSALNT0288903 | HSALNG0126842 | CARD8-AS1 | LOC100505812 | transcriptional regulation | pathogenic process | leukemia and neuroblastoma | Neoplasms |
HSALNT0064729 | HSALNG0030929 | KCNMB2-AS1 | RP11-385J1.2 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289548 | HSALNG0141663 | AC013264.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289857 | HSALNG0141972 | GUCY1B2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290190 | HSALNG0142305 | RP11-385J1.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290216 | HSALNG0142331 | RP1-317E23.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290317 | HSALNG0142432 | TUBA4B | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290375 | HSALNG0142490 | XLOC_000371 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290397 | HSALNG0142512 | Z82214.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289735 | HSALNG0141850 | DALIR | DALI | transcriptional regulation | NA | NA | NA |
HSALNT0290376 | HSALNG0142491 | XLOC_000620 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
HSALNT0290380 | HSALNG0142495 | XLOC_004122 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
HSALNT0290381 | HSALNG0142496 | XLOC_004562 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
HSALNT0290382 | HSALNG0142497 | XLOC_005912 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
HSALNT0290391 | HSALNG0142506 | XLOC_014388 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
HSALNT0290028 | HSALNG0142143 | LOC652276 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290162 | HSALNG0142277 | R05532 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0098175 | HSALNG0046752 | LINC01411 | RP11-267A15.1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290025 | HSALNG0142140 | LOC401317 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289726 | HSALNG0141841 | CTD-2574D22.4 | AC120114.2 | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0290141 | HSALNG0142256 | PMS2L2 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0289974 | HSALNG0142089 | lncRNA-422 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289520 | HSALNG0133454 | AATBC | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289311 | HSALNG0141637 | LINC00974 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0089943 | HSALNG0042820 | ZBED3-AS1 | NA | NA | developmental process | NA | NA |
HSALNT0289116 | HSALNG0135958 | LINC01589 | CTA-941F9.9,TCONS_00029353 | NA | pathogenic process | NA | NA |
HSALNT0289910 | HSALNG0142025 | LINC01426 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0290341 | HSALNG0142456 | uc002yug.2 | NA | splicing regulation | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0290250 | HSALNG0142365 | SNCG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289949 | HSALNG0142064 | lnc-AF085935 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289996 | HSALNG0142111 | lnc-uc003wbd | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289559 | HSALNG0141674 | AF085935 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290347 | HSALNG0142462 | uc003wbd | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290098 | HSALNG0142213 | NR_001284 | TNXA | NA | pathogenic process | chronic thromboembolic pulmonary hypertension | Cardiovascular Diseases |
HSALNT0290327 | HSALNG0142442 | uc.343 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0289196 | HSALNG0094525 | NRAV | DYNLL1-AS1 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
HSALNT0290140 | HSALNG0142255 | PLEC | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
HSALNT0290172 | HSALNG0142287 | UCSC-2000-3182 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
HSALNT0290173 | HSALNG0142288 | UCSC-9199-1005 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
HSALNT0290174 | HSALNG0142289 | CombinedLit_316_550 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
HSALNT0289714 | HSALNG0141829 | CR613944 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289933 | HSALNG0142048 | lincRNA-CALCA | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290200 | HSALNG0142315 | RP11-501G6.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290208 | HSALNG0142323 | RP11-672F9.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290405 | HSALNG0142520 | C14orf132 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289937 | HSALNG0142052 | lincRNA-TSPAN8 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290225 | HSALNG0142340 | RP5-1014O16.1 | AC244098.1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290275 | HSALNG0142390 | TCONS_00026102 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0290277 | HSALNG0142392 | TCONS_00032546 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0289037 | HSALNG0096978 | LINC00441 | RB1-DT,ncRNA-RB1 | NA | pathogenic process | NA | NA |
HSALNT0289661 | HSALNG0141776 | C1401f132 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289141 | HSALNG0039030 | LINC02365 | LVCAT8 | NA | pathogenic process | NA | NA |
HSALNT0288885 | HSALNG0095161 | ADGRD1-AS1 | LACAT8 | NA | NA | NA | NA |
HSALNT0289142 | HSALNG0034152 | LINC02475 | LVCAT1 | NA | NA | NA | NA |
HSALNT0289542 | HSALNG0141657 | Abhd11os | NA | NA | pathogenic process | neurodegenerative diseases | Nervous System Diseases |
HSALNT0288895 | HSALNG0124521 | BISPR | NA | NA | pathogenic process | virus infection | Virus Diseases |
HSALNT0233975 | HSALNG0112910 | MAFTRR | linc-MAF-4 | transcriptional regulation | NA | NA | NA |
HSALNT0290058 | HSALNG0142173 | MRAK052686 | NA | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
HSALNT0290221 | HSALNG0142336 | RP4-583P15.10 | AL121845.1 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0211341 | HSALNG0101470 | KTN1-AS1 | C14orf33,MYCLo-3 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0266752 | HSALNG0129835 | DLGAP4-AS1 | CCAT7 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289682 | HSALNG0141797 | CCAT3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289684 | HSALNG0141799 | CCAT8 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289898 | HSALNG0142013 | LINC00659 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289683 | HSALNG0141798 | CCAT7 | NA | NA | pathogenic process | NA | NA |
HSALNT0289627 | HSALNG0141742 | BALR-2 | NA | NA | pathogenic process | B cell acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289948 | HSALNG0142063 | lnc-ACACA-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289953 | HSALNG0142068 | lnc-BMP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289955 | HSALNG0142070 | lnc-CPN2-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289958 | HSALNG0142073 | lnc-FOXG1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289960 | HSALNG0142075 | lnc-FZD1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289962 | HSALNG0142077 | lnc-ITPR2-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289965 | HSALNG0142080 | lnc-LCP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289988 | HSALNG0142103 | lnc-RP3-368B9 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289991 | HSALNG0142106 | lnc-SLC30A4-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289992 | HSALNG0142107 | lnc-SPAM1-6 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289995 | HSALNG0142110 | lnc-TTC34-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0222064 | HSALNG0106856 | DRAIC | NA | NA | pathogenic process | prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0005037 | HSALNG0002618 | LINC01137 | LOC728431 | NA | pathogenic process | NA | NA |
HSALNT0290390 | HSALNG0142505 | XLOC_014172 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290014 | HSALNG0142129 | LOC149086 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290183 | HSALNG0142298 | RP11-160H22.5 | AL121983.2 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289945 | HSALNG0142060 | LNC00964-3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289616 | HSALNG0141731 | Arid2-IR | NA | NA | pathogenic process | renal inflammation | NA |
HSALNT0289716 | HSALNG0141831 | CR619813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289739 | HSALNG0141854 | DDX6P1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289938 | HSALNG0142053 | lincRNA-ZNF532 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290011 | HSALNG0142126 | LOC105372753 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290013 | HSALNG0142128 | LOC105377769 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290205 | HSALNG0142320 | RP11-58D2.1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0288946 | HSALNG0105101 | ENST00000434223 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0288947 | HSALNG0082178 | ENST00000442037 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0288953 | HSALNG0088449 | ENST00000540136 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290103 | HSALNG0142218 | NR_038125 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290136 | HSALNG0142251 | PDLIM3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290335 | HSALNG0142450 | uc001gch.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290336 | HSALNG0142451 | uc001gzl.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290351 | HSALNG0142466 | uc004bbl.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290369 | HSALNG0142484 | VNN2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289577 | HSALNG0141692 | AK022798 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289663 | HSALNG0141778 | C1orf74 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289602 | HSALNG0141717 | AKR7L | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289711 | HSALNG0141826 | COL3A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289878 | HSALNG0141993 | KCNE2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289636 | HSALNG0141751 | BC015134 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289713 | HSALNG0141828 | CR594506 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289928 | HSALNG0142043 | lincRNA-BBOX1-2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0271719 | HSALNG0132223 | LINC00320 | PRED14,FLJ37539 | NA | pathogenic process;developmental process | cortical white matter | Nervous System Diseases |
HSALNT0289823 | HSALNG0141938 | EVADR | NA | NA | pathogenic process | pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289944 | HSALNG0142059 | Lnc_bc060912 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289952 | HSALNG0142067 | lnc-bc060912 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289613 | HSALNG0141728 | APF | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
HSALNT0289617 | HSALNG0141732 | AS Uchl1 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0289104 | HSALNG0099739 | LINC01296 | FLJ39632 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290403 | HSALNG0142518 | ZXF2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290113 | HSALNG0142228 | P14695 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290114 | HSALNG0142229 | P16984 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290115 | HSALNG0142230 | P19780 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290116 | HSALNG0142231 | P23099 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290117 | HSALNG0142232 | P24363 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290118 | HSALNG0142233 | P28210 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290120 | HSALNG0142235 | P33863 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290121 | HSALNG0142236 | P4091 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290122 | HSALNG0142237 | P6391 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290123 | HSALNG0142238 | P6488 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290124 | HSALNG0142239 | P700 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290125 | HSALNG0142240 | P8611 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290126 | HSALNG0142241 | P8725 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290127 | HSALNG0142242 | P8860 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290128 | HSALNG0142243 | P9745 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289269 | HSALNG0044864 | TH2LCRR | TH2-LCR | transcriptional regulation | pathogenic process | allergic asthma | Respiratory Tract Diseases;Immune System Diseases |
HSALNT0289964 | HSALNG0142079 | lnc-LCE5A-1 | NA | NA | pathogenic process | laryngeal cancer;head and neck squamous cell cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms |
HSALNT0055198 | HSALNG0026441 | FAM3D-AS1 | lnc-KCTD6-3 | NA | pathogenic process | tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289843 | HSALNG0141958 | FRLnc1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0242005 | HSALNG0117109 | ENST00000575202 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288952 | HSALNG0089220 | ENST00000539009 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288954 | HSALNG0089242 | ENST00000544591 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289752 | HSALNG0141867 | EHHADH-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289812 | HSALNG0141927 | ENST00000468960 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290276 | HSALNG0142391 | TCONS_00026506 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0189952 | HSALNG0091595 | LRP1-AS | NA | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0032045 | HSALNG0015125 | LINC01122 | FLJ30838,AC007092.1 | NA | NA | NA | NA |
HSALNT0289565 | HSALNG0141680 | AI364715 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289921 | HSALNG0142036 | LINC0949 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
HSALNT0289680 | HSALNG0141795 | CCAL | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289079 | HSALNG0077354 | LINC00993 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289811 | HSALNG0141926 | ENST00000460164 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290282 | HSALNG0142397 | TCONS_l2_00003938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289888 | HSALNG0142003 | LGALS3 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289963 | HSALNG0142078 | lnc-KCMF1-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289967 | HSALNG0142082 | lnc-LLPH-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289971 | HSALNG0142086 | lnc-PLA2R1-1:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289972 | HSALNG0142087 | lnc-PSD4-1:14 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290066 | HSALNG0142181 | n335550 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290070 | HSALNG0142185 | n340790 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290072 | HSALNG0142187 | n386477 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290286 | HSALNG0142401 | TCONS_l2_00010365 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0288944 | HSALNG0129184 | ENST00000422494 | NA | NA | NA | NA | NA |
HSALNT0289118 | HSALNG0038513 | LINC01612 | RP11-789C1.1,TCONS_00008319 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289610 | HSALNG0141725 | AP001439.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289671 | HSALNG0141786 | CACNAICAS3 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289853 | HSALNG0141968 | GS1-5L10.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289875 | HSALNG0141990 | INTS7 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290065 | HSALNG0142180 | MYLK-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290157 | HSALNG0142272 | PRSS21 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290202 | HSALNG0142317 | RP11-528G1.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290207 | HSALNG0142322 | RP11-643M14.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290209 | HSALNG0142324 | RP11-789C1.1 | LINC01612 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290314 | HSALNG0142429 | TSNAX-DISC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290386 | HSALNG0142501 | XLOC_010235 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289558 | HSALNG0141673 | AF075041 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289564 | HSALNG0141679 | AF339813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289575 | HSALNG0141690 | AK022029 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289576 | HSALNG0141691 | AK022159 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289604 | HSALNG0141719 | AL389956 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289640 | HSALNG0141755 | BC023629 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290096 | HSALNG0142211 | NONHSAT125629 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290393 | HSALNG0142508 | XR_250621.1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288951 | HSALNG0033002 | ENST00000503938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290085 | HSALNG0142200 | NONHSAT012762 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289151 | HSALNG0023952 | LMCD1-AS1 | NA | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289926 | HSALNG0142041 | linc-PXN-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290281 | HSALNG0142396 | TCONS_l2_00001418 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290285 | HSALNG0142400 | TCONS_l2_00008237 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290287 | HSALNG0142402 | TCONS_l2_00011130 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290288 | HSALNG0142403 | TCONS_l2_00013175 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290294 | HSALNG0142409 | TCONS_l2_00022611 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290295 | HSALNG0142410 | TCONS_l2_00022670 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290352 | HSALNG0142467 | uc004bdv.3 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290363 | HSALNG0142478 | ULK4P2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289942 | HSALNG0142057 | LK4P2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289538 | HSALNG0141653 | AB019562 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
HSALNT0091661 | HSALNG0043585 | ENST00000503710 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289806 | HSALNG0141921 | ENST00000445734 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289807 | HSALNG0141922 | ENST00000448093 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289815 | HSALNG0141930 | ENST00000502941 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290340 | HSALNG0142455 | uc002nbr.3 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290348 | HSALNG0142463 | uc003xut. | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290356 | HSALNG0142471 | uc021re1.1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289549 | HSALNG0141664 | AC016745.3 | AC016745.1 | NA | pathogenic process | glioma | Neoplasms |
HSALNT0290180 | HSALNG0142295 | RP11-128A17.1 | AC078909.1 | NA | pathogenic process | glioma | Neoplasms |
HSALNT0290377 | HSALNG0142492 | XLOC_001711 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289975 | HSALNG0142090 | lncRNA-AK058003 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289061 | HSALNG0034072 | LINC00682 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289305 | HSALNG0089456 | LINC01559 | FLJ33810 | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289854 | HSALNG0141969 | GSTT1-AS1 | NA | transcriptional regulation | pathogenic process | mycobacterium tuberculosis infection | Bacterial Infections and Mycoses |
HSALNT0289978 | HSALNG0142093 | lncRNA-CD244 | NA | transcriptional regulation | pathogenic process | tuberculosis infection | Bacterial Infections and Mycoses |
HSALNT0289237 | HSALNG0068014 | SAMD12-AS1 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0290179 | HSALNG0142294 | RP11-119F7.4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290278 | HSALNG0142393 | TCONS_00068220 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0285573 | HSALNG0139654 | DANT1 | NA | transcriptional regulation | NA | NA | NA |
HSALNT0288926 | HSALNG0139662 | DANT2 | NA | transcriptional regulation | NA | NA | NA |
HSALNT0290399 | HSALNG0142514 | ZMAT1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289554 | HSALNG0141669 | AC100865.1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
HSALNT0289228 | HSALNG0105273 | RAD51-AS1 | TODRA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289743 | HSALNG0141858 | DKFZP434K028 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289630 | HSALNG0141745 | BC002811 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
HSALNT0290387 | HSALNG0142502 | XLOC_010967 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
HSALNT0288955 | HSALNG0084672 | ENST00000545440 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
HSALNT0288981 | HSALNG0133391 | FRGCA | LncRNA-AP001631.9 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289611 | HSALNG0141726 | AP001631.9 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289976 | HSALNG0142091 | LncRNA-AP001631.9 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289686 | HSALNG0141801 | CD99P1 | NA | ceRNA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
HSALNT0289119 | HSALNG0074097 | LINC01613 | n341773 | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
HSALNT0289844 | HSALNG0141959 | FTH1P3 | FTH1P3 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
HSALNT0289855 | HSALNG0141970 | GTF2IRD2P1 | GTF2IRD2P1 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
HSALNT0290135 | HSALNG0142250 | PDIA3F | NA | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
HSALNT0289329 | HSALNG0026562 | LINC00994 | NA | NA | pathogenic process | inflammatory bowel disease | Digestive System Diseases |
HSALNT0289208 | HSALNG0077290 | PCAT5 | LINC01452,TPCAT-10-36067 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0114870 | HSALNG0054158 | LUADT1 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289154 | HSALNG0107133 | LOXL1-AS1 | NA | NA | pathogenic process | exfoliation syndrome | Eye Diseases |
HSALNT0289734 | HSALNG0141849 | DACOR1 | TCONS_00023265 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289060 | HSALNG0114548 | LINC00675 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0288889 | HSALNG0070759 | B4GALT1-AS1 | NA | transcriptional regulation | pathogenic process | NA | NA |
HSALNT0289348 | HSALNG0083371 | LINC01616 | n341006 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0290068 | HSALNG0142183 | n336934 | NA | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
HSALNT0290240 | HSALNG0142355 | SIRT1-AS | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290198 | HSALNG0142313 | RP11-457M11.2 | NA | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0150768 | HSALNG0072141 | LINC01507 | XLOC_000303 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289903 | HSALNG0142018 | LINC01057 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289914 | HSALNG0142029 | LINC01617 | C8orf23,NCRNA00249,XLOC_006844 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290015 | HSALNG0142130 | LOC152578 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0072252 | HSALNG0034426 | LINC01618 | LOC152578 | NA | pathogenic process | NA | NA |
HSALNT0156870 | HSALNG0075266 | NALT1 | MIR4674HG,LINC01573,TCONS_l2_00029132 | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289083 | HSALNG0045290 | MALINC1 | LINC01024,MA-linc1 | NA | pathogenic process | human breast and lung cancer | Neoplasms |
HSALNT0289902 | HSALNG0142017 | LINC01024 | MA-linc1 | NA | pathogenic process | osteosarcoma;lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289120 | HSALNG0071043 | LINC01627 | RP11-397D12.4 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289121 | HSALNG0015617 | LINC01628 | AC007403.1 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289820 | HSALNG0141935 | ERICH1-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290193 | HSALNG0142308 | RP11-397D12.4 | LINC01627 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289122 | HSALNG0102605 | LINC01629 | linc-KIAA1737-2 | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury | NA |
HSALNT0290161 | HSALNG0142276 | PTPRG-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289980 | HSALNG0142095 | lncRNA-DLEU1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289983 | HSALNG0142098 | lncRNA-Hh | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288986 | HSALNG0072437 | GAS1RR | LncRNA-Hh | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288908 | HSALNG0005250 | CCDC18-AS1 | ENST00000440778.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
HSALNT0289055 | HSALNG0132813 | LINC00649 | TCONS_00028768 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
HSALNT0289219 | HSALNG0075966 | PRKCQ-AS1 | ENST00000414894.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
HSALNT0290203 | HSALNG0142318 | RP11-567G11.1 | LINC02041 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289805 | HSALNG0141920 | ENST00000438550 | RPS24P1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0290083 | HSALNG0142198 | NONHSAG011351 | NA | NA | pathogenic process | type 1 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0290049 | HSALNG0142164 | MCHR2-AS1 | NA | NA | pathogenic process | psychiatric disease | Nervous System Diseases |
HSALNT0289799 | HSALNG0141914 | ENST00000414355 | NA | NA | pathogenic process | cadmium toxicology | Disorders of Environmental Origin |
HSALNT0290241 | HSALNG0142356 | SKP2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289837 | HSALNG0141952 | FLJ90757 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290017 | HSALNG0142132 | LOC283663 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290019 | HSALNG0142134 | LOC338651 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290132 | HSALNG0142247 | PCATs | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0086786 | HSALNG0041277 | EGFLAM-AS1 | lncRNA-LOWEG | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290031 | HSALNG0142146 | LOWEG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289635 | HSALNG0141750 | BC014579 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289721 | HSALNG0141836 | CTB-167B5.2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289863 | HSALNG0141978 | HELLS | NA | NA | pathogenic process | leukemia | Neoplasms |
HSALNT0290195 | HSALNG0142310 | RP11-401P9.4 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290252 | HSALNG0142367 | SNHG19 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289557 | HSALNG0141672 | AF070632 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289569 | HSALNG0141684 | AK021443 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289728 | HSALNG0141843 | CTD-3080P12.3 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289987 | HSALNG0142102 | lncRNA-n336928 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289723 | HSALNG0141838 | CTC-523E23.5 | AC008555.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0289724 | HSALNG0141839 | CTD-2246P4.1 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0290055 | HSALNG0142170 | MIR132 | MIRN132,miRNA132,mir-132 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0290189 | HSALNG0142304 | RP11-363G2.4 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0290191 | HSALNG0142306 | RP11-38F22.1 | LINC02424 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0290223 | HSALNG0142338 | RP4-639J15.1 | AC006967.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0290233 | HSALNG0142348 | RUNX1-IT1 | C21orf96 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0288943 | HSALNG0053446 | ENST00000415964 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
HSALNT0290009 | HSALNG0142124 | LOC101927497 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289956 | HSALNG0142071 | lnc-CYP4A22-2/3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289999 | HSALNG0142114 | lnc-ZNF180-2 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290086 | HSALNG0142201 | NONHSAT037832 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289658 | HSALNG0141773 | BX647187 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288920 | HSALNG0017086 | CNNM3-DT | LOC100506036 | NA | NA | NA | NA |
HSALNT0289584 | HSALNG0141699 | AK056155 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
HSALNT0290057 | HSALNG0142172 | MR1 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
HSALNT0289543 | HSALNG0141658 | AC002454.1 | AC002454.1 | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289909 | HSALNG0142024 | LINC01420 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
HSALNT0289531 | HSALNG0141646 | 53BP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290101 | HSALNG0142216 | NR_024118 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0290239 | HSALNG0142354 | SGO1-AS1 | SGOL1-AS1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289293 | HSALNG0127764 | ZNF667-AS1 | MORT | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289984 | HSALNG0142099 | lncRNA-HIF2PUT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288945 | HSALNG0018617 | ENST00000433673 | AC068282.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0288948 | HSALNG0008353 | ENST00000454271 | AL021940.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289495 | HSALNG0141606 | ENST00000432431 | AC023128.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289918 | HSALNG0142033 | LINC01828 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0290388 | HSALNG0142503 | XLOC_011402 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289873 | HSALNG0141988 | ICAM-1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289668 | HSALNG0141783 | C5T1lncRNA | NA | transcriptional regulation | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289667 | HSALNG0141782 | C5T1 | NA | NA | pathogenic process | NA | NA |
HSALNT0289666 | HSALNG0141781 | C5-OT1 | C5T1lncRNA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289626 | HSALNG0141741 | AX800134 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290338 | HSALNG0142453 | uc001ncr | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290330 | HSALNG0142445 | uc.48+ | NA | NA | pathogenic process | diabetic neuropathic pain | Male Urogenital Diseases |
HSALNT0289098 | HSALNG0038313 | LINC01207 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289628 | HSALNG0141743 | BALR-6 | NA | transcriptional regulation | pathogenic process | B-lymphoblastic leukemia | Hemic and Lymphatic Diseases |
HSALNT0290022 | HSALNG0142137 | LOC389641 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0289725 | HSALNG0141840 | CTD-2541M15 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289940 | HSALNG0142055 | LINK-A | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290107 | HSALNG0142222 | NUTF2P3 | NUTF2P3 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290095 | HSALNG0142210 | NONHSAT123350 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290362 | HSALNG0142477 | UHRF1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290366 | HSALNG0142481 | UPAT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289307 | HSALNG0114404 | LINC00324 | FLJ34790,MGC104931 | NA | pathogenic process | NA | NA |
HSALNT0289969 | HSALNG0142084 | lnc-MX1-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290024 | HSALNG0142139 | LOC400891 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289883 | HSALNG0141998 | LA16c-313D11.11 | NA | ceRNA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290192 | HSALNG0142307 | RP11-395G23.3 | AC027031.2 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289742 | HSALNG0141857 | DILC | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289957 | HSALNG0142072 | lnc-DILC | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289581 | HSALNG0141696 | AK027294 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290371 | HSALNG0142486 | WISP1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0206117 | HSALNG0099020 | FGF14-AS2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290131 | HSALNG0142246 | PCAT2 | CARLo-4,PCA2,TCONS_00015167 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289528 | HSALNG0141643 | 2700086A05Rik | 2700086A05Rik | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
HSALNT0290251 | HSALNG0142366 | SNED1 | NA | NA | pathogenic process | Idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
HSALNT0290333 | HSALNG0142448 | uc.77 | NA | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
HSALNT0289816 | HSALNG0141931 | ENST00000537266 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289860 | HSALNG0141975 | HAGLROS | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289881 | HSALNG0141996 | KRT18P55 | KRT18P55 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0229266 | HSALNG0110450 | IL21R-AS1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
HSALNT0290112 | HSALNG0142227 | OTTHUMT00000387022 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
HSALNT0000551 | HSALNG0000226 | PRKCZ-AS1 | RP11-181G12.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0030981 | HSALNG0014612 | LINC01833 | RP11-89,K21.1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0290214 | HSALNG0142329 | RP11-89K21 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0165271 | HSALNG0079188 | LINC00857 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290109 | HSALNG0142224 | OR3A4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290046 | HSALNG0142161 | MAGI1-IT1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
HSALNT0290242 | HSALNG0142357 | SLC26A4-AS1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
HSALNT0289302 | HSALNG0141636 | KRT7-AS | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0218672 | HSALNG0105101 | LINC01852 | ENST00000434223 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290178 | HSALNG0142293 | RP11-1008C21.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289592 | HSALNG0141707 | AK123072 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289573 | HSALNG0141688 | AK021954 | NA | NA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
HSALNT0288916 | HSALNG0105961 | CERNA1 | LOC100129973 | ceRNA | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
HSALNT0018525 | HSALNG0008959 | LAMC1-AS1 | lnc-LAMC2-1:1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290087 | HSALNG0142202 | NONHSAT040387 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0290092 | HSALNG0142207 | NONHSAT098586 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0289213 | HSALNG0108626 | PCSK6-AS1 | NA | NA | NA | NA | NA |
HSALNT0289637 | HSALNG0141752 | BC016831 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289874 | HSALNG0141989 | IGKV | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290196 | HSALNG0142311 | RP11-434D9.1 | AC112206.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289885 | HSALNG0142000 | LCAL6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289650 | HSALNG0141765 | BC088254 | NA | NA | pathogenic process | myocardial hypertrophy | Cardiovascular Diseases |
HSALNT0289596 | HSALNG0141711 | AK124454 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289731 | HSALNG0141846 | CYP4B1-PS1 | NA | NA | pathogenic process | diabetic nephropathy | Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289106 | HSALNG0094020 | LINC01405 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290259 | HSALNG0142374 | ST8SIA6-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289278 | HSALNG0047244 | TRIM52-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289634 | HSALNG0141749 | BC012900 | NA | NA | pathogenic process | ulcerative colitis | Digestive System Diseases |
HSALNT0274011 | HSALNG0133283 | UMODL1-AS1 | FLJ33471 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289454 | HSALNG0075449 | ARRDC1-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289456 | HSALNG0071200 | FAM74A3 | OTTHUMG00000067149 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289834 | HSALNG0141949 | FH | NA | NA | pathogenic process | Fumarase deficiency | Respiratory Tract Diseases;Neoplasms |
HSALNT0289961 | HSALNG0142076 | lnc-HOXC4-3:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289994 | HSALNG0142109 | lnc-TEAD4-1:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290270 | HSALNG0142385 | TCONS_00003876 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289825 | HSALNG0141940 | EVI1 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290235 | HSALNG0142350 | SARCC | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290360 | HSALNG0142475 | ucoo2kmd.1 | NA | ceRNA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289015 | HSALNG0001020 | KAZN-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289722 | HSALNG0141837 | CTB-89H12.4 | AC021078.1 | ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289496 | HSALNG0141607 | EPB41L4A-AS2 | FLJ11235 | NA | pathogenic process | lung cancer;breast cancer;kidney cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289146 | HSALNG0004554 | LINC02567 | ENST00000427806 | NA | pathogenic process | attention deficit hyperactivity disorder | Mental Disorders |
HSALNT0289833 | HSALNG0141948 | FGFR3-AS1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289707 | HSALNG0141822 | CILinc01 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0289708 | HSALNG0141823 | CILinc02 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0286597 | HSALNG0140235 | LINC00629 | LINC00629AB,LINC00629C,LINC00629D,LINC00629 | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289665 | HSALNG0141780 | C2dat1 | NA | NA | pathogenic process | ischemic brain injury | Cardiovascular Diseases |
HSALNT0289217 | HSALNG0057357 | POU6F2-AS2 | FLJ12971 | protein localization | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
HSALNT0289946 | HSALNG0142061 | lnc13 | NA | NA | pathogenic process | celiac disease | Nutritional and Metabolic Diseases;Digestive System Diseases |
HSALNT0289729 | HSALNG0141844 | CTD903 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290093 | HSALNG0142208 | NONHSAT104436 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0289550 | HSALNG0141665 | AC024560.2 | AC024560.1 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289483 | HSALNG0134219 | ENST00000436681 | AP000552.1 | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289536 | HSALNG0141651 | AA584040 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289537 | HSALNG0141652 | AA709223 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289657 | HSALNG0141772 | BX478947 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0247515 | HSALNG0119819 | LINC00668 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289719 | HSALNG0141834 | CRNDE-h | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0142879 | HSALNG0068121 | SMILR | NA | NA | pathogenic process | vascular pathologies | Cardiovascular Diseases |
HSALNT0290396 | HSALNG0142511 | Z38 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0197213 | HSALNG0095037 | LINC00507 | NA | NA | developmental process | NA | NA |
HSALNT0289086 | HSALNG0113270 | LINC01082 | TCONSNA00024492 | NA | pathogenic process | alveolar capillary dysplasia with misalignment of pulmonary veins | Cardiovascular Diseases |
HSALNT0289094 | HSALNG0015253 | LINC01185 | FLJ16341 | NA | pathogenic process | NA | NA |
HSALNT0290160 | HSALNG0142275 | PTPRD-AS1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290186 | HSALNG0142301 | RP11-254I22.1 | MIR583HG | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290204 | HSALNG0142319 | RP11-57P19.1 | AC009432.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290211 | HSALNG0142326 | RP11-80H5.7 | AL157400.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290215 | HSALNG0142330 | RP1-223E5.4 | AL441883.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290224 | HSALNG0142339 | RP4-799P18.3 | AL122008.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289126 | HSALNG0045514 | LINC01844 | LOC101926975 | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0289947 | HSALNG0142062 | Lnc34a | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289150 | HSALNG0075977 | LINP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289951 | HSALNG0142066 | lncARSR | NA | ceRNA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289392 | HSALNG0005967 | RBM15-AS1 | AS-RBM15 | translational control | pathogenic process | acute megakaryocytic leukemia | Neoplasms |
HSALNT0290089 | HSALNG0142204 | NONHSAT073641 | NA | NA | pathogenic process | vascular diseases | Cardiovascular Diseases |
HSALNT0290027 | HSALNG0142142 | LOC572558 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289582 | HSALNG0141697 | AK033210 | NA | NA | pathogenic process;developmental process | bronchopulmonary dysplasia | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0289848 | HSALNG0141963 | GClnc1 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289572 | HSALNG0141687 | AK021630 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0289603 | HSALNG0141718 | AL049437 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0290007 | HSALNG0142122 | LOC100507661 | NA | NA | pathogenic process | thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289084 | HSALNG0122663 | LINC01029 | NA | NA | pathogenic process | cognitive functions and neuronal plasticity | Nervous System Diseases |
HSALNT0290169 | HSALNG0142284 | RMEL3 | NA | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289959 | HSALNG0142074 | lnc-FRG2C-3 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
HSALNT0289966 | HSALNG0142081 | lnc-LIN54-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
HSALNT0289997 | HSALNG0142112 | lnc-USP50-2 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
HSALNT0290000 | HSALNG0142115 | lnc-ZNF354A-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
HSALNT0288949 | HSALNG0017887 | ENST00000455309 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0289920 | HSALNG0142035 | LINC02384 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0289998 | HSALNG0142113 | Lnc-UTS2D-1:1 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0290067 | HSALNG0142182 | n336161 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0290069 | HSALNG0142184 | n340599 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0290099 | HSALNG0142214 | NR_002712 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0290290 | HSALNG0142405 | TCONS_l2_00014794 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0290170 | HSALNG0142285 | RMRP | CHH,NME1R,RRP2,RMRP | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289900 | HSALNG0142015 | LINC00961 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289077 | HSALNG0068551 | LINC00977 | NA | NA | pathogenic process | primary spontaneous pneumothorax | Respiratory Tract Diseases |
HSALNT0289560 | HSALNG0141675 | AF085995 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289566 | HSALNG0141681 | AK000053 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289571 | HSALNG0141686 | AK021595 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289574 | HSALNG0141689 | AK022024 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289595 | HSALNG0141710 | AK124307 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289639 | HSALNG0141754 | BC020384 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289642 | HSALNG0141757 | BC030759 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289715 | HSALNG0141830 | CR615992 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289954 | HSALNG0142069 | lnc-CC3 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289614 | HSALNG0141729 | APOC1P1-3 | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290365 | HSALNG0142480 | UNMIBC | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290323 | HSALNG0142438 | uc.167 | NA | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0290212 | HSALNG0142327 | RP11-838N2.4 | GAPLINC | ceRNA | pathogenic process | glioblastoma | Neoplasms |
HSALNT0289109 | HSALNG0121223 | LINC01478 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
HSALNT0289313 | HSALNG0016990 | LINC00342 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289677 | HSALNG0141792 | CAR10 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289365 | HSALNG0141638 | MAPT-AS1 | NA | transcriptional regulation | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0289679 | HSALNG0141794 | CAT104 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290260 | HSALNG0142375 | STXBP5-AS1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289861 | HSALNG0141976 | HAR1 | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290359 | HSALNG0142474 | UCHL1-AS1 | NA | translational control | pathogenic process | Parkinson's disease | Nervous System Diseases |
HSALNT0290238 | HSALNG0142353 | SCAANT1-AS | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289648 | HSALNG0141763 | BC041488 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290188 | HSALNG0142303 | RP11-359E19.2 | AC022733.1 | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289669 | HSALNG0141784 | C6orf176-TV1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289670 | HSALNG0141785 | C6orf176-TV2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289851 | HSALNG0141966 | GIHCG | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289649 | HSALNG0141764 | BC087858 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290353 | HSALNG0142468 | uc004cov.4 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
HSALNT0290357 | HSALNG0142472 | uc022bqu.1 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
HSALNT0127837 | HSALNG0060796 | CFTR-AS1 | BGas | transcriptional regulation | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0046367 | HSALNG0021858 | MYOSLID | NA | NA | pathogenic process | vascular smooth muscle cell (VSMC) contractile phenotype | Cardiovascular Diseases |
HSALNT0290331 | HSALNG0142446 | uc.63 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290106 | HSALNG0142221 | numb | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
HSALNT0289847 | HSALNG0141962 | GCASPC | TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
HSALNT0289568 | HSALNG0141683 | AK001094 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289588 | HSALNG0141703 | AK093735 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289631 | HSALNG0141746 | BC003519 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290100 | HSALNG0142215 | NR_003573 | ANXA2P2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290119 | HSALNG0142234 | P2RX7-V3 | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
HSALNT0290308 | HSALNG0142423 | TMSB4 | NA | ceRNA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
HSALNT0288928 | HSALNG0090163 | DDX11-AS1 | CONCR | NA | pathogenic process | NA | NA |
HSALNT0290052 | HSALNG0142167 | MELOE | NA | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0290231 | HSALNG0142346 | RSU1P2 | RSU1P2 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290165 | HSALNG0142280 | RBMY2FP | RBMY2FP | NA | NA | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290071 | HSALNG0142186 | n375709 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289748 | HSALNG0141863 | DUXAP8 | DUXAP8 | NA | NA | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290030 | HSALNG0142145 | LOC729966 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290143 | HSALNG0142258 | POIR | NA | ceRNA | pathogenic process | periodontitis | Stomatognathic Diseases |
HSALNT0067481 | HSALNG0031988 | MELTF-AS1 | MFI2-AS1,AC068302.3 | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0290053 | HSALNG0142168 | MFI2 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289922 | HSALNG0142037 | linc-223 | NA | ceRNA | pathogenic process | acute myeloid leukemia | Neoplasms |
HSALNT0014603 | HSALNG0006859 | LINC01138 | LINC00875,FLJ39739 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290262 | HSALNG0142377 | SUZ12P1 | SUZ12P1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0290005 | HSALNG0142120 | LOC100505976 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0290392 | HSALNG0142507 | XLOC_l2_010636 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
HSALNT0090295 | HSALNG0043014 | RASGRF2-AS1 | CTC-459I6.1 | NA | pathogenic process | sepsis-induced endothelial dysfunction | Bacterial Infections and Mycoses |
HSALNT0289852 | HSALNG0141967 | GPC3-AS1 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0189472 | HSALNG0091321 | HOXC-AS1 | NA | transcriptional regulation | pathogenic process | atherosclerosis | Cardiovascular Diseases |
HSALNT0289157 | HSALNG0057557 | LUARIS | lncRNA#32 | transcriptional regulation | NA | NA | NA |
HSALNT0289371 | HSALNG0044828 | MIR3936HG | LOC553103,SLC22A5-AS1 | NA | pathogenic process | gastric cancer;nasopharyngeal cancer | Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290148 | HSALNG0142263 | Ppp1r1b | NA | transcriptional regulation | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289038 | HSALNG0099182 | LINC00460 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290194 | HSALNG0142309 | RP1-13P20.6 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0290364 | HSALNG0142479 | Unigene56159 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290355 | HSALNG0142470 | uc009yby.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289406 | HSALNG0048011 | TFAP2A-AS2 | HIPSTR | NA | developmental process | NA | NA |
HSALNT0289704 | HSALNG0141819 | Chaer | NA | transcriptional regulation | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
HSALNT0289865 | HSALNG0141980 | HIF-2α | NA | NA | pathogenic process | NA | NA |
HSALNT0211378 | HSALNG0101489 | LINC00520 | C14orf34 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0087374 | HSALNG0041561 | MRPS30-DT | BRCAT54 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289388 | HSALNG0092662 | PPP1R12A-AS1 | R12A-AS1 | translational control | NA | NA | NA |
HSALNT0289013 | HSALNG0088600 | ITFG2-AS1 | NA | NA | NA | NA | NA |
HSALNT0290088 | HSALNG0142203 | NONHSAT041499 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
HSALNT0290091 | HSALNG0142206 | NONHSAT089447 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
HSALNT0289970 | HSALNG0142085 | lnc-NKX2-3-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289989 | HSALNG0142104 | lnc-RTN4R-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289821 | HSALNG0141936 | ERL | NA | NA | pathogenic process | Marek's disease | Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases |
HSALNT0192459 | HSALNG0092867 | LINC02258 | RP11-248E9.5 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
HSALNT0241871 | HSALNG0117085 | SKAP1-AS1 | RP11-456D7.1 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
HSALNT0289439 | HSALNG0049760 | DINOL | DINO | NA | NA | NA | NA |
HSALNT0288901 | HSALNG0000547 | CAMTA1-DT | lncCAMTA1 | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0290328 | HSALNG0142443 | uc.345 | NA | transcriptional regulation | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290060 | HSALNG0142175 | MSNP1AS | NA | translational control | pathogenic process | autism spectrum disorder | Mental Disorders |
HSALNT0289376 | HSALNG0004596 | NEXN-AS1 | C1orf118,FLJ90637 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0183194 | HSALNG0088083 | LINC02098 | RP11-702B10.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0198055 | HSALNG0095473 | PSPC1-AS2 | RP11-523H24.3 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0289155 | HSALNG0114857 | LRRC75A-AS1 | C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289220 | HSALNG0077999 | PRKG1-AS1 | RP11-573I11.2 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289262 | HSALNG0076970 | SVIL-AS1 | RP11-534G20.3 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289281 | HSALNG0108169 | VPS33B-DT | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289804 | HSALNG0141919 | ENST00000438399 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0290228 | HSALNG0142343 | RPKG1-AS1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0290350 | HSALNG0142465 | uc004afb.1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289398 | HSALNG0135015 | SLC5A4-AS1 | RP1-90G24.10 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289411 | HSALNG0063964 | TNFRSF10A-AS1 | RP11-1149O23.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289727 | HSALNG0141842 | CTD-2616J11.14 | AC008750.7 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290182 | HSALNG0142297 | RP11-150O12.3 | AC124067.4 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289730 | HSALNG0141845 | CXCL1P1 | CXCL1P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289803 | HSALNG0141918 | ENST00000438347 | CCND3P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289897 | HSALNG0142012 | LINC00601 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289503 | HSALNG0141614 | KIAA0087 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289827 | HSALNG0141942 | FAM212B-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290010 | HSALNG0142125 | LOC102723552 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290181 | HSALNG0142296 | RP11-140I24 | LINC01568 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290201 | HSALNG0142316 | RP11-501O2 | LINC02046 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290206 | HSALNG0142321 | RP11-600K151 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290084 | HSALNG0142199 | NONHSAG051968 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290090 | HSALNG0142205 | NONHSAT076747 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290094 | HSALNG0142209 | NONHSAT122730 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0138768 | HSALNG0066240 | MIR2052HG | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289096 | HSALNG0096884 | LINC01198 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289274 | HSALNG0096821 | TPT1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289924 | HSALNG0142039 | linc-cdh4-2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0144641 | HSALNG0068878 | LINC02055 | RP1130-1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289737 | HSALNG0141852 | DBCCR1 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289547 | HSALNG0141662 | AC012065.7 | NA | NA | pathogenic process | chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289229 | HSALNG0116565 | RAMP2-AS1 | NA | NA | pathogenic process | glioblastoma | Neoplasms |
HSALNT0289591 | HSALNG0141706 | AK098081 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289644 | HSALNG0141759 | BC037331 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289646 | HSALNG0141761 | BC040303 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289717 | HSALNG0141832 | CR749831 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289250 | HSALNG0040073 | SNHG18 | NA | NA | pathogenic process | glioma | Neoplasms |
HSALNT0106140 | HSALNG0050030 | FOXP4-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0026202 | HSALNG0012584 | RNASEH1-AS1 | LOC100506054 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288993 | HSALNG0088026 | GSEC | ST3GAL4-AS1,DCPS-AS1,FLJ39051 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0060264 | HSALNG0028799 | DNAJB8-AS1 | NA | NA | NA | NA | NA |
HSALNT0248137 | HSALNG0120059 | CHMP1B-AS1 | NA | NA | NA | NA | NA |
HSALNT0021970 | HSALNG0010602 | TGFB2-AS1 | NR_046268 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0078323 | HSALNG0037356 | SLC7A11-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0134663 | HSALNG0064248 | INTS9-AS1 | ENST00000520055 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0231572 | HSALNG0111641 | MMP2-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0267869 | HSALNG0130456 | SLC12A5-AS1 | RP11-465L10.10 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0288921 | HSALNG0002415 | CSMD2-AS1 | ENST00000434181 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0288997 | HSALNG0052934 | HDAC2-AS2 | ENST00000421891 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289012 | HSALNG0105327 | INO80-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289140 | HSALNG0075065 | LINC02247 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289161 | HSALNG0059170 | MAGI2-AS3 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289188 | HSALNG0062699 | MNX1-AS2 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289245 | HSALNG0140277 | SMIM10L2B-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289407 | HSALNG0102543 | TGFB3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289457 | HSALNG0073036 | HSD17B3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289919 | HSALNG0142034 | LINC02246 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289288 | HSALNG0100050 | ZNF710-AS1 | ENST00000558334 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289266 | HSALNG0007188 | TDRKH-AS1 | RP11-98D18.9 | NA | pathogenic process | NA | NA |
HSALNT0289128 | HSALNG0057684 | LINC01952 | AC004854.4 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0290075 | HSALNG0142190 | NCF4-AS1 | CTA-833B7.2 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289360 | HSALNG0029603 | LNCSRLR | lncRNA-SRLR | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288918 | HSALNG0021529 | CFLAR-AS1 | ALS2CR10 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0289710 | HSALNG0141825 | COL1A2-AS1 | TCONS_00013888,lncRNA8975-1 | transcriptional regulation | pathogenic process | hypertrophic scar | Skin and Connective Tissue Diseases |
HSALNT0075075 | HSALNG0035847 | LNCPRESS2 | lncPRESS2 | transcriptional regulation | NA | NA | NA |
HSALNT0011289 | HSALNG0005432 | LINC01930 | EU358092 | NA | pathogenic process | schizophrenia | Mental Disorders |
HSALNT0097120 | HSALNG0046325 | HMMR-AS1 | NA | NA | pathogenic process | basal-like breast cancer | Neoplasms |
HSALNT0184498 | HSALNG0088703 | CCND2-AS1 | CCND2-AS2 | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289045 | HSALNG0030884 | LINC00578 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
HSALNT0288884 | HSALNG0026576 | ADAMTS9-AS1 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0080041 | HSALNG0038152 | FAM198B-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0103007 | HSALNG0048820 | LINC00240 | C6orf41,NCRNA00240,bA373D17.1 | ceRNA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
HSALNT0289071 | HSALNG0122453 | LINC00909 | NA | NA | NA | NA | NA |
HSALNT0289509 | HSALNG0141620 | LINC00680 | NA | NA | NA | NA | NA |
HSALNT0129070 | HSALNG0061394 | LINC00513 | AC016831.7 | NA | NA | NA | NA |
HSALNT0289129 | HSALNG0115960 | LINC02001 | RP11-1094M14.11 | NA | NA | NA | NA |
HSALNT0289215 | HSALNG0092950 | POC1B-AS1 | RP11-734K2.4 | NA | NA | NA | NA |
HSALNT0289241 | HSALNG0060049 | SLC12A9-AS1 | RP11-126L15.4 | NA | NA | NA | NA |
HSALNT0289275 | HSALNG0050617 | TRAM2-AS1 | NA | NA | NA | NA | NA |
HSALNT0002243 | HSALNG0001176 | LINC01772 | ENSG00000226029 | ceRNA | pathogenic process | oesophageal cancer | Neoplasms |
HSALNT0288941 | HSALNG0009693 | ELF3-AS1 | ENST00000415582 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289134 | HSALNG0025450 | LINC02158 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289350 | HSALNG0133329 | LINC01671 | BC041455 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289124 | HSALNG0132343 | LINC01684 | lnc-JAM2-6 | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
HSALNT0289036 | HSALNG0096092 | LINC00365 | NA | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0289111 | HSALNG0043625 | LINC01554 | C5orf27,FLJ38821,FIS | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0289132 | HSALNG0136701 | LINC02154 | GS1-600G8.5 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0137721 | HSALNG0065704 | LINC02155 | RP11-705O24.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0225363 | HSALNG0108398 | LINC02157 | RP11-327J17.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0289133 | HSALNG0090758 | LINC02156 | RP1-90J4.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0133924 | HSALNG0063832 | LINC02153 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
HSALNT0181656 | HSALNG0087394 | LINC02151 | TCONS_00019174 | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
HSALNT0227367 | HSALNG0109385 | LINC02152 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
HSALNT0029246 | HSALNG0013844 | BRE-AS1 | NA | NA | NA | NA | NA |
HSALNT0289251 | HSALNG0056623 | SNHG26 | AC005682.5 | NA | pathogenic process | bladder urothelial cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0252719 | HSALNG0122284 | LIVAR | lnc18q22.2 | NA | pathogenic process | nonalcoholic steatohepatiti | Digestive System Diseases |
HSALNT0289074 | HSALNG0031832 | LINC00969 | ENST00000453324 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289138 | HSALNG0140259 | LINC02243 | ENST00000441841 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289399 | HSALNG0039449 | SLC9A3-AS1 | UC011CLY.2 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0288934 | HSALNG0126602 | DM1-AS | NA | NA | pathogenic process | myotonic dystrophy type 1 | Musculoskeletal Diseases;Nervous System Diseases |
HSALNT0009014 | HSALNG0004475 | LINC02238 | RP4-788P17.1 | NA | pathogenic process | B cell lymphoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289163 | HSALNG0043374 | MEF2C-AS2 | CTC-467M3.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
HSALNT0289181 | HSALNG0003824 | MIR4422HG | RP11-101C11.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
HSALNT0289403 | HSALNG0082800 | SPON1-AS1 | RP11-21,L19.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
HSALNT0289461 | HSALNG0083610 | CD44-AS1 | RP1-68D18.4 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
HSALNT0262277 | HSALNG0127560 | LILRB1-AS1 | AC009892.10 | NA | pathogenic process | NA | NA |
HSALNT0289546 | HSALNG0141661 | AC009892.10 | LILRB1-AS1 | NA | NA | B cell lymphoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0282241 | HSALNG0137635 | LINC01186 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289168 | HSALNG0131657 | MHENCR | NA | ceRNA | pathogenic process | melanoma | Neoplasms |
HSALNT0072994 | HSALNG0034801 | LINC02232 | RP11-707A18.1 | NA | pathogenic process | NA | NA |
HSALNT0080161 | HSALNG0038220 | LINC02233 | RP11-6C14.1 | NA | pathogenic process | NA | NA |
HSALNT0084027 | HSALNG0039930 | LINC02236 | RP11-332J15.1 | NA | pathogenic process | NA | NA |
HSALNT0091870 | HSALNG0043678 | LINC02234 | RP11-455B3.1 | NA | pathogenic process | NA | NA |
HSALNT0139521 | HSALNG0066607 | LINC02235 | RP11-354A14.1 | NA | pathogenic process | NA | NA |
HSALNT0142040 | HSALNG0067779 | LINC02237 | RP11-1101K5.1 | NA | pathogenic process | NA | NA |
HSALNT0289135 | HSALNG0111295 | LINC02179 | RP11-189E14.4 | NA | pathogenic process | NA | NA |
HSALNT0289351 | HSALNG0132340 | LINC01689 | AP000469.2 | NA | pathogenic process | NA | NA |
HSALNT0289137 | HSALNG0091963 | LINC02231 | RP11-766N7.4 | NA | pathogenic process | Esophageal squamous cell cancer | Neoplasms |
HSALNT0220239 | HSALNG0105903 | MIR4713HG | RP11-108K3.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288967 | HSALNG0037858 | FAM160A1-DT | RP11-610P16.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289239 | HSALNG0021423 | SATB2-AS1 | NA | translational control | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289512 | HSALNG0141623 | LINC01826 | lnc-MKI67IP-3 | ceRNA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
HSALNT0289024 | HSALNG0104253 | LINC00226 | C14orf97,NCRNA00226 | NA | pathogenic process | pancreatic ductaladenocarcinoma | Neoplasms |
HSALNT0082192 | HSALNG0039173 | F11-AS1 | NA | NA | NA | NA | NA |
HSALNT0219108 | HSALNG0105295 | SPINT1-AS1 | RP11-532F12.5 | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289177 | HSALNG0088950 | MIR200CHG | U47924.27 | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289328 | HSALNG0031153 | LINC00888 | NA | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289309 | HSALNG0116205 | LINC00672 | NA | transcriptional regulation | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289198 | HSALNG0085691 | P4HA3-AS1 | NA | NA | pathogenic process | parkinson's disease | Nervous System Diseases |
HSALNT0197312 | HSALNG0095075 | TMEM132D-AS1 | LOC283352 | NA | pathogenic process | human dermal fibroblasts | Cell Physiological Phenomena |
HSALNT0289472 | HSALNG0113128 | ATP2C2-AS1 | RP11-517C16.2-001 | NA | NA | NA | NA |
HSALNT0233849 | HSALNG0112863 | WWOX-AS1 | RP11-190D6.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0128829 | HSALNG0061246 | FLNC-AS1 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
HSALNT0289889 | HSALNG0142004 | LIF-AS1 | Lnc-LIF-AS | NA | pathogenic process | cervical squamous cancer | Neoplasms |
HSALNT0011283 | HSALNG0005428 | DPYD-AS2 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
HSALNT0289836 | HSALNG0141951 | FLICR | NA | transcriptional regulation | pathogenic process | autoimmune diabete | Immune System Diseases |
HSALNT0289356 | HSALNG0090563 | LINC02402 | ENST00000550337.1 | NA | pathogenic process | diabetes | Endocrine System Diseases |
HSALNT0137118 | HSALNG0065453 | CERNA3 | CTA | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0090838 | HSALNG0043312 | LINC02488 | CTD-2316B1 | NA | pathogenic process | NA | NA |
HSALNT0174947 | HSALNG0083979 | LINC02489 | CTD-2589M5 | NA | pathogenic process | NA | NA |
HSALNT0220441 | HSALNG0105991 | LINC02490 | RP11-209E8 | NA | pathogenic process | NA | NA |
HSALNT0289260 | HSALNG0045650 | STK32A-AS1 | CTC-255N20 | NA | pathogenic process | NA | NA |
HSALNT0289143 | HSALNG0055190 | LINC02487 | NA | NA | pathogenic process | squamous cell cancer | Neoplasms |
HSALNT0095585 | HSALNG0045503 | SPRY4-AS1 | THCAT68 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0288927 | HSALNG0090908 | DDN-AS1 | CAT1507 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0012862 | HSALNG0006150 | SLC16A1-AS1 | NA | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
HSALNT0289412 | HSALNG0000276 | TNFRSF14-AS1 | ENST00000416860.2 | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
HSALNT0259139 | HSALNG0125745 | LINC00665 | NA | NA | NA | NA | NA |
HSALNT0040268 | HSALNG0019085 | DARS-AS1 | NA | NA | pathogenic process | renal disease | NA |
HSALNT0288913 | HSALNG0125425 | CEBPA-AS1 | CEBPA-DT | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289011 | HSALNG0057479 | INHBA-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0288988 | HSALNG0067472 | GASAL1 | GASL1 | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289127 | HSALNG0021881 | LINC01857 | AC079767.4 | NA | pathogenic process | tuberculosis | Bacterial Infections and Mycoses |
HSALNT0289091 | HSALNG0004949 | LINC01140 | FLJ41676 | NA | NA | NA | NA |
HSALNT0281957 | HSALNG0137521 | PINCR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289344 | HSALNG0139543 | LINC00890 | NA | NA | pathogenic process | leiomyoma | Neoplasms |
HSALNT0019828 | HSALNG0009573 | LINC00862 | C1orf98,SMIM16 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0073790 | HSALNG0035237 | LINC02562 | RP11-44F21.5 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0263101 | HSALNG0127961 | LINC02560 | CTD-2619J13.13 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0289144 | HSALNG0088252 | LINC02551 | RP11-890B15.2 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0289458 | HSALNG0078773 | DDIT4-AS1 | RP11-442H21.2 | NA | pathogenic process | cystic Fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0288992 | HSALNG0089423 | GPRC5D-AS1 | RP11-392P7.6 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289386 | HSALNG0015768 | PCBP1-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0289405 | HSALNG0044141 | STARD4-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0201547 | HSALNG0097004 | LINC00462 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0207103 | HSALNG0099453 | SOX1-OT | LINC00403 | NA | pathogenic process | NA | NA |
HSALNT0002131 | HSALNG0001107 | SLC25A34-AS1 | RP11-169K16.4 | NA | NA | NA | NA |
HSALNT0289218 | HSALNG0075163 | PPP1R26-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289047 | HSALNG0064310 | LINC00589 | C8orf75,TSLNC8 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289516 | HSALNG0141627 | TPM1-AS | TPM1-AS1 | splicing regulation | pathogenic process | esophageal cancer | Neoplasms |
HSALNT0289314 | HSALNG0141631 | LINC01101 | FLJ14816 | NA | pathogenic process | HPV-induced cervical neoplasia | Neoplasms |
HSALNT0289147 | HSALNG0018748 | LINC02572 | AC079776.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0096804 | HSALNG0046188 | LINC02202 | NA | NA | NA | NA | NA |
HSALNT0289076 | HSALNG0027511 | LINC00973 | CTD-2021J15.2 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288625 | HSALNG0141401 | TTTY10 | NCRNA00133 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289323 | HSALNG0133418 | LINC00319 | C21orf125,NCRNA00319,PRED49,FLJ38036 | ceRNA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0015533 | HSALNG0007394 | IL6R-AS1 | RP11-350G8.5 | NA | NA | NA | NA |
HSALNT0090330 | HSALNG0043020 | CKMT2-AS1 | NA | NA | NA | NA | NA |
HSALNT0012995 | HSALNG0006203 | HIPK1-AS1 | NA | NA | NA | NA | NA |
HSALNT0289216 | HSALNG0050214 | POLH-AS1 | RP3-337H4.8 | NA | NA | NA | NA |
HSALNT0289276 | HSALNG0053237 | TRDN-AS1 | HRAT13 | NA | NA | NA | NA |
HSALNT0289159 | HSALNG0069213 | LY6E-DT | LOC100133669 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289434 | HSALNG0040409 | BASP1-AS1 | LOC285696 | NA | pathogenic process | NA | NA |
HSALNT0288991 | HSALNG0069691 | GLIS3-AS1 | C9orf70,MGC16153 | NA | NA | NA | NA |
HSALNT0288896 | HSALNG0070213 | BNC2-AS1 | RP11-62F24.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289292 | HSALNG0078947 | ZNF503-AS1 | NA | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
HSALNT0159506 | HSALNG0076434 | VIM-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0288882 | HSALNG0011058 | ACBD3-AS1 | RP11-275I14.4 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289156 | HSALNG0005074 | LRRC8C-DT | FLJ27354 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289447 | HSALNG0058889 | ELN-AS1 | CTB-51J22.1 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0076712 | HSALNG0036645 | LINC02264 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0093666 | HSALNG0044495 | LINC02201 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0271685 | HSALNG0132198 | LINC02573 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289125 | HSALNG0015785 | LINC01816 | LOC100133985 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289355 | HSALNG0091335 | LINC02381 | LOC400043 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289366 | HSALNG0029874 | MBNL1-AS1 | LOC401093 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289513 | HSALNG0141624 | MIR4697HG | LINC00947,LOC283174 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289073 | HSALNG0065480 | LINC00968 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0114453 | HSALNG0053963 | NMBR-AS1 | RP11-137J7.2 | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289300 | HSALNG0077499 | LINC01518 | NA | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0003783 | HSALNG0002009 | LINC02574 | RP11-288L9.1 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0032721 | HSALNG0015486 | LINC02579 | AC007365.1 | NA | pathogenic process | NA | NA |
HSALNT0030828 | HSALNG0014519 | LINC02580 | AC093609.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0032808 | HSALNG0015519 | LINC02576 | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0127022 | HSALNG0060386 | LINC02577 | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0154722 | HSALNG0074062 | LINC02578 | RP11-127L21.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288962 | HSALNG0084388 | FAM111A-DT | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289148 | HSALNG0133545 | LINC02575 | AP001065.15 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0025249 | HSALNG0012143 | KIF26B-AS1 | RP11-62I21.1 | NA | NA | NA | NA |
HSALNT0177212 | HSALNG0085146 | RPS6KB2-AS1 | AP003419.16 | NA | pathogenic process | agingâassociated idiopathic pulmonary fibrosis | Physiological Phenomena |
HSALNT0289072 | HSALNG0090150 | LINC00941 | lncRNA-MUF | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289338 | HSALNG0075045 | LINC00094 | FLJ35348,bA374P20.3 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0114192 | HSALNG0053894 | FILNC1 | NA | translational control | pathogenic process | renal tumor | Neoplasms |
HSALNT0289199 | HSALNG0128600 | PARAL1 | NA | ceRNA | pathogenic process | obesity | Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
HSALNT0244832 | HSALNG0118528 | SOX9-AS1 | FLJ37644 | transcriptional regulation | NA | NA | NA |
HSALNT0289236 | HSALNG0118528 | ROCR | LINC02095 | transcriptional regulation | NA | NA | NA |
HSALNT0056667 | HSALNG0027060 | LINC02027 | LOC728290 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289424 | HSALNG0141124 | TTTY22 | NCRNA00147 | NA | NA | NA | NA |
HSALNT0289069 | HSALNG0030090 | LINC00880 | NA | NA | NA | NA | NA |
HSALNT0252974 | HSALNG0122396 | LINC02582 | CTD-2354A18.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289035 | HSALNG0097712 | LINC00364 | LncRNA00364 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0060981 | HSALNG0029189 | NCK1-DT | NCK1-AS1,SLC35G2-AS1 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0288890 | HSALNG0067505 | BAALC-AS1 | lncFZD6,FZD6-DT | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0046602 | HSALNG0021972 | CPS1-IT1 | CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | NA | pathogenic process | hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289445 | HSALNG0059740 | DLX6-AS1 | DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | transcriptional regulation | pathogenic process | split hand/split foot malformation disorder;lung adenocarcinoma | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms |
HSALNT0289891 | HSALNG0142006 | LINC00114 | NA | NA | NA | NA | NA |
HSALNT0289415 | HSALNG0138601 | TSIX | LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | transcriptional regulation | pathogenic process | systemic sclerosis | Skin and Connective Tissue Diseases |
HSALNT0217334 | HSALNG0104503 | MKRN3-AS1 | ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290256 | HSALNG0142371 | SRA | lnc-SRA1-1:1,SRA1,ENSG00000213523 | transcriptional regulation | pathogenic process | nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289442 | HSALNG0049271 | HCP5 | 6S2650E,D6S2650E,P5-1 | NA | pathogenic process | AIDS | Immune System Diseases;Virus Diseases |
HSALNT0289284 | HSALNG0083476 | WT1-AS | WIT1,WIT-1,WT1A, WT1-AS1 | transcriptional regulation | pathogenic process | gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0289421 | HSALNG0082235 | KCNQ1OT1 | KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases |
HSALNT0263784 | HSALNG0128372 | PCNA-AS1 | PCNAA, PCNA-AS | transcriptional regulation | pathogenic process | gastric cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289524 | HSALNG0049107 | HCG9 | PERB11,HCGIX,HCGIX4,HCGIX-4 | NA | NA | NA | NA |
HSALNT0289264 | HSALNG0103448 | TCL6 | TCL6e1,TNG2,TNG1 | NA | pathogenic process;developmental process | renal cell cancer;leukemia | Male Urogenital Diseases;Neoplasms |
HSALNT0289203 | HSALNG0072040 | PCA3 | DD3,NCRNA00019,PCAT3 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289462 | HSALNG0082178 | H19 | ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | transcriptional regulation;ceRNA | developmental process;pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
HSALNT0288932 | HSALNG0097105 | DLEU1 | BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | transcriptional regulation;ceRNA | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
HSALNT0289493 | HSALNG0141604 | DBH-AS1 | NCRNA00118,BPR | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0088415 | HSALNG0042101 | PART1 | DKFZP586D0823,NCRNA00206 | NA | pathogenic process | prostate cancer;glioblastoma | Male Urogenital Diseases;Neoplasms |
HSALNT0289463 | HSALNG0082197 | IGF2-AS | IGF2A,PEG8,IGF2-AS1 | transcriptional regulation | pathogenic process | liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0269786 | HSALNG0131285 | GNAS-AS1 | GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | transcriptional regulation | pathogenic process | non-small cell lung cancer;pseudohypoparathyroidism type Ib | Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms |
HSALNT0289252 | HSALNG0051709 | SNHG5 | C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | NA | pathogenic process | gastric cancer;lymphoma;melanoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0023827 | HSALNG0011462 | DISC2 | DISC1-AS1,DISC1O, NCRNA00015 | transcriptional regulation | pathogenic process | bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms |
HSALNT0203415 | HSALNG0097806 | ATXN8OS | SCA8,KLHL1A,NCRNA00003 | transcriptional regulation | pathogenic process | spinocerebellar ataxia;spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0290312 | HSALNG0142427 | TRAF3IP2-AS1 | C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | transcriptional regulation | pathogenic process | schizophrenia;cocaine abuse | Chemically-Induced Disorders;Mental Disorders |
HSALNT0289008 | HSALNG0054049 | HYMAI | NCRNA00020 | NA | pathogenic process | transient neonatal diabetes | Nutritional and Metabolic Diseases |
HSALNT0288968 | HSALNG0071146 | FAM201A | C9orf122 | NA | pathogenic process | leukemia | Neoplasms |
HSALNT0288969 | HSALNG0093910 | FAM222A-AS1 | NA | NA | pathogenic process | NA | NA |
HSALNT0289484 | HSALNG0138575 | FAM226A | CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | NA | pathogenic process | NA | NA |
HSALNT0289497 | HSALNG0141608 | FAM215A | C17orf88,APR-2,LINC00530 | NA | pathogenic process | ovarian cancer;leukemia | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289230 | HSALNG0025991 | RBM5-AS1 | LUST | transcriptional regulation | pathogenic process | tumor | Neoplasms |
HSALNT0002923 | HSALNG0001554 | LINC00339 | NCRNA00339,HSPC157 | NA | pathogenic process;developmental process | Pancreatic ductal adenocarcinoma | Neoplasms |
HSALNT0144027 | HSALNG0068615 | ASAP1-IT1 | ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289212 | HSALNG0021208 | PCGEM1 | NCRNA00071,LINC00071,PCAT9 | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;prostate cancer;glioma | Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0289016 | HSALNG0082243 | KCNQ1DN | BWRT,HSA404617 | NA | pathogenic process | aging;Wilms' tumor | Physiological Phenomena;Neoplasms |
HSALNT0288933 | HSALNG0097101 | DLEU2 | DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | transcriptional regulation | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
HSALNT0217624 | HSALNG0104558 | PWAR4 | PAR4,PAR-4 | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289165 | HSALNG0103778 | MEG8 | SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome;temple syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289482 | HSALNG0133856 | CECR7 | SAHL1 | NA | pathogenic process | hepatocellular cancer;cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
HSALNT0074223 | HSALNG0035451 | PCAT4 | GDEP,PCAN1,PCA4 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0061175 | HSALNG0029318 | PISRT1 | NCRNA00195 | transcriptional regulation | developmental process;pathogenic process | blepharophimosis syndrome | Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0190912 | HSALNG0092137 | IFNG-AS1 | Tmevpg1,LincR-Ifng-3'A, NEST | transcriptional regulation | pathogenic process | Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases |
HSALNT0038178 | HSALNG0018067 | FAM138B | F379 | NA | NA | NA | NA |
HSALNT0145703 | HSALNG0069515 | FAM138C | F379 | NA | NA | NA | NA |
HSALNT0288963 | HSALNG0000006 | FAM138A | F379 | NA | NA | NA | NA |
HSALNT0183947 | HSALNG0088434 | FAM138D | F379 | NA | NA | NA | NA |
HSALNT0226092 | HSALNG0108677 | FAM138E | F379 | NA | NA | NA | NA |
HSALNT0253925 | HSALNG0122829 | FAM138F | F379 | NA | NA | NA | NA |
HSALNT0289326 | HSALNG0141632 | LINC00312 | LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | transcriptional regulation | pathogenic process | nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
HSALNT0288886 | HSALNG0054798 | AIRN | AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | transcriptional regulation | pathogenic process | NA | NA |
HSALNT0254857 | HSALNG0123415 | MIR7-3HG | C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | NA | pathogenic process | liver cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0185751 | HSALNG0089375 | LOH12CR2 | LOH2CR12 | NA | pathogenic process | pre-B acute lymphoblastic leukaemia | Hemic and Lymphatic Diseases |
HSALNT0289479 | HSALNG0133055 | DSCR8 | C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | NA | pathogenic process | Down syndrome;melanoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
HSALNT0289030 | HSALNG0133422 | LINC00313 | C21orf84,NCRNA00313, | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289029 | HSALNG0132830 | LINC00310 | C21orf82,NCRNA00310 | NA | pathogenic process | NA | NA |
HSALNT0272435 | HSALNG0132500 | LINC00161 | C21orf100,NCRNA00161 | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289184 | HSALNG0132027 | MIR99AHG | C21orf35,FLJ38295,C21orf34,LINC00478,MONC | NA | pathogenic process | myeloid leukemia | Hemic and Lymphatic Diseases |
HSALNT0289005 | HSALNG0056865 | HOXA11-AS | HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | ceRNA | pathogenic process | uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0193654 | HSALNG0093342 | RMST | NCRM, NCRNA00054,LINC00054 | transcriptional regulation | developmental process;pathogenic process | breast cancer;rhabdomyosarcoma | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290079 | HSALNG0142194 | ncR-PAR | NCRUPAR,ENSG00000225407 | transcriptional regulation | developmental process;pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289167 | HSALNG0061370 | MESTIT1 | MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | NA | pathogenic process | Silver-Russell syndrome | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
HSALNT0273791 | HSALNG0133168 | DSCAM-AS1 | M41 | NA | pathogenic process | adolescent idiopathic scoliosis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289391 | HSALNG0104546 | PWARSN | PAR-SN,PARSN | NA | pathogenic process | NA | NA |
HSALNT0127791 | HSALNG0060774 | ST7-AS1 | ST7OT1,ST7AS1 | NA | pathogenic process | glioma;autism | Mental Disorders;Neoplasms |
HSALNT0206298 | HSALNG0099122 | DAOA-AS1 | DAOAA, DAOA-A,G30 | NA | pathogenic process | panic disorder;schizophrenia;bipolar disorder | Mental Disorders |
HSALNT0167060 | HSALNG0080104 | OLMALINC | C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
HSALNT0026878 | HSALNG0012802 | LINC00299 | C2orf46,NCRNA00299,FLJ45673 | NA | pathogenic process;developmental process | intellectual and developmental disability;neurodevelopmental disabilities | Mental Disorders;Nervous System Diseases |
HSALNT0289081 | HSALNG0039816 | LINC01020 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0101186 | HSALNG0048016 | LINC00518 | C6orf218,MGC40222 | NA | pathogenic process | NA | NA |
HSALNT0083960 | HSALNG0039909 | LINC01018 | SRHC | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289361 | HSALNG0031463 | LPP-AS2 | MYCLo-5,MYCLo-6 | NA | NA | NA | NA |
HSALNT0143233 | HSALNG0068292 | LINC00964 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289364 | HSALNG0094063 | MAPKAPK5-AS1 | C12orf47,FLJ39616 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289053 | HSALNG0027872 | LINC00635 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289327 | HSALNG0141633 | LINC00636 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0262657 | HSALNG0127758 | ZNF582-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289020 | HSALNG0000022 | LINC00115 | NCRNA00115,FLJ22639 | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289254 | HSALNG0075291 | SNHG7 | MGC16037,NCRNA00061 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289162 | HSALNG0020412 | MAP3K20-AS1 | MLK7-AS1 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0145357 | HSALNG0069280 | RHPN1-AS1 | C8orf51,MGC3113 | NA | NA | NA | NA |
HSALNT0289343 | HSALNG0138602 | XIST | DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | transcriptional regulation;ceRNA | pathogenic process | non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289389 | HSALNG0128330 | PRNT | M8 | NA | pathogenic process | NA | NA |
HSALNT0288942 | HSALNG0080912 | EMX2OS | NCRNA00045,EMX2-AS1 | transcriptional regulation | pathogenic process | NA | NA |
HSALNT0200443 | HSALNG0096546 | LINC00598 | TTL | NA | pathogenic process | NA | NA |
HSALNT0289517 | HSALNG0141628 | TTTY17A | NCRNA00140 | NA | NA | NA | NA |
HSALNT0027901 | HSALNG0013206 | MYCNOS | NCYM,N-CYM,MYCN-AS1 | transcriptional regulation | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0047175 | HSALNG0022192 | DIRC3 | FLJ14199 | NA | pathogenic process | familial renal cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289363 | HSALNG0084905 | MALAT1 | PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA | pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0289744 | HSALNG0141859 | DLG2-AS1 | DLG2A, DLG2-A,PSZA11q14,SZ-1 | NA | pathogenic process | schizophrenia;myotonic dystrophy type 1;heart failure | Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases |
HSALNT0289164 | HSALNG0103778 | MEG3 | FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | translational control;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0290298 | HSALNG0142413 | TERC | DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | NA | pathogenic process | prostate cancer;dyskeratosis congenita;lung squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases |
HSALNT0288907 | HSALNG0080948 | CASC2 | NA | ceRNA | pathogenic process | colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0205332 | HSALNG0098601 | MIR17HG | C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | NA | pathogenic process | diffuse large B-cell lymphoma;syndromic developmental defect;cancer | Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0288716 | HSALNG0141456 | TTTY6 | TTY6,TTTY6A,LINC00127 | NA | NA | NA | NA |
HSALNT0288731 | HSALNG0141468 | TTTY4 | TTY4,TTTY4A,LINC00123 | NA | NA | NA | NA |
HSALNT0288815 | HSALNG0141548 | TTTY3 | TTY3,TTTY3A,LINC00121 | NA | NA | NA | NA |
HSALNT0288703 | HSALNG0141450 | TTTY5 | TTY5,LINC00126 | NA | NA | NA | NA |
HSALNT0289255 | HSALNG0036656 | SNHG8 | NCRNA00060,LINC00060 | NA | pathogenic process | gastric cancer;malignant pleural mesothelioma | Neoplasms;Digestive System Diseases |
HSALNT0289486 | HSALNG0141597 | BCYRN1 | BC200,BC200a,NCRNA00004,LINC00004 | splicing regulation;translational control | pathogenic process | aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases |
HSALNT0144426 | HSALNG0068805 | ZFAT-AS1 | ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | NA | pathogenic process | autoimmune disease | Immune System Diseases |
HSALNT0289285 | HSALNG0077083 | ZEB1-AS1 | NA | NA | pathogenic process | esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | Immune System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289185 | HSALNG0135987 | MIRLET7BHG | linc-Ppara | NA | developmental process | NA | NA |
HSALNT0289374 | HSALNG0116616 | NBR2 | NCRNA00192 | transcriptional regulation | pathogenic process | gastric cancer;breast cancer;cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289417 | HSALNG0134930 | TUG1 | FLJ20618,NCRNA00080,LINC00080 | transcriptional regulation;ceRNA | pathogenic process | osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0288973 | HSALNG0079552 | FAS-AS1 | FASA, FAS-A,SAF | transcriptional regulation | pathogenic process | ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
HSALNT0288996 | HSALNG0068110 | HAS2-AS1 | HAS2A, HAS2-A,HASNT,NCRNA00077 | transcriptional regulation | NA | NA | NA |
HSALNT0289390 | HSALNG0049245 | PSORS1C3 | NCRNA00196 | NA | pathogenic process | rheumatoid arthritis;psoriasis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
HSALNT0289868 | HSALNG0141983 | HLA-AS1 | NA | NA | pathogenic process | psoriasis;liver injury;multiple sclerosis;AIDS | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0290154 | HSALNG0142269 | PRINS | NCRNA00074 | transcriptional regulation | pathogenic process | psoriasis;prostate cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0262809 | HSALNG0127790 | PEG3-AS1 | PEG3AS,PEG3-AS,APEG3,NCRNA00155 | NA | NA | NA | NA |
HSALNT0289533 | HSALNG0141648 | 7SL | 7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | protein localization | pathogenic process | AIDS;Leishmaniasis;dermatomyositis;polymyositis | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases |
HSALNT0290081 | HSALNG0142196 | NDM29 | 29A,lnc-C11orf16-1:1 | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0289382 | HSALNG0074439 | NRON | NCRNA00194 | NA | pathogenic process | AIDS;Down syndrome;HIV | Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases |
HSALNT0289253 | HSALNG0065926 | SNHG6 | U87HG,HBII-276HG,NCRNA00058 | translational control;ceRNA | pathogenic process | hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289653 | HSALNG0141768 | Beta-globin transcript | AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 | NA | NA | NA | NA |
HSALNT0290398 | HSALNG0142513 | Zfhx2as | Zfh-5AS,ENSG00000157306,ENST00000554403.1 | NA | NA | NA | NA |
HSALNT0011306 | HSALNG0005433 | MIR137HG | NA | NA | pathogenic process | schizophrenia;lung cancer;malignant lymphoma | Respiratory Tract Diseases;Mental Disorders;Neoplasms |
HSALNT0289449 | HSALNG0056858 | HOXA-AS3 | HOXA6as | NA | pathogenic process | glioma | Neoplasms |
HSALNT0289451 | HSALNG0068551 | CCDC26 | MGC27434,RAM | transcriptional regulation | pathogenic process | hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289893 | HSALNG0142008 | LINC00271 | C6orf217,NCRNA00271 | NA | pathogenic process | type 2 diabetes;schizophrenia | Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases |
HSALNT0288892 | HSALNG0109621 | BCAR4 | NA | transcriptional regulation | pathogenic process | osteosarcoma;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289890 | HSALNG0142005 | LINC00032 | C9orf14,NCRNA00032 | NA | pathogenic process | narcolepsy;melanoma | Mental Disorders;Neoplasms;Nervous System Diseases |
HSALNT0274572 | HSALNG0133591 | PICSAR | C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | transcriptional regulation | pathogenic process | testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases |
HSALNT0256354 | HSALNG0124398 | UCA1 | CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | transcriptional regulation;ceRNA | developmental process;pathogenic process | oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0003871 | HSALNG0002066 | SNHG3 | NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB | NA | pathogenic process | ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease | Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0289475 | HSALNG0131591 | HAR1A | HAR1F,NCRNA00064,LINC00064 | transcriptional regulation | pathogenic process | Huntington disease;Alzheimer's disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases |
HSALNT0288995 | HSALNG0131589 | HAR1B | HAR1R,NCRNA00065,LINC00065 | transcriptional regulation | pathogenic process | Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
HSALNT0288958 | HSALNG0044150 | EPB41L4A-AS1 | C5orf26,NCRNA00219,TIGA1 | NA | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289170 | HSALNG0134655 | MIAT | C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | splicing regulation;ceRNA | pathogenic process | prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
HSALNT0289007 | HSALNG0047947 | HULC | NCRNA00078,LINC00078,HCCAT1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0288940 | HSALNG0023880 | EGOT | EGO,NCRNA00190 | NA | pathogenic process;developmental process | prostate cancer;breast cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0289387 | HSALNG0001461 | PINK1-AS | PINK1-AS1,FLJ00387,PINK1A, naPINK1 | transcriptional regulation | pathogenic process | glucose metabolism disorder;Parkinson's disease;diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases |
HSALNT0289225 | HSALNG0068477 | PVT1 | NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | transcriptional regulation;translational control | pathogenic process | murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289189 | HSALNG0073233 | NAMA | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0246525 | HSALNG0119442 | NARF-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0147433 | HSALNG0070397 | CDKN2B-AS1 | CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | siRNA;transcriptional regulation;ceRNA | pathogenic process | glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0050854 | HSALNG0024099 | GHRLOS | NCRNA00068,GHRL-AS1 | transcriptional regulation | NA | NA | NA |
HSALNT0288959 | HSALNG0026279 | ESRG | HESRG | NA | pathogenic process | embryonal cancer | Neoplasms |
HSALNT0287173 | HSALNG0140560 | FMR1-AS1 | FMR1A, FMR1-A,ASFMR1,FMR4 | transcriptional regulation | pathogenic process | fragile X syndrome;neurological disorder | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289499 | HSALNG0141610 | HCG4 | HCGIV-10,HCGIV.9 | NA | pathogenic process | NA | NA |
HSALNT0288994 | HSALNG0038609 | HAND2-AS1 | DEIN,NBLA00301,FLJ11539 | NA | pathogenic process | neuroblastoma | Neoplasms |
HSALNT0289286 | HSALNG0019362 | ZEB2-AS1 | ZEB2A, ZEB2-A,ZEB2NAT | splicing regulation | pathogenic process | bladder cancer;hepatocellular cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0017702 | HSALNG0008545 | GAS5 | SNHG2,NCRNA00030 | transcriptional regulation;ceRNA | pathogenic process | varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0288891 | HSALNG0087449 | BACE1-AS | BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | translational control;transcriptional regulation | pathogenic process | ovarian cancer;colorectal cancer;Alzheimer's disease | Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289414 | HSALNG0133533 | TRPM2-AS | TRPM2-AS1 | NA | pathogenic process | melanoma;prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288935 | HSALNG0008462 | DNM3OS | DNM3-AS1,MIR199A2HG | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0288930 | HSALNG0133982 | DGCR5 | NCRNA00037,LINC00037 | transcriptional regulation | pathogenic process | Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
HSALNT0288893 | HSALNG0083307 | BDNF-AS | BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | siRNA;transcriptional regulation | developmental process;pathogenic process | Huntington disease;schizophrenia;psychiatric disease;obesity | Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases |
HSALNT0120317 | HSALNG0056850 | HOTAIRM1 | HOXA-AS1,NCRNA00179,HOXA1-AS1 | transcriptional regulation | pathogenic process;developmental process | colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0290158 | HSALNG0142273 | PTCSC1 | PTCSC,AK023948,NCRNA00197 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289004 | HSALNG0091318 | HOTAIR | HOXC-AS4,HOXC11-AS1,NCRNA00072 | siRNA;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0289192 | HSALNG0084892 | NEAT1 | NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0095094 | HSALNG0045213 | SNHG4 | U19H,NCRNA00059 | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
HSALNT0245443 | HSALNG0118855 | SNHG16 | ncRAN,Nbla12061,Nbla10727 | NA | pathogenic process | bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0288897 | HSALNG0023698 | BOK-AS1 | BOKA,NCRNA00151,NAToB | NA | pathogenic process | esophageal squamous cell cancer;testicular cancer;cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289532 | HSALNG0141647 | 7SK | 7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | transcriptional regulation | developmental process;pathogenic process | cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases |
HSALNT0289182 | HSALNG0017872 | MIR4435-2HG | MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289200 | HSALNG0016500 | PARTICL | PARTICLE | transcriptional regulation | pathogenic process | low-dose irradiation | Disorders of Environmental Origin |
HSALNT0289172 | HSALNG0069266 | MINCR | LINC01604,TCONS_00015189 | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;Burkitt lymphoma | Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases |
HSALNT0001792 | HSALNG0000905 | NPPA-AS1 | NPPAA, NPPA-AS | splicing regulation | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
HSALNT0290230 | HSALNG0142345 | RRP1B | NA | transcriptional regulation | pathogenic process | spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
HSALNT0289467 | HSALNG0093062 | CLLU1 | NA | NA | NA | NA | NA |
HSALNT0289173 | HSALNG0087764 | MIR100HG | AGD1,lncRNA-N2,linc-NeD125 | NA | developmental process;pathogenic process | myeloid leukemia;myopia;cervical cancer;neuroblastoma | Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0059175 | HSALNG0028235 | TUSC7 | LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | transcriptional regulation;ceRNA | pathogenic process | glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289647 | HSALNG0141762 | BC040587 | NA | NA | pathogenic process | osteosarcoma;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0059186 | HSALNG0028242 | LINC00901 | LSAMP-AS4,TCONS_00005428,BC040587 | NA | pathogenic process | osteosarcoma;gastric cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0233366 | HSALNG0112604 | HCCAT5 | HTA,FJ222407 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290040 | HSALNG0142155 | LSINCT5 | NA | NA | pathogenic process | chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0179611 | HSALNG0086377 | DISC1FP1 | Boymaw | transcriptional regulation | pathogenic process | schizophrenia | Mental Disorders |
HSALNT0217643 | HSALNG0104567 | SNHG14 | 115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | ceRNA | pathogenic process | Angelman syndrome;cerebral infarction;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
HSALNT0289273 | HSALNG0000343 | TP73-AS1 | KIAA0495,PDAM | NA | pathogenic process | esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
HSALNT0290311 | HSALNG0142426 | TP53COR1 | Trp53cor1 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0289221 | HSALNG0068414 | PRNCR1 | CARLo-3,PCAT8 | transcriptional regulation | pathogenic process | gastric cancer;prostate cancer;glioma;colorectal cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
HSALNT0020131 | HSALNG0009743 | PCAT6 | KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | transcriptional regulation | pathogenic process | prostate cancer;triple-negative breast cancer;lung cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0289277 | HSALNG0130723 | TRERNA1 | LINC00651,ncRNA-a7,treRNA | transcriptional regulation | NA | NA | NA |
HSALNT0014972 | HSALNG0007045 | FALEC | LINC00568,ncRNA-a1,FAL1 | transcriptional regulation | pathogenic process | ovarian cancer;thyroid cancer | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms |
HSALNT0290008 | HSALNG0142123 | LOC100887755 | Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0290248 | HSALNG0142363 | snaR | EU035784.1,lnc-BSPH1-1:1 | transcriptional regulation | NA | NA | NA |
HSALNT0289342 | HSALNG0138609 | JPX | NCRNA00183,ENOX,LINC00183,DCBALD06 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289231 | HSALNG0001716 | RCAN3AS | TCONS_00001428 | NA | NA | NA | NA |
HSALNT0289280 | HSALNG0069631 | VLDLR-AS1 | lincRNA-VLDLR | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0288982 | HSALNG0138614 | FTX | NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | transcriptional regulation | pathogenic process | hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0091079 | HSALNG0043383 | MEF2C-AS1 | NA | NA | pathogenic process | gastric cancer;Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases |
HSALNT0189341 | HSALNG0091277 | PCBP2-OT1 | TUC338 | NA | pathogenic process | hepatocellular cancer;tongue squamous cell cancer | Neoplasms;Digestive System Diseases |
HSALNT0290373 | HSALNG0142488 | WRAP53 | NA | NA | pathogenic process | hepatocellular cancer;cancer;dyskeratosis congenita | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
HSALNT0289265 | HSALNG0049949 | TDRG1 | LINC00532,lincRNA-NRNA024015 | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0289175 | HSALNG0132382 | MIR155HG | MIRHG2,BIC,NCRNA00172 | NA | pathogenic process | B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289051 | HSALNG0024293 | LINC00620 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0120390 | HSALNG0056871 | HOTTIP | NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | transcriptional regulation | pathogenic process | hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289287 | HSALNG0130661 | ZFAS1 | C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289259 | HSALNG0045502 | SPRY4-IT1 | SPRIGHTLY | transcriptional regulation | pathogenic process | prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0105595 | HSALNG0049759 | PANDAR | PANDA | transcriptional regulation | pathogenic process | colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0068185 | HSALNG0032415 | HTT-AS | HTT-AS1,HTTAS | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0099036 | HSALNG0047200 | HEIH | LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0222533 | HSALNG0107117 | NPTN-IT1 | lncRNA-LET | NA | pathogenic process | gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases |
HSALNT0289747 | HSALNG0141862 | DQ786243 | NA | transcriptional regulation | pathogenic process | crohn's disease;colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289204 | HSALNG0068414 | PCAT1 | PCAT-1,PCA1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0275894 | HSALNG0134403 | PCAT14 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0211999 | HSALNG0101780 | HIF1A-AS2 | 3'aHIF-1A,aHIF | translational control | pathogenic process | bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0288999 | HSALNG0101776 | HIF1A-AS1 | 5'aHIF-1A,5'aHIF1alpha | NA | pathogenic process | acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications |
HSALNT0289258 | HSALNG0031034 | SOX2-OT | SOX2OT,DKFZp761J1324,NCRNA00043 | transcriptional regulation | pathogenic process | colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases |
HSALNT0289700 | HSALNG0141815 | CDR1-AS | CDR1NAT,ciRS-7,CDR1as | ceRNA | NA | NA | NA |
HSALNT0289149 | HSALNG0050599 | LINCMD1 | MIR133BHG,LINC-MD1 | ceRNA | developmental process;pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
HSALNT0288894 | HSALNG0082362 | BGLT3 | LINC01083,BGL3,lncRNA-BGL3 | ceRNA | pathogenic process | chronic myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289042 | HSALNG0055058 | LINC00473 | C6orf176,bA142J11.1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;renal cell cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0101681 | HSALNG0048223 | LINC01108 | LncRNA-ES1 | NA | developmental process | NA | NA |
HSALNT0289418 | HSALNG0103465 | TUNAR | LINC00617,TUNA,HI-LNC78 | transcriptional regulation | developmental process;pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289197 | HSALNG0105343 | OIP5-AS1 | cyrano,linc-OIP5 | NA | developmental process | NA | NA |
HSALNT0289046 | HSALNG0048515 | LINC00581 | NA | NA | pathogenic process | West Syndrome;West syndrome | Nervous System Diseases |
HSALNT0289656 | HSALNG0141771 | BX118339 | NA | NA | pathogenic process | West syndrome | Nervous System Diseases |
HSALNT0021726 | HSALNG0010465 | LINC00538 | Yiya,PROX1UT | NA | pathogenic process | colorectal cancer;cancer | Neoplasms;Digestive System Diseases |
HSALNT0273249 | HSALNG0132926 | CBR3-AS1 | PlncRNA-1,PlncRNA1 | ceRNA | pathogenic process | esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289179 | HSALNG0070363 | MIR31HG | LOC554202,hsa-lnc-31,LncHIFCAR | ceRNA | pathogenic process | bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0288925 | HSALNG0034419 | DANCR | KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | transcriptional regulation | developmental process;pathogenic process | prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases |
HSALNT0290329 | HSALNG0142444 | uc.388 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289842 | HSALNG0141957 | FR0348383 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289279 | HSALNG0141211 | TTTY15 | DKFZP434I143,NCRNA00138 | NA | pathogenic process | NA | NA |
HSALNT0289718 | HSALNG0141833 | CRNDE | LOC643911,LINC00180,CRNDEP | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289685 | HSALNG0141800 | CCND1 | NA | NA | pathogenic process | tumor;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289935 | HSALNG0142050 | lincRNA-p21 | NA | transcriptional regulation | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290134 | HSALNG0142249 | PCNCR1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289492 | HSALNG0141603 | DBET | DBE-T,DUX4L30 | transcriptional regulation | developmental process;pathogenic process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0289455 | HSALNG0071734 | BANCR | LINC00586 | transcriptional regulation | pathogenic process | osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0209589 | HSALNG0100636 | PTCSC3 | NA | ceRNA | pathogenic process | papillary thyroid cancer;thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0290063 | HSALNG0142178 | MVIH | NA | ceRNA | pathogenic process | hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Digestive System Diseases |
HSALNT0289103 | HSALNG0052921 | LINC01268 | LOC285758 | NA | pathogenic process | NA | NA |
HSALNT0289070 | HSALNG0031716 | LINC00887 | linc-ATP13A4-8,HEIRCC | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0288931 | HSALNG0100075 | DHRS4-AS1 | C14orf167,PRO1488,AS1DHRS4 | transcriptional regulation | NA | NA | NA |
HSALNT0288974 | HSALNG0113304 | FENDRR | FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | transcriptional regulation | developmental process;pathogenic process | osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0106473 | HSALNG0050235 | LINC01512 | LOC100132354,TCONS_00011120,HI-LNC77 | NA | pathogenic process | lung adenocarcinoma;type 2 diabetes | Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms |
HSALNT0289059 | HSALNG0118547 | LINC00673 | HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | transcriptional regulation | pathogenic process | pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289107 | HSALNG0128306 | LINC01433 | LOC728228 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0143571 | HSALNG0068424 | CCAT1 | CARLo-5,onco-lncRNA-40 | ceRNA | pathogenic process | gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289408 | HSALNG0123467 | TINCR | ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | translational control | pathogenic process;developmental process | bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0289152 | HSALNG0060113 | LNCPRESS1 | lncPRESS1 | translational control | NA | NA | NA |
HSALNT0289145 | HSALNG0075843 | LINC02561 | RP11-445P17.8 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0289065 | HSALNG0140616 | LINC00850 | KUCG1 | NA | pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
HSALNT0289431 | HSALNG0032699 | AFAP1-AS1 | AFAP1A, AFAP1-A,MGC10981 | NA | pathogenic process | non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289519 | HSALNG0141630 | XACT | NA | NA | NA | NA | NA |
HSALNT0248684 | HSALNG0120344 | GATA6-AS1 | locus5689,BM742401 | NA | pathogenic process | gastric cancer;chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0289222 | HSALNG0073144 | PTCSC2 | NA | transcriptional regulation | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
HSALNT0289655 | HSALNG0141770 | BTG3-AS1 | ASBEL | translational control | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289224 | HSALNG0070801 | PTENP1 | NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290129 | HSALNG0142244 | PAN | NA | transcriptional regulation | pathogenic process | Kaposi's sarcoma | Neoplasms;Virus Diseases |
HSALNT0289939 | HSALNG0142054 | LINC-ROR | lincRNA-RoR,lincRNA-ST8SIA3,ROR | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0290322 | HSALNG0142437 | UBE3A-ATS | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0091004 | HSALNG0043367 | LINC00461 | EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | NA | pathogenic process;developmental process | retinal and visual function | Eye Diseases |
HSALNT0289491 | HSALNG0141602 | CTBP1-AS | PCAT10 | transcriptional regulation | pathogenic process | chronic hepatitis C;prostate cancer;polycystic ovary syndrome | Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0037401 | HSALNG0017694 | GACAT1 | LINC00876,AC096655.1-002 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0120344 | HSALNG0056854 | HOXA-AS2 | HOXA3as | transcriptional regulation | pathogenic process | promyelocytic leukemia;gastric cancer | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
HSALNT0091313 | HSALNG0043441 | LUCAT1 | SCAL1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289425 | HSALNG0009941 | BLACAT1 | linc-UBC1,LINC00912,onco-lncRNA-30 | transcriptional regulation | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0149012 | HSALNG0071221 | GLIDR | LINC01172,MGC21881,TCONS_00015562 | NA | pathogenic process | glioblastoma | Neoplasms |
HSALNT0217561 | HSALNG0104548 | PWAR5 | PAR5,PAR-5 | NA | pathogenic process | glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
HSALNT0289272 | HSALNG0059377 | TP53TG1 | TP53AP1,H_RG012D21.9,LINC00096 | NA | pathogenic process | non-small cell lung cancer;ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
HSALNT0289598 | HSALNG0141713 | AK126698 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0217598 | HSALNG0104558 | IPW | NCRNA00002 | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
HSALNT0143633 | HSALNG0068443 | CCAT2 | NCCP1,LINC00873 | transcriptional regulation | pathogenic process | non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289026 | HSALNG0129180 | LINC00261 | C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289078 | HSALNG0000303 | LINC00982 | FLJ42875 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0290082 | HSALNG0142197 | NEAT1_2 | NEAT1_2 | protein localization | pathogenic process | amyotrophic lateral sclerosis | Nutritional and Metabolic Diseases;Nervous System Diseases |
HSALNT0288989 | HSALNG0076040 | GATA3-AS1 | NA | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289427 | HSALNG0004297 | GNG12-AS1 | NA | transcriptional regulation | NA | NA | NA |
HSALNT0290395 | HSALNG0142510 | YAM1 | Yam-1 | transcriptional regulation | pathogenic process;developmental process | skeletal myogenesis | Musculoskeletal Diseases |
HSALNT0289202 | HSALNG0018036 | PAX8-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0054469 | HSALNG0026023 | RASSF1-AS1 | ANRASSF1 | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0290261 | HSALNG0142376 | SUMO1P3 | SUMO1P3 | NA | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289002 | HSALNG0094549 | HNF1A-AS1 | C12orf27,NCRNA00262,FLJ38690,HAS1 | ceRNA | pathogenic process | esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases |
HSALNT0289377 | HSALNG0041218 | NIPBL-AS1 | NIPBL-DT,NIPBL-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
HSALNT0289249 | HSALNG0057702 | SNHG15 | C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | NA | pathogenic process | gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
HSALNT0235898 | HSALNG0113835 | MIR22HG | C17orf91,MGC14376,DKFZp686O06159 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0235898 | HSALNG0113835 | MIR22HG | C17orf91,MGC14376,DKFZp686O06159 | NA | NA | NA | NA |
HSALNT0288984 | HSALNG0119881 | GACAT2 | MTCL1-AS1,HMlincRNA717 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289369 | HSALNG0134448 | MIF-AS1 | LOC284889,MIF-AS | transcriptional regulation | pathogenic process | malaria;nephrolithiasis | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases |
HSALNT0129086 | HSALNG0061385 | LINC-PINT | MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | transcriptional regulation | pathogenic process | colorectal cancer;heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289240 | HSALNG0020769 | SCHLAP1 | LINC00913,SChLAP1,PCAT11 | transcriptional regulation | pathogenic process | bladder cancer;prostate cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0193241 | HSALNG0093119 | SOCS2-AS1 | NA | transcriptional regulation | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0138824 | HSALNG0066261 | CASC9 | ESCCAL-1,ESSCAL1,LINC00981 | NA | pathogenic process | esophageal squamous cell cancer;esophageal cancer | Neoplasms |
HSALNT0267627 | HSALNG0130306 | HNF4A-AS1 | uc002xlx | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289194 | HSALNG0131196 | NKILA | NA | NA | pathogenic process | nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289304 | HSALNG0088539 | LINC00942 | NA | NA | pathogenic process | ovarian cancer;autism spectrum disorder | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms |
HSALNT0289187 | HSALNG0062700 | MNX1-AS1 | CCAT5,LOC645249 | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289518 | HSALNG0141629 | VPS9D1-AS1 | MYU | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0290266 | HSALNG0142381 | TC0101441 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
HSALNT0289426 | HSALNG0009856 | ERLNC1 | TC0101441,ElncRNA1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290050 | HSALNG0142165 | Mdgt | NA | NA | NA | NA | NA |
HSALNT0043560 | HSALNG0020594 | HAGLR | HOXD-AS1,Mdgt | NA | pathogenic process | bladder cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289092 | HSALNG0017541 | LINC01158 | PANTR1,linc-Brn1a,linc-POU3F3 | transcriptional regulation | pathogenic process;developmental process | esophageal squamous cell cancer;gastric cancer;glioma | Neoplasms;Digestive System Diseases |
HSALNT0289448 | HSALNG0062110 | GHET1 | lncRNA-GHET1 | NA | pathogenic process | bladder cancer;gastric cancer;colorectal cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289514 | HSALNG0141625 | PEG13 | NA | transcriptional regulation | pathogenic process | intellectual disabilities | Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases |
HSALNT0289183 | HSALNG0140233 | MIR503HG | MGC16121,H19X | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289201 | HSALNG0083445 | PAUPAR | NA | transcriptional regulation | pathogenic process;developmental process | uveal melanoma | Neoplasms |
HSALNT0288956 | HSALNG0094171 | LINC01234 | LCAL84,onco-lncRNA-32 | ceRNA | pathogenic process | oesophageal squamous cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289021 | HSALNG0016642 | CYTOR | C2orf59,NCRNA00152,MGC4677 | transcriptional regulation;ceRNA | pathogenic process | colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289706 | HSALNG0141821 | CHRF | NA | ceRNA | pathogenic process | cardiac hypertrophy;silicosis | Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases |
HSALNT0143635 | HSALNG0068436 | CASC8 | LINC00860,CARLo-1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0143672 | HSALNG0068465 | CASC11 | TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289032 | HSALNG0133191 | LINC00323 | PRED42,FLJ37173 | NA | pathogenic process | breast cancer;hereditary haemorrhagic telangiectasia | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms |
HSALNT0024655 | HSALNG0011845 | LINC01139 | LINK-A,TCONS_00000027 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0289018 | HSALNG0036270 | LEF1-AS1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia;colorectal cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
HSALNT0247326 | HSALNG0119753 | LINC00667 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
HSALNT0290145 | HSALNG0142260 | POU3F3 | NA | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;glioma | Neoplasms |
HSALNT0199349 | HSALNG0096112 | LINC00426 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
HSALNT0155974 | HSALNG0074744 | LINC00963 | MetaLnc9 | NA | pathogenic process | prostate cancer;renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289211 | HSALNG0086124 | PCF11-AS1 | NA | NA | pathogenic process | hepatocellular cancer;adolescent idiopathic scoliosis | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289534 | HSALNG0141649 | 91H | NA | transcriptional regulation | pathogenic process | osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289446 | HSALNG0055679 | ELFN1-AS1 | MYCLo-2 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288883 | HSALNG0079547 | ACTA2-AS1 | uc001kfo.1,ZXF1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289443 | HSALNG0059132 | APTR | RSBN1L-AS1 | transcriptional regulation | pathogenic process | liver fibrosis;glioblastoma | Neoplasms;Digestive System Diseases |
HSALNT0289986 | HSALNG0142101 | lncRNA-MVIH | NA | NA | pathogenic process | hepatocellular cancer;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289977 | HSALNG0142092 | lncRNA-ATB | NA | ceRNA | pathogenic process | colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289622 | HSALNG0141737 | ATB | NA | ceRNA | pathogenic process | prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0289586 | HSALNG0141701 | AK057054 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0278370 | HSALNG0135702 | LINC01315 | lnc-C22orf32-1,C22orf32-1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0055601 | HSALNG0026583 | ADAMTS9-AS2 | NA | NA | pathogenic process | non-small cell lung cancer;glioma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289383 | HSALNG0009103 | PACERR | PACER,PTGS2-AS1 | transcriptional regulation | pathogenic process | osteosarcoma;osteoarthritis;inflammation and cancer | Musculoskeletal Diseases;Neoplasms |
HSALNT0289268 | HSALNG0010604 | TGFB2-OT1 | FLJ11812 | ceRNA | NA | NA | NA |
HSALNT0288938 | HSALNG0027860 | DUBR | LINC00883 | ceRNA | pathogenic process | asthma and chronic obstructive pulmonary disease | Respiratory Tract Diseases |
HSALNT0290147 | HSALNG0142262 | POXCUT | TCONS_00011636 | NA | NA | NA | NA |
HSALNT0289440 | HSALNG0047407 | FOXCUT | LINC01379,TCONS_00011636 | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | Neoplasms |
HSALNT0288924 | HSALNG0059521 | CYP51A1-AS1 | ENST00000453068,LRRD1-AS1 | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289395 | HSALNG0036288 | RPL34-AS1 | FLJ37673,RP11-462C24.1 | NA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289435 | HSALNG0045015 | C5orf66-AS1 | CTC-276P9.1,Epist | NA | pathogenic process | esophageal squamous cell cancer;bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289052 | HSALNG0006924 | LINC00623 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
HSALNT0289831 | HSALNG0141946 | FER1L4 | FER1L4 | ceRNA | pathogenic process | gastric cancer;endometrial cancer;colorectal cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0288985 | HSALNG0013215 | GACAT3 | LINC01458,lncRNA-AC130710 | NA | pathogenic process | ovarian cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0288881 | HSALNG0058863 | ABHD11-AS1 | WBSCR26,LINC00035,NCRNA00035 | NA | pathogenic process | gastric cancer;mutant huntingtin | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
HSALNT0282263 | HSALNG0137651 | ZNF674-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289207 | HSALNG0106864 | PCAT29 | NA | NA | pathogenic process | prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
HSALNT0289672 | HSALNG0141787 | CADM1 | NA | NA | NA | NA | NA |
HSALNT0289297 | HSALNG0007253 | LINC01527 | lnc-SPRR2D-1,RP1-13P20.6 | NA | pathogenic process | squamous cell cancer | Neoplasms |
HSALNT0289158 | HSALNG0108520 | LUNAR1 | NA | transcriptional regulation | pathogenic process | diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | Hemic and Lymphatic Diseases |
HSALNT0289830 | HSALNG0141945 | FAR2P1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289263 | HSALNG0053580 | TARID | EYA4-AS1 | transcriptional regulation | pathogenic process | kidney clear cell sarcoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0145373 | HSALNG0069286 | MAFA-AS1 | RP11-909N17.3,TCONS_00014882 | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290229 | HSALNG0142344 | RPLP0P2 | RPLP0P2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0289291 | HSALNG0133273 | ZNF295-AS1 | C21orf121,NCRNA00318,PRED87 | NA | pathogenic process | lung adenocarcinoma;epithelial ovarian cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0084473 | HSALNG0040150 | LINC01513 | RP11-1C1.7,TCONS_00009352 | NA | pathogenic process | NA | NA |
HSALNT0289471 | HSALNG0108507 | IRAIN | IGF1R-AS | transcriptional regulation | pathogenic process | pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases |
HSALNT0290402 | HSALNG0142517 | ZNRD1-AS1 | NA | NA | pathogenic process | hepatocellular cancer;lung cancer;cervical cancer | Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289504 | HSALNG0141615 | LCAL1 | onco-lncRNA-27 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289169 | HSALNG0100038 | MHRT | Myheart | transcriptional regulation | pathogenic process | heart hypertrophy;acute myocardial infarction | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0289859 | HSALNG0141974 | HA117 | NA | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
HSALNT0026673 | HSALNG0012722 | NRIR | lncRNA-CMPK2 | transcriptional regulation | pathogenic process | chronic hepatitis C;HCV | Digestive System Diseases;Virus Diseases |
HSALNT0289887 | HSALNG0142002 | LET | NA | NA | pathogenic process | gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases |
HSALNT0007921 | HSALNG0004023 | NFIA-AS1 | RP5-833A20.1 | transcriptional regulation | pathogenic process | atherosclerosis;glioma | Cardiovascular Diseases;Neoplasms |
HSALNT0247156 | HSALNG0119710 | GAPLINC | LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | siRNA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288917 | HSALNG0079313 | CERNA2 | HOST2,lncRNA-HOST2 | ceRNA | pathogenic process | hepatocellular cancer;epithelial ovarian cancer | Neoplasms;Digestive System Diseases |
HSALNT0289113 | HSALNG0050689 | LINC01564 | TCONS_00011314 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
HSALNT0289088 | HSALNG0012685 | LINC01105 | FLJ30594,LOC150622 | NA | pathogenic process | gastric cancer;leukemia and neuroblastoma | Neoplasms;Digestive System Diseases |
HSALNT0289464 | HSALNG0091650 | AGAP2-AS1 | LOC100130776,PUNISHER | transcriptional regulation | pathogenic process | non-small cell lung cancer;glioma;leukemia and neuroblastoma | Respiratory Tract Diseases;Neoplasms |
HSALNT0288960 | HSALNG0106834 | EWSAT1 | TMEM84,NCRNA00277,LINC00277,FLJ33768 | transcriptional regulation | pathogenic process | Ewing sarcoma | Neoplasms |
HSALNT0289242 | HSALNG0074573 | SLC25A25-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289317 | HSALNG0130331 | KCNK15-AS1 | RP11-445H22.4 | NA | pathogenic process | osteoarthritis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289864 | HSALNG0141979 | HIF2PUT | NA | NA | pathogenic process | osteosarcoma;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289267 | HSALNG0019370 | TEX41 | DKFZp686O1327,LINC00953 | transcriptional regulation | NA | NA | NA |
HSALNT0290361 | HSALNG0142476 | UFC1 | NA | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;hepatocellular cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289886 | HSALNG0142001 | LEIGC | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289367 | HSALNG0049188 | MDC1-AS1 | MDC1-AS | NA | pathogenic process | bladder cancer;glioma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289190 | HSALNG0048542 | NBAT1 | CASC14,NBAT-1 | transcriptional regulation | pathogenic process | breast cancer;renal clear cell cancer;neuroblastoma | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
HSALNT0234826 | HSALNG0113287 | LINC00917 | NA | NA | pathogenic process | intervertebral disc degeneration;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289419 | HSALNG0094327 | LINC00173 | NCRNA00173,FLJ42957 | NA | pathogenic process | HIV-1-infected;hepatocelluar cancer | Virus Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290138 | HSALNG0142253 | PEG10 | NA | NA | pathogenic process | diffuse large B-cell lymphoma;esophageal cancer | Neoplasms;Hemic and Lymphatic Diseases |
HSALNT0289136 | HSALNG0041549 | LINC02224 | BRCAT107,ENST00000505706 | NA | pathogenic process | active tuberculosis | Bacterial Infections and Mycoses |
HSALNT0289866 | HSALNG0141981 | HIT | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0003927 | HSALNG0002075 | SNHG12 | ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | NA | pathogenic process | osteosarcoma;endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289099 | HSALNG0002236 | LINC01225 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0290047 | HSALNG0142162 | MALAT2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0176345 | HSALNG0084672 | SNHG1 | LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | NA | pathogenic process | astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases |
HSALNT0094592 | HSALNG0044933 | WSPAR | TCONS_00009511-XLOC_004555,lncTCF7 | transcriptional regulation | pathogenic process | hepatocellular cancer;liver cancer | Neoplasms;Digestive System Diseases |
HSALNT0289308 | HSALNG0118552 | LINC00511 | onco-lncRNA-12 | NA | pathogenic process | lung adenocarcinoma;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0289452 | HSALNG0069321 | FAM83H-AS1 | onco-lncRNA-3 | NA | pathogenic process | NA | NA |
HSALNT0289041 | HSALNG0051162 | LINC00472 | C6orf155,dJ288M22.3,FLJ13189 | NA | pathogenic process | ovarian cancer;breast cancer | Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases |
HSALNT0289925 | HSALNG0142040 | linc-ITGB1 | NA | NA | pathogenic process | gallbladder cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0016239 | HSALNG0007801 | LINC01133 | lncRNA-PAGBC | transcriptional regulation | pathogenic process | non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289489 | HSALNG0141600 | CCEPR | CCHE1,lncRNA-CCHE1 | transcriptional regulation | pathogenic process | hepatocellular cancer;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
HSALNT0289402 | HSALNG0098682 | SOX21-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;oral squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0288905 | HSALNG0048533 | CASC15 | LINC00340,lnc-SOX4-1 | NA | pathogenic process | basal cell cancer;melanoma;neuroblastoma | Neoplasms |
HSALNT0289555 | HSALNG0141670 | AC104699.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0096322 | HSALNG0045923 | CLMAT3 | SPARC-AS1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0289233 | HSALNG0043698 | RGMB-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0289908 | HSALNG0142023 | LINC01419 | LVCAT7,TCONS_00014497 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289541 | HSALNG0141656 | AB209630 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
HSALNT0289608 | HSALNG0141723 | AOC4P | AOC4P | NA | pathogenic process | colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
HSALNT0289082 | HSALNG0040781 | PURPL | LINC01021,LOC643401,RP11-46C20.1 | NA | pathogenic process | NA | NA |
HSALNT0196121 | HSALNG0094605 | LINC01089 | LIMT | NA | pathogenic process | breast cancer;astrocytoma | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0123080 | HSALNG0058166 | EGFR-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
HSALNT0289539 | HSALNG0141654 | AB073614 | NA | NA | pathogenic process | ovarian cancer;glioma | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0242418 | HSALNG0117322 | CACNA1G-AS1 | NA | NA | pathogenic process | keloid | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues |
HSALNT0170814 | HSALNG0081992 | MIR210HG | NA | transcriptional regulation | pathogenic process | hypoxic and inflammatory stress | NA |
HSALNT0288979 | HSALNG0113319 | FOXC2-AS1 | ODRUL | NA | pathogenic process | osteosarcoma | Neoplasms |
HSALNT0289022 | HSALNG0132865 | LINC00160 | C21orf52,NCRNA00160 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0105274 | HSALNG0049582 | LINC01016 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288904 | HSALNG0045753 | CARMN | MIR143HG,CARMEN | transcriptional regulation | pathogenic process | cardiac differentiation | Cardiovascular Diseases |
HSALNT0289123 | HSALNG0121579 | LINC01630 | LOC100287225 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0288971 | HSALNG0104253 | FAM30A | C14orf110,KIAA0125,HSPC053 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
HSALNT0289506 | HSALNG0141617 | LINC00346 | C13orf29,NCRNA00346 | NA | pathogenic process | hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289643 | HSALNG0141758 | BC032469 | NA | ceRNA | pathogenic process | esophageal squamous cell cancer;gastric cancer | Neoplasms;Digestive System Diseases |
HSALNT0289580 | HSALNG0141695 | AK024171 | NA | NA | pathogenic process | intervertebral disc degeneration;gastric cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
HSALNT0290187 | HSALNG0142302 | RP11-284N8.3.1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289839 | HSALNG0141954 | FMR6 | NA | NA | pathogenic process | fragile X syndrome;fragile X-associated premature ovarian insufficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases |
HSALNT0290152 | HSALNG0142267 | PRAL | lncRNA-PRAL | NA | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289380 | HSALNG0129818 | NORAD | LINC00657 | transcriptional regulation;translational control | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0086803 | HSALNG0041283 | LIFR-AS1 | NA | NA | pathogenic process | preterm | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0076183 | HSALNG0036373 | PANCR | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
HSALNT0288975 | HSALNG0060982 | FEZF1-AS1 | NA | transcriptional regulation | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0238475 | HSALNG0115230 | CCDC144NL-AS1 | NA | ceRNA | pathogenic process | ovarian cancer;cardiac hypertrophy | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms |
HSALNT0290102 | HSALNG0142217 | NR_026689 | NA | NA | pathogenic process | ovarian cancer;lung cancer | Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0289522 | HSALNG0075559 | ADARB2-AS1 | C10orf109,NCRNA00168,bA466B20.1 | NA | pathogenic process | breast cancer;pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms |
HSALNT0288936 | HSALNG0018139 | DPP10-AS1 | BC032913 | NA | pathogenic process | breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289474 | HSALNG0113682 | GAS8-AS1 | C16orf3 | NA | pathogenic process | papillary thyroid cancer;breast cancer | Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms |
HSALNT0289063 | HSALNG0075802 | MANCR | LINC00704 | NA | pathogenic process | NA | NA |
HSALNT0289238 | HSALNG0026715 | SAMMSON | LINC01212 | NA | pathogenic process | melanoma | Neoplasms |
HSALNT0289027 | HSALNG0007238 | LINC00302 | C1orf46,NCRNA00302,XP33 | NA | developmental process | NA | NA |
HSALNT0245543 | HSALNG0118895 | SNHG20 | C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
HSALNT0015631 | HSALNG0007463 | DCST1-AS1 | RP11-307C12.11 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0149810 | HSALNG0071682 | PGM5-AS1 | FAM233A,LOC572558 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
HSALNT0290236 | HSALNG0142351 | SBF2-AS1 | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
HSALNT0290325 | HSALNG0142440 | uc.338 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
HSALNT0289973 | HSALNG0142088 | LNCRI | lnc-RI | ceRNA | NA | NA | NA |
HSALNT0290002 | HSALNG0142117 | LOC100130476 | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cardia adenocarcinoma | Neoplasms |
HSALNT0289049 | HSALNG0063356 | LINC00599 | Rncr3 | NA | pathogenic process | diabetes | Endocrine System Diseases |
HSALNT0020406 | HSALNG0009871 | LINC00628 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |